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ABSTRACT OF THE DISSERTATION 
Investigating Cyanobacteria Metabolism and Channeling-based Regulations via Isotopic 
Nonstationary Labeling and Metabolomic A nalyses 
 
by 
Mary H. Abernathy  
Doctor of Philosophy in Energy, Environmental & Chemical Engineering 
 
Washington University in St. Louis, 2018 
Yinjie Tang, Chair 
Cyanobacteria have the potential to be low-cost and sustainable cell factories for bio-
products; however, many challenges face cyanobacteria as biorefineries. This dissertation seeks 
to advance non-model photosynthetic organisms for biotechnology applications by 
characterizing central carbon metabolism and its regulations.  Cyanobacteria phenotypes for bio-
production are examined and their intracellular metabolism is quantified. Using isotopic labeling 
experiments, phenotypic relationships between biomass composition, central carbon fluxes, and 
metabolite pool sizes are investigated. Metabolic analyses of cyanobacteria led to new 
investigations of flux regulation mechanisms via protein spatial organizations or metabolite 
channeling. Metabolite channeling is further explored as a hypothesis to explain enigmatic 
labeling patterns and as a method to organize and regulate enzymes for robust central 
metabolisms. The insights reveal strategies for redirecting central metabolic fluxes for value-
added chemicals as well as broad impacts for intracellular modeling approaches.  
First, Synechococcus UTEX 2973 was probed with isotopic nonstationary metabolic flux 
analysis under changing growth conditions. Despite similar genetics to Synechococcus 7942, 
Synechococcus UTEX 2973’s exhibits a fast growth phenotype with greater carbon fixation 
driven by higher energy charges, optimal ATP/NADPH ratios, low glycogen production during 
xiii 
 
exponential growth, and a central metabolism that reduces CO2 loss. Unusual labeling patterns 
indicated metabolite channeling as a possible flux regulation mechanism. As cyanobacteria are 
known to have carboxysomes, a microcompartment that concentrates CO2 for RuBisCO, it was 
hypothesized that carboxysome mutants may reveal channeling mechanisms. Carboxysome-free 
mutants (high CO2 requiring phenotypes) were found to accumulate metabolites and reach higher 
steady state 13C enrichment, indicating more homogenous cytoplasms. Carboxysome-free 
mutants may provide a method for unlocking cyanobacteria flux constraints, reducing catabolic 
repression, and providing a way to contain genetically modified cyanobacteria.  
To ease the constraints of highly regulated and complex metabolic networks, platform or 
non-model strains can be used to provide a good starting point for small molecules of interest. To 
take advantage of cyanobacterial native sugar phosphate metabolisms, Synechococcus was 
engineered for the photoautotrophic production of a high-value polysaccharide, heparosan, which 
is an unsulfated polysaccharide important for cosmetic and pharmaceutical applications. Via 
overexpressing two key enzymes, the recombinant strain improves heparosan production by over 
50 folds. Synechococcus was also found to naturally synthesize multiple glycosaminoglycans.  
Lastly, to further explore metabolite channeling as evidenced by isotopic labeling 
patterns, we developed cell-free glycolysis pathways and compared their performance with in 
vivo glycolysis functions in E. coli and its PTS mutants. Enzyme assays, dynamic metabolite 
labeling and flux analysis further confirmed the hypothesized channel of EMP enzymes where 
the PTS may be an anchor point to initiate enzyme assemblies. In summary, the outcomes of this 
thesis provide new insights into non-model phototrophic microbial chassis, reveal flux control 
mechanisms beyond genetic or transcriptional regulations, and offer practical guidelines for 
sustainable bio-production via synthetic biology approaches.  
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Chapter 1: Introduction 
This chapter was partially adapted from the following publications: 
Abernathy MH, Wan N, Shui W, Tang Y. “Chapter 18: Dynamic 13C labeling of fast turnover 
metabolites for analysis of metabolic fluxes and metabolite channeling.” Microbial 
Metabolomics: Methods and Protocols, edited by Edward E.K. Baidoo, vol 1859, Humana Press, 
2019.   
Wan N, Abernathy MH, Tang JKH, Tang Y, You L. Cyanobacterial photo-driven mixotrophic 
metabolism and its advantages for biosynthesis. Front. Chem. Sci. Eng. 2015;9(3):308-316. [I 
contributed a figure and to some writing of this manuscript.] 
Abstract 
Cyanobacteria are promising platforms for carbon neutral bioproductions. However, 
cyanobacteria face numerous challenges, such as slower growth than their heterotrophic 
counterparts, complex carbon and energy metabolisms, and tightly-wired cellular regulation. 
Using isotopically nonstationary 13C flux analysis, which is a powerful tool for precise carbon 
flux quantification (e.g., metabolic flux analysis of photoautotrophic organisms), we can 
investigate pathway bottlenecks, a cell’s phenotype, and metabolite channeling. In general, 
isotopically nonstationary metabolic flux analysis requires three main components: (1) transient 
isotopic labeling experiments; (2) metabolite quenching and isotopomer analysis using LC-MS; 
(3) metabolic network construction and flux quantification. Labeling dynamics through cascade 
metabolites may also identify channeling phenomena in which metabolites are passed between 
enzymes without mixing with the bulk phase. In this chapter, experimental protocols are outlined 
to probe metabolic pathways through dynamic labeling. Protocols are described for labeling 
experiments, metabolite quenching and extraction, LC-MS analysis, computational flux 
quantification, and metabolite channeling observations. 
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Figure 
1.1 Cyanobacteria as cell factories for sustainable production of biofuels, bioplastics, and 
biopharmaceuticals from light energy and carbon dioxide.  
 
1.1 Cyanobacteria as cell factories  
1.1.1 Inherent challenges facing cyanobacteria bioproductions.  E. coli and yeast are the most 
widely used microbial cell factory due to their tractability, fast growth, and easy genetic 
manipulation (Nielson and Keasling, 2016). However, glucose as the sole source of fermentable 
sugar is costly, and new technology of lignocellulose utilization as a source of feedstock is still 
very expensive. Cyanobacteria have the potential to be carbon neutral cell factories and are of 
special biotechnological interest due to their fast growth compared to other photosynthetic 
orgamisms, unicellular anatomy, and high photosynthetic efficiency. Since the economic and 
environmental benefits of CO2 utilization are vast, engineered cyanobacterial biorefineries were 
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first developed for sustainable ethanol production in 1999 (Sayre, 2010). More and more genetic 
parts have been developed for cyanobacterial systems in the past decade, including new promoter 
systems and genome databases. Currently, metabolic engineers can manipulate cyanobacterial 
metabolism by eliminating competing pathways, redirecting biosynthesis fluxes, and balancing 
cofactors. Using CRISPR-Cas (Clustered Regularly Interspaced Short Palindrome Repeats) 
systems, cyanobacteria genomes can be efficiently and precisely edited for multiple genomic 
modifications (Scholz et al., 2013; Wendt et al., 2016; Ungerer and Pakrasi, 2016). 
Cyanobacteria can naturally produce or have been engineered to produce numerous biofuels 
(Wang et al., 2013b), bioplastics (Kamravamanesh et al., 2018) and biopharmaceuticals 
(McPhail et al., 2007; Singh et al., 2005) (Figure 1.1). Figure 1.2 compares E. coli and 
cyanobacteria for biosynthesis of alcohols and fatty acid derived compounds. It is clear that 
modern molecular biology can engineer cyanobacteria to produce chemicals from CO2 with 
similar carbon yields as E. coli glucose fermentations. However, E. coli still outperforms 
cyanobacteria with production rates and titers (by ten to hundreds of folds) due to its 
heterotrophic nature. As engineered pathways become more complicated, cyanobacterial 
biosynthesis pathways unavoidably face shortages of both energy molecules and building blocks. 
More knowledge is ultimately needed about how cyanobacteria coordinate their energy and 
carbon metabolisms to aid biorefineries. Photo-fermentation, increased photosynthetic 
efficiency, and more insights into cyanobacteria metabolic regulations may help remove some of 
the roadblocks for low production titer and rates.  
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Figure 1.2 Comparison of biofuel production in cyanobacteria verus E. coli. Yields for 
cyanobacteria were calculated by milligrams of carbon from the product divided by gram CO2 
fixed. It is assumed carbon content was approximately 50% of the biomass. Yields for E. coli are 
calculated by gram of product per gram of glucose used in the culture media. It is assumed that 
an OD730 and OD600 of 1 is equal to 0.4 g of dry cell weight (DCW).  The data collected is from 
published reports (Atsumi et al., 2009; Ruffing, 2014; Gao et al., 2012; Trinh et al., 2008; Baez 
et al., 2011; Tan et al., 2011; Zheng et al., 2012; Wang et al., 2013b; Schirmer et al., 2010). 
 
1.1.2 Rewiring cellular metabolism is difficult. Synthetic biology has made great progress in 
establishing molecular tools for genome editing and controlling gene expression. However, 
redirecting metabolic fluxes for effective bioproduction remains difficult because hosts often 
naturally suppress heterologous pathways and have undesired metabolic shifts, resulting in low 
titers and production rates. Metabolic fluxes do not always directly correlate with metabolite 
concentrations or gene/enzyme expressions. In reality, cell metabolism is highly regulated and 
coordinated through multiple interactions between genes, enzymes and metabolites (Figure 1.3). 
Substrate level regulations modulate the catalytic activity of enzymes via metabolite-protein 
interactions, namely allosteric inhibition (Piazza et al., 2018). In general, metabolite-protein 
interactions are highly conserved across evolutionarily divergent species for the maintenance of 
metabolic homeostasis (Reznik et al., 2017), and this regulation is responsible for fast metabolic 
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dynamics under changing growth environments (Khodayari and Maranas, 2016). Additionally, 
gene-protein interactions affect metabolic fluxes by regulating enzyme expressions. 
Transcriptional regulation is a commonly employed mechanism used to orchestrate metabolic 
responses (Utrilla et al., 2016); however transcriptional fold changes do not always correlate 
with metabolic fluxes (Schwender et al., 2014). Less experimentally explored, enzymes may 
dynamically associate via pairwise interactions to form “pearl necklace like” channels or via 
non-pairwise interactions to form enzyme clusters (Sweetlove and Fernie, 2018). Unlike 
transcription or protein expressions that often show significant variations, channeling provides 
flux constraints under environmental/genetic perturbations (Fischer and Sauer, 2005; Fischer et 
al., 2004). Because small metabolite diffusion is considered sufficiently fast for enzyme kinetics 
(Abernathy et al., 2017b), channeling may increase reaction rates, but it is more likely 
channeling functions as a regulatory role in controlling metabolic fluxes and protecting reaction 
intermediates from competing reactions or harsh cytosol environments (Sweetlove and Fernie, 
2018). Although it has been recognized that enzymes can organize spatially and temporarily to 
shuttle intermediates without releasing them into the cytosol, it is difficult to validate weak 
transient interactions between enzymes under in vitro (cell free) conditions (Zhang, 2011), thus 
proximity channeling in bacteria remains controversial (Wheeldon et al., 2016). As for 
cyanobacteria, carboxysome microcompartmentalization and photosystems co-localization on 
membranes leads to heterogeneous distributions of enzymes inside the cell. It is likely that 
central metabolite intermediates are passed without being released into the bulk cytosol phase, as 
revealed by our paper (Abernathy et al., 2017a).  
1.1.3 Channeling has significant biotechnology impacts. Metabolite channeling is integral to 
biotechnology applications because channeled pathways would constrain and repress 
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heterologous pathways (van Winden et al., 2001). Metabolite channeling increases the robustness 
of native pathways under environmental and genetic perturbations (Fischer et al., 2004 ; Fischer 
and Sauer, 2005) and may prevent native pathways from releasing intermediates as the 
precursors for engineered pathways.  
 
 
Figure 1.3 Schematic representation of flux control mechanisms and analysis tools.  
 
Understanding channeling-based regulation can help resolve inferior efficiencies in heterologous 
pathways by making proper co-localizations of engineered enzymes (Dueber et al., 2009; Lee et 
al., 2013). Moreover, the heterogeneous distribution of intracellular enzymes may also confound 
kinetic modeling and multiple-omics analyses. Since metabolic flux analysis (MFA) relies on the 
assumption that all metabolites are homogenously distributed in the cell and no diffusion 
limitations exist, metabolite channeling may cofound metabolic flux values or be revealed during 
MFA.  Understanding the scope and the rules dictating the formation of metabolite channeling in 
native pathways may improve genome-to-phoneme mapping, pathway engineering, and 
metabolic modeling (van Winden et al., 2001; Antoniewicz et al., 2007). Greater cognizance of 
channeling will enable bio-systems engineers to add an extra level of control on cellular 
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metabolic fluxes to current methods that rely mostly on gene copy numbers and transcriptional 
and translational regulations. 
1.2 Isotopically nonstationary metabolic flux analysis as a tool for decoding 
cellular phenotypes 
13C-metabolic flux analysis (MFA) provides quantitative information about carbon flux through 
metabolic networks. Traditional 13C-MFA relies on the labeling of proteinogenic amino acids, 
which have slow turnover rates and require isotopically steady state tracer experiments. On the 
other hand, transient labeling dynamics of fast-turnover central metabolites can provide 
snapshots of cell metabolism and offer rich insights into pathway activities. Using 
experimentally measured labeling dynamics of free metabolites, isotopically nonstationary MFA 
(INST-MFA) has been developed (Antoniewicz, 2015a). Unlike isotopically steady state MFA 
(cells are cultured with a specific 13C-tracer for a long period), INST-MFA requires measuring 
the change of free metabolite or amino acid labeling after a cell’s culture has been switched from 
non-labeled medium to labeled medium (e.g., pulse 13C-substrates into non-labeled cultures).  
Since metabolite labeling speed is correlated to flux rate and metabolite pool sizes, the 
knowledge of labeling dynamics of key metabolites can be used to decipher metabolic fluxes and 
pool sizes through a metabolic network. 
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Figure 1.4 INST-MFA of steady state metabolism. Left pane: after 13C-substrate pulse (CIN), 
the flux rate through a key metabolite (CA) determines the labeling rate of CA as seen below. 
Right pane: in the top panel, the shaded circle represents the measurement time points for INST-
MFA, while the non-shaded circle represents measurements taken at isotopic steady state. The 
dotted line represents metabolic fluxes at steady state. An example of an isotopic labeling 
experiment is shown in the bottom pane. When labeled CO2 is introduced into an algal culture, 
Calvin cycle metabolites become progressively labeled. The labeling dynamics for 3PGA is 
illustrated. Once isotopic steady state is reached, the metabolites will be fully labeled.  
 
INST-MFA has been applied to photoautotrophic organisms that can only utilize CO2 
because steady state CO2 labeling provides no unique isotopomer data to gain flux information 
(Young et al., 2011). To perform INST-MFA, transient labeling data are collected immediately 
following the introduction of a 13C-tracer for multiple time points (Figure 1.4; shaded circle). 
Due to fast metabolite turnover rates, a protocol to rapidly and precisely quench cell metabolism 
is required. The metabolite labeling patterns are commonly analyzed using LC/MS (Bennette et 
al., 2011). The labeling dynamics can be used to quantify metabolic fluxes, assuming: 1) the 
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cells are at metabolic steady-state; 2) there is no enzyme preference between 12C and 13C atoms; 
3) the cell is homogeneous (no diffusion limitations exist) (Zamboni et al., 2009). For flux 
estimation, a non-linear least squares regression is solved where the objective function is to 
minimize the sum of squared residuals (SSR) between the measured (m) and predicted mass 
isotopomer distributions (x(t)), pool size (C), and metabolic rates (r) (Antoniewicz, 2015a).    
Equation 1.1:                    min 𝑆𝑆𝑅 =  ∑
(𝑥(𝑡)−𝑥𝑚(𝑡))
2 
𝜎𝑥
2 + ∑
(𝑟−𝑟𝑚)
2 
𝜎𝑟
2 + ∑
(𝐶−𝐶𝑚)
2 
𝜎𝐶
2    
𝑠. 𝑡. 𝐶 ×
𝑑𝑥
𝑑𝑡 
=  𝑓𝑖𝑠𝑜𝑡𝑜𝑝𝑜𝑚𝑒𝑟 𝑚𝑜𝑑𝑒𝑙(𝑣, 𝑥(𝑡)) 
𝑅 × 𝑣 = 𝑟 
𝑆 × 𝑣 = 0 
The metabolic network and fluxes (v) are subject to constraint by the stoichiometry matrices (S 
and R) and external metabolic rates (r). Metabolite pool sizes (C) can be measured or fitted using 
isotopomer data (Young, 2014). The elementary metabolite unit (EMU) framework can be used 
for effective isotopomer calculations (Antoniewicz et al., 2007; Young et al., 2008). INCA 
(Young, 2014) and OpenMebius (Kajihata et al., 2014) are excellent dynamic flux analysis 
softwares, which resolve fluxomes experimentally determined time-dependent labeling data. The 
workflow of INST-MFA is shown in Figure 1.5. 
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Figure 1.5 INST-MFA workflow. The workflow consists of three major parts: (1) experiment 
design, and isotopic labeling experiments (ILE); (2) metabolite extraction and dynamic labeling 
data analysis; (3) metabolic network construction and quantification of fluxes.  
 
Isotopic nonstationary labeling provides an enhanced understanding of exchange fluxes 
and metabolite pool sizes (Schaub et al., 2008) and is particularly useful for studying mammalian 
cells and other higher organisms (Wiechert and Nöh, 2013; Niklas et al., 2011; Nargund et al., 
2014). INST-MFA provides reliable and experimentally determined quantitative measurements 
of metabolic fluxes (Schaub et al., 2008; Wahl et al., 2008).  INST-MFA is also useful for 
elucidating hidden pathway constraints such as metabolic reflux (Nargund et al., 2014), pathway 
bottlenecks, and metabolite channeling (Hollinshead et al., 2016).  Metabolite channeling creates 
two metabolite pools: a fast turnover pool (inside the channel) and an inactive pool (outside the 
channel). In this case, INST-experiments may generate unsequential labeling along cascade 
metabolites (i.e., downstream metabolites are labeled faster than their precursors).  
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1.2.1 Materials associated with INST-MFA 
1 Transient isotope labeling experiments  
1.1 Cell culture at metabolic steady-state: Minimal media cultures in their exponential growth 
phase at metabolic steady-state. Prepare regular (for seed cultures) and minimal cell media (see 
Note 1) specific to the strain being cultured. The volume of culture needed for the experiment is 
dependent on the strain’s cell density, number of experimental time points and sampling 
procedure (see Note 2). Follow specific media instructions for storage conditions.  
1.2 13C-tracer: Prepare a stock solution of the 13C-tracer (e.g., NaH13CO3 or U-
13C-glucose) 
using equation 2 below, where Cculture is the desired final culture concentration (see Note 3), 
Cstock is the concentration of the stock solution being prepared, Vculture is the volume of the 
culture(s), and Vstock is the volume of stock solution being pulsed (see Note 4). 
Equation 1.2:                                 Cculture  × Vculture = Cstock × Vstock 
1.3 Quenching supplies: Minimal (no carbon) media or phosphate buffered saline and dry 
ice/liquid N2 (see Note 5).  
1.4 Bench-top centrifuge with refrigeration options: Pre-chill centrifuge prior to the experiment 
(make sure the centrifuge temperature close to 0 oC). Pre-chilled centrifuge tubes (50 mL or 15 
mL tubes) are used.  
2 Analytical determination of Mass Isotopomer Distributions  
2.1 Extraction solution: The choice of extraction solution depends on the species and the 
metabolites of interest (see Note 6). Additionally, the volume of extraction solution can be 
optimized.  
2.2 De-ionized water.  
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2.3 Centrifuge filters for LC/MS analysis: Amicon Ultra centrifuge filters-3kDa (EMD 
Millipore, USA), Costar Spin-X centrifuge tube filters-0.45 μm cellulose acetate membrane 
(Corning, USA) or centrifugal filter nylon-0.45 μm (VWR, USA) are recommended depending 
on instrument technique and metabolites of interest.  
2.4 Vortexer/Lyophilizer/vacuum  
2.5 Liquid chromatography-mass spectrometer (LC/MS): Two examples of LC settings are 
following. All solvents and reagents used should be of HPLC grade. (a) Reverse phase-ion 
pairing: 10mM tributylamine and 15mM acetic acid in water (mobile phase A), 100% HPLC 
grade methanol (mobile phase B), Phenomenex Synergi Fusion-RP column or an alternative 
column. (b) Hydrophilic interaction liquid chromatography (HILIC): 10 mM ammonium 
carbonate in water (mobile phase A) and 10 mM ammonium carbonate in 70% acetonitrile and 
30% water (mobile phase B), SeQuant ZIC-pHILIC column (EMD Millipore) or an alternative 
HILIC column.  High-resolution mass spectrometers (e.g. TOF or Orbitrap) and/or triple-
quadruple instruments for multiple reaction monitoring (MRM) analysis are recommended for 
reliable metabolite identification. A MS analysis software will be needed along with other 
LC/MS consumables.  
2.6 Internal standards: Approximately 1 µg/mL analytical metabolite standards should be 
prepared to aid in peak identification. Additionally, standards should be spiked into biological 
samples and analyzed to observe matrix effects.  
3 Metabolic flux analysis  
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3.1 Computer and software: Equipped with the ability to perform isotopically nonstationary 
metabolic flux analysis and run appropriate software, such as INCA (isotopomer network 
compartmental analysis) (Young, 2014).  
3.2 Biomass composition analysis: Dried biomass washed with 0.9% saline solution, analytical 
instruments and their associated reagents. Common measurements are total protein content, 
amino acid composition, lipid measurement, and carbohydrate measurement. National 
Renewable Energy Laboratory developed procedures for standard biomass analysis 
(http://www.nrel.gov/bioenergy/biomass-compositional-analysis.html) (optional). 
3.3 Growth rate analysis: a growth curve for the species of interest measured at the appropriate 
absorbance using a plate reader or UV/Vis spectrometer (optional). 
3.4 Carbon uptake and excretion measurements: a steady state culture, a HPLC, GC, GC-MS 
and/or enzymatic kits, appropriate solvents, consumables, and sampling equipment.   
1.2.2 Methods for performing INST-MFA 
1 Transient isotope labeling experiments and fast-cooling protocol  
1.1 Prepare cultures. Depending on the strain’s cell density and number of time points, prepare 
proper amount of non-labeled cultures (see Note 2). To capture the labeling dynamics where the 
slope is changing rapidly (Ma et al., 2014) (i.e., the earlier time points), numerous time-course 
samples have to be taken after 13C-pulse experiments (see Note 7).  
1.2 Prepare 13C tracer stock. For example, NaH13CO3 is used to probe photoautotrophic cultures, 
and U-13C-glucose is often used to study heterotrophic organisms (see Note 8).  
14 
 
1.3 Set up for tracer experiment. Before 13C-pulse, obtain dry ice or liquid nitrogen and have the 
quenching solution and centrifuge tubes pre-chilled in the appropriate apparatus. Then, deliver 
the 13C-substrate into the culture and begin timing.  
1.4 Metabolite quenching. At the measured time point, sample the aliquot of culture. If using a 
quenching solution, the culture should be quickly mixed in with the quenching solution (e.g., an 
icy cold buffer) then the sample tubes should be submerged in liquid nitrogen (or dry ice) to cool 
cultures to ~0 oC as fast as possible (Hollinshead et al., 2016) (see Note 9). If the quenching 
temperature is not low enough, central metabolic reactions may be active during sampling 
processes. Therefore, it is important to quickly quench cell metabolism at ~0 ºC using both liquid 
nitrogen and cold buffer.  
1.5 Centrifuge cell culture to pellet the quenched biomass at 0 oC. Use appropriate speed (e.g., 
6000 × g) and time to pellet cell biomass, while trying to keep centrifuge time short. Cell pellets 
can be stored at -80 °C before extraction.  
2 Analytical determination of Mass Isotopomer Distributions via LC/MS  
2.1 Extract metabolites from cell biomass. While on ice, add internal standard to cell pellet or 
biomass (see Note 10) if trying to quantify metabolites. Mix 1 mL of cold extraction solution 
(see Note 6) with biomass then transfer to a new vial. Shake for 4 hours to overnight at ~0 °C. 
After shaking in extraction solution, add 0.5 mL of ddH2O, vortex, and spin down at 5,000 x g 
for 2 min. Pipet out methanol-water layer into a new vial. Repeat extraction with ddH2O. Filter 
methanol-water layer using centrifuge filter and transfer filtered sample into a new vial.  
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2.2 Concentrate metabolite extraction. Dry down water-methanol samples using 
lyophilizer/vacuum or N2 gas. Re-suspend the sample in ddH2O with 100 μL ddH2O (or ddH2O-
acetonitrile solution, if also looking at water insoluble compounds using the HILIC-MS method).  
2.3 LC/MS Analysis (see Note 11). Filter all mobile phases before LC/MS analysis. A brief 
description of reverse phase ion-pairing LC/MS operation is as follows: A recommended 
injection volume of 10 μL and a column flow rate of 0.2-0.3 mL/min may be used. An LC 
gradient as follows is suggested: 0% of mobile phase B (0 min), 8% B (8 min), 22% B (18 min), 
40% B (28 min), 60% B (32 min), 90% B (34 min), 90% B (37 min), 0% B (39 min), and 0% B 
(49 min) (Young et al., 2011; Ma et al., 2014). The mass spectrometer usually operates with an 
ESI source under negative ionization mode for analysis of organic acids and sugar phosphates. In 
targeted metabolite analysis by MRM mode, first optimize the collision energy and define MRM 
transitions for each metabolite using its chemical standard.   
A brief description of HILIC- LC/MS protocol developed by the Joint Bioenergy Institute 
(Hollinshead et al., 2016) is as follows: A HILIC column, such as a SeQuant ZIC-pHILIC 
(2.1mm x 150mm and 5-μm particle size), should be used. For the ZIC-pHILIC column, the 
recommended flow rate and injection volume are 0.2 mL/min and 1-2 µL. Metabolites are 
separated via gradient elution under the following conditions: 100% B (0 min), 60% B (9 min), 
60% B (11.8 min), 100% B (12 min), and 100% B (22 min). Additionally, optimize LC and MS 
conditions with standard solutions.  
2.4 Data analysis. The metabolite labeling pattern is analyzed as mass isotopomer distributions 
(MID). For example, M+0 of 3-Phosphoglyceric acid (3PGA) represents the fraction of 
unlabeled 3PGA, whereas M+3 represents the fraction of a fully labeled 3PGA (Figure 1.4). A 
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metabolite has 2n isotopomers, where n represents the number of carbons. To determine the 
fractions of all isotopomers, high resolution MS methods have to be employed for distinguishing 
authentic labeled isotopomers from ion interferences. Internal standards and technical replicates 
are essential for confident identification of each metabolite, integration of all isotopomers (M+0, 
M+1, M+2, etc.), and an assessment of analytical variations. Metabolite identification is usually 
based on LC retention time, high-accuracy mass measurement, or specific MRM transitions. 
Mass spectral libraries such as METLIN or the NIST Mass Spectral Database may be used for 
compound structural assignment when standards are not available (Jazmin and Young, 2013; 
Schultz et al., 2013). Next, the MID values can be calculated based on the isotopic envelop 
detected for each metabolite. The M+0 distribution will be the peak area of M+0 divided by the 
sum of all the isotopomer peak areas for that metabolite. In principle, the sum of all the MID 
percentages for a metabolite should be equal to one. Biological replicates are needed for deriving 
the standard deviation for each MID distribution. More accurate MID results can be acquired if 
using specific algorithms to normalize the natural isotope occurrence (Niedenführ et al., 2016). 
However, this type of normalization is not normally required for LC/MS data processing as the 
natural abundances of labeled isotopes are much lower than the experimental variation.  
3 Metabolic flux analysis  
3.1 INST-MFA platform. OpenMebius (Kajihata et al., 2014), INCA (Young, 2014), or another 
appropriate platform can be utilized. INCA integrates transient balances using a custom linear 
ODE solver that involves computing the matrix exponential of each state-transition matrix. 
INCA allows for the compartmentalization of metabolites, fitting of metabolite pool sizes, and 
use of dilution parameters if one observes dilution from unlabeled sources, such as glycogen, 
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biomass reflux, or metabolite channeling. OpenMebius is an open source software, but requires 
pool size information for precise flux estimation.  
3.2 Metabolic network reconstruction. First, build a network based on the genome of the species 
of interest and biochemical literature. Useful databases are KEGG, BRENDA, and BioCyc 
Database Collection. The equations should contain information on reaction stoichiometry, 
reversibility, and atom transitions. The metabolic network should contain enough information to 
resolve simulated measurements based on all experimental measurements while also avoiding 
unnecessary reactions that can lead to overfitting the model. Linear pathways may be grouped to 
reduce computational costs (see Note 12). Energy and redox balancing reactions are often 
omitted from the model.  
3.3 MID data and biomass equations. Flux calculation requires MID data and a biomass 
equation. The biomass equation represents a proportioned sink (in millimoles per gram of 
biomass) of all the metabolites required for biomass growth (Antoniewicz, 2015a; Shastri and 
Morgan, 2005). The flux values are affected by biomass equations. Although a standard biomass 
equation is often used as an approximate for other bacterial species, a non-model species may 
have different biomass compositions (such as amino acid composition, lipids, and carbohydrates) 
(Pramanik and Keasling, 1997). For example, cyanobacteria tend to have high protein content 
due to the abundance of its photosystems.  
3.4 Substrate uptake, extracellular metabolite excretion and growth rate. Additional 
measurements of inflows and outflows offer constraints for precise flux analysis. Carbon uptake 
is expressed in units (mmol/gDCW/h). Extracellular metabolite excretions constrain the outflows 
of metabolic network. Measured growth rate (h-1) can be used to validate flux model predictions. 
These constrains will improve the accuracy of the model.  
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3.5 Estimation of fluxes and pool sizes. INST-MFA model obtains flux solutions by minimizing 
the difference between measured and simulated mass isotopomer distributions. It is 
recommended to restart the flux estimation numerous times from different random starting points 
to obtain a global solution (Crown and Antoniewicz, 2013).  The goodness-of-fit is based on the 
sum of squared residuals (SSR) and the degrees of freedom. The confidence intervals of flux 
values are determined through either parameter continuation or Monte Carlo methods. Parameter 
continuation is performed using a flux coupling analysis and predictor-corrector method of 
minimized computational expense. The Monte Carlo method introduces random errors from a 
normal distribution and flux measurements are repeated with perturbed data sets. In general, 
parameter continuation is a more efficient method for calculating flux confidence intervals 
(Antoniewicz et al., 2006). Moreover, pool size measurement is important for dynamic flux 
analysis. However, precise pool size analysis is difficult because of metabolite leakage during 
sample processing and the requirement of internal standards. To overcome this problem, the 
INCA platform fits the metabolite pool sizes based on isotopomer data. In this case, INST-MFA 
can also generate a set of predictions of metabolite pool sizes in addition to flux values.  
3.6 Model Assessment. One should look at reactions with large confidence intervals, which 
indicate the flux cannot be determined precisely. Additional measurements of metabolite pool 
sizes may improve the flux determinations. A poor squared residual or weighted residual for an 
individual metabolite could mean there is an error with the measurement or there is a mistake in 
the metabolic network. Furthermore, it is important to check whether the regression residuals are 
distributed evenly. Statistical analysis can reveal the importance of a particular measurement for 
determining certain flux values. 
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1.2.3 Consideration of metabolite channeling in INST-MFA. During channeling, metabolites 
can be passed through a pathway without mixing with the bulk phase. Channeling may change 
molecule labeling orientations or bypass the denoted pathway reactions. Certain metabolic nodes 
of a channeled pathway must be leaky for connecting other pathways that share the same 
intermediates. At a leaky node, the intermediate can diffuse outside the channel and form an 
inactive cytosol pool, which will have a slower turnover rate. In this case, dynamic 13C-pulse 
experiments may be used to identify a “channeling signature”: downstream metabolites are 
labeled faster than their precursors (Hollinshead et al., 2016). Dynamic 13C labeling can 
elucidate leaky channels by observing whether there is any unsequential order for labeling 
cascade metabolites. To date, there is little knowledge of how microbes channel their native 
pathways. Metabolic flux analyses (including INST-MFA) are highly sensitive to the effect of 
channels on molecule orientation and pathway preferences (Williams et al., 2011).  Any 
observation of channeling in dynamic labeling experiments should provide caution during 
construction of metabolic pathways and analysis of labeling data  
Channeling establishes microcompartmentation of certain metabolites, which must be 
considered in MFA. If unsequential labeling of cascade metabolites occurs due to channeling 
effects (presence of multiple pools of same metabolites), it may cause issues obtaining an 
accurate and best-fit solution. To improve model fitting quality, dilution parameters are used to 
account for inactive metabolite pools outside of channels (Young et al., 2011). While the 
introduction of these dilution factors helps reduce model fitting errors, it also introduces addition 
degrees of freedom into the model. This may increase undetermined parts of the metabolic 
network (van Winden et al., 2001). In INST-MFA, dilution parameters can be introduced into the 
model (Kelleher and Masterson, 1992; Antoniewicz at al., 2007). For example, let CB be the 
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active pool of metabolite B (the pool involved in the cascade reaction) and CB’ be the inactive 
pool of B. CB, bulk is the total sampled pool (mix of CB and CB’). Then three reactions can be 
added to the model in such form: (1) CB CB, bulk (2) CB’ CB, bulk; (3) CB CB’.   
1.2.4 Notes on INST-MFA 
1. Minimal cell media should not include any carbon sources which the cell may uptake in 
addition to the 13C-tracer. While a rich media may be required to analyze the cell at the 
desired phenotype, this will create difficulties in analyzing the results later due to multiple 
nutrition compounds in the culture medium interfering with the intracellular analytes (Madji-
Hounoum et al., 2016). If using rich media, cells are often washed with a saline solution 
before extraction (Murphy et al., 2013). 
2. Depending on a strain’s cell density, different volumes of cell broth may be needed to obtain 
quality analytical data. For example, typically 5 mL of log phase E. coli (OD600 = 1) is 
sufficient for LC/MS samples (Oldiges, 2004), while 25 mL of log phase cyanobacteria 
(OD730 = 0.4) may be needed for improved LC/MS peak quality. 
3. The final concentration of the substrate added can be estimated from literature uptake values 
and from the longest time point planned. To achieve metabolic steady-state, the cell should 
be saturated with labeled substrate during the entire experiment so as to not affect the uptake 
and growth rates (Nöh et al., 2006).  
4. It is best to perform all actions as swiftly as possible: 1) Make sure to have the appropriate 
tools to inject the entire 13C-stock solution into culture as quickly as possible; 2) High 
concentration 13C-substrate stock solution is preferred but may be limited by substrate 
solubility.   
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5. INST experiments require proper quenching methods (Faijes et al., 2007; Chen et al., 2014; 
Millard et al., 2014). In this paper, we focus on a fast-cooling method (Table 1.1), which 
allows for quenching with high time precision and minimal metabolite leakage. Other 
methods may also be applicable for rapid quenching procedures.  
6. The extraction solution should be optimized to the species and metabolites of interest based 
on peak height, area, or ion count (Bennette et al., 2011; Bajad et al., 2006). Common 
extraction mixtures are methanol/water, chloroform/methanol, acetonitrile/methanol/water 
(Prasad and Ferenci, 2003; Madji-Hounoum et al., 2016). Additionally, if one is interested in 
nucleotide triphosphates, it has been shown that the addition of 0.1M formic acid in 
acetonitrile improves extraction (Rabinowitz and Kimball, 2007; Bennett et al., 2008) (after 
which ammonium hydroxide is combined with the extract to prevent metabolite degradation 
through neutralization). The amount of extraction solution used is typically between 0.5 and 
1.5 mL and is also open to optimization.  
7. One can optimize the sampling time points to improve computational quality (Nöh et al., 
2006; Nöh et al., 2007). In general, it is desired to take more time points during the period of 
fast labeling changes. One group calculates sampling times through the parameterization of 
the time points (Nöh et al., 2006) (refer to cited publication for more details). 
8. Parallel labeling experiments can provide temporal resolution of certain fluxes and also 
improve flux precision to a certain point (Antoniewicz, 2015b). INCA contains a feature that 
allows a user to search for optimal parallel tracer combinations that minimize the optimality 
criterion (Young, 2014; Möllney et al., 1999).   
9. Use a digital thermometer as the stirring apparatus to help mixing, prevent freezing and 
inform when the cell culture is quenched (< 0 °C). 
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10. Possible internal standards: uniformly isotopically-labeled metabolites, PIPES (parent mass- 
301) (Ma et al., 2014), Naphthyl phosphate (Schaub et al., 2008), N-acetyl-glutamine (Bajad 
et al., 2006), 2-amino-3-bromo-5-methylbenzoic acid (Baran et al., 2010).  
11. Hydrophilic interaction chromatography (HILIC) can achieve separations of common polar 
metabolites, such as low abundant metabolites, organic compounds, and amino acids (Bajad 
et al., 2006) , while reverse phase ion-pairing chromatography is particularly good for 
measuring sugar phosphates (Ma et al., 2014; Young et al., 2011; Arrivault, 2009). A triple-
quadrupole (QqQ) MS instrument can detect a pre-selected set of targeted metabolites by 
MRM, which offers supreme sensitivity and accurate quantification, while high-resolution 
MS provides highly specific analysis of low concentration intracellular metabolites (Young 
et al., 2011; Schultz et al., 2013). A common soft ionization technique used in MS analysis is 
electrospray ionization (ESI), which is particularly useful for chemically unstable 
metabolites, such as nicotinamide adenine dinucleotide phosphate (NADPH), adenosine 
triphosphate (ATP), and phosphoenolpyruvate (PEP) (Ma et al., 2014). Depending on 
metabolites of interest and available instruments, multiple combinations of LC and MS 
systems could be considered.  
12. The oxidative pentose phosphate pathway with atom transitions (represented by abcedf) can 
be group as glucose-6-phosphate (G6P) (abcdef)  ribulose-5-phosphate (RU5P) (bcdef) + 
CO2 (a) or if 6-phosphogluconic acid (6PG) MID is obtained, the reaction can be broken 
down into 2 separate reactions: G6P (abcdef)  6PG (abcdef), 6PG (abcdef)  RU5P 
(bcdef) + CO2 (a). 
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Table 1.1 Brief description of quenching methods 
Quenching method Description 
Methanol solution  Use a pre-chilled methanol solution (< -50 °C, either pure methanol 
or a 40%-75% methanol and water solution can be utilized) 
Fast-cooling method Use pre-chilled minimal media or buffer solution (< -10 °C) while 
bathing culture in dry ice or liquid N2.  
Fast filtration  Set up a vacuum filtration system that can pull liquid through 
rapidly (<5s) with a nylon filter (25 mm).  
Rapid Sampling Unit 
(Nöh et al., 2007; Link 
et al., 2015)  
Use a sampling valve aiewicznd port injector to rapidly sample 
from bioreactor; may still a quenching solvent such as cold 
methanol or hot ethanol 
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Chapter 2: Deciphering cyanobacterial phenotypes for 
fast photoautotrophic growth via isotopically 
nonstationary metabolic flux analysis  
 
This chapter has been reproduced from the following publication: 
Abernathy MH, Yu J, Ma F, Liberton M, Ungerer J, Hollinshead WD, Gopalakrishnan S, He L, 
Maranas CD, Pakrasi HB, Allen DK, Tang YJ. Deciphering cyanobacterial phenotypes for fast 
photoautotrophic growth via isotopically nonstationary metabolic flux analysis. Biotechnol. 
Biofuels. 2017;10:273. 
Abstract 
Background: Synechococcus elongatus UTEX 2973 is the fastest growing cyanobacterium 
characterized to date. Its genome was found to be 99.8% identical to S. elongatus 7942 yet 
it grows twice as fast. Current genome-to-phenome mapping is still poorly performed for non-
model organisms. Even for species with identical genomes, cell phenotypes can be strikingly 
different. To understand Synechococcus 2973's fast-growth phenotype and its metabolic features 
advantageous to photo-biorefineries, 13C isotopically nonstationary metabolic flux analysis 
(INST-MFA), biomass compositional analysis, gene knockouts, and metabolite profiling were 
performed on both strains under various growth conditions. 
Results: The Synechococcus 2973 flux maps show substantial carbon flow through the Calvin 
cycle, glycolysis, photorespiration and pyruvate kinase, but minimal flux through the malic 
enzyme and oxidative pentose phosphate pathways under high light/CO2 conditions. During fast 
growth, its pool sizes of key metabolites in central pathways were lower than suboptimal growth. 
Synechococcus 2973 demonstrated similar flux ratios to Synechococcus 7942 (under fast growth 
conditions), but exhibited greater carbon assimilation, higher NADPH concentrations, higher 
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energy charge (relative ATP ratio over ADP and AMP), less accumulation of glycogen, and 
potentially metabolite channeling. Furthermore, Synechococcus 2973 has very limited flux 
through the TCA pathway with small pool sizes of acetyl-CoA/TCA intermediates under all 
growth conditions. 
Conclusions: This study employed flux analysis to investigate phenotypic heterogeneity among 
two cyanobacterial strains with near-identical genome background. The flux/metabolite 
profiling, biomass composition analysis, and genetic modification results elucidate a highly 
effective metabolic topology for CO2 assimilatory and biosynthesis in Synechococcus 2973. 
Comparisons across multiple Synechococcus strains indicate faster metabolism is also driven by 
proportional increases in both photosynthesis and key central pathway fluxes. Moreover, the flux 
distribution in Synechococcus 2973 supports the use of its strong sugar phosphate pathways for 
optimal bio-productions. The integrated methodologies in this study can be applied for 
characterizing non-model microbial metabolism. 
 
2.1 Introduction 
 To achieve metrics required for commercialization, cyanobacterial photobiorefineries 
must have comparable biosynthesis capability to commonly used heterotrophic organisms. 
Recently, Synechococcus elongatus UTEX 2973, a cyanobacterium, was isolated, whose growth 
rate reaches a doubling time of 2 h under high light and high CO2 conditions (Yu et al., 2015). In 
comparison, Synechococcus elongatus PCC 7942 exhibits a doubling time of ~5 h although its 
genome sequence is 99.8% identical to Synechococcus 2973 (55 single nucleotide 
polymorphisms and a large 188 kb inversion between Synechococcus 2973 and 7942) (Yu et al., 
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2015). To understand how cyanobacteria achieve maximal growth rates, this study aims to 
decipher Synechococcus 2973 flux topology under diverse growth conditions. 
 Metabolic flux analysis (MFA) can provide a quantitative description of the metabolic 
network, link genome profiling to phenome analysis, and reveal pathway regulations through 
comparative studies. Currently, the cyanobacterial strain, Synechocystis sp. PCC 6803 (doubling 
time ~8 h), is considered the model cyanobacterium whose metabolism has been extensively 
profiled by flux analysis tools (Young et al., 2011; Xiong et al., 2015; Yang et al., 2000; You et 
al., 2014). Synechocystis 6803 has significant flux through malic enzyme and oxidative pentose 
phosphate pathways (OPPP) under the photoautotrophic and photomixtrophic conditions. It also 
operates a cyclic TCA cycle via the GABA shunt. To profile Synechocystis 6803 
photoautotrophic metabolism, 13C-pulse experiments and isotopically nonstationary metabolic 
flux analysis (INST-MFA) were developed (Young et al., 2011). Using the software package, 
INCA, mass isotopomer data from dynamic labeling experiments can be used quantify fluxes 
without the need to precisely determine metabolite pool sizes (which are fitted as parameters to 
account for transient labeling data) (Young, 2014), and is therefore more convenient than other 
flux profiling methods (Yuan et al., 2008). In the current study, INST-MFA, gene knockouts, and 
metabolite analysis were performed to obtain insights into the physiology and metabolic 
regulations of Synechococcus 2973 under different bioreactor conditions. Meanwhile, aspects of 
biomass composition were measured to reveal changes in macromolecule tradeoffs that correlate 
to cell growth and bioreactor conditions (Pramanik and Keasling, 1997). The outcome highlights 
the advantages and hurdles of establishing Synechococcus 2973 as a new platform organism for 
bio-production.    
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2.2 Results  
2.2.1 Synechococcus 2973 growth and biomass compositions. In optimal 
photobioreactor (PBR) conditions, Synechococcus 2973 exhibited a growth rate of 0.33 ± 0.05 h-
1 and Synechococcus 7942 grew at 0.14 ± 0.02 h-1 (Figure 2.1a). There was no statistically 
significant decrease in growth rates in Synechococcus 2973 OPPP pathway mutants (the pgl 
deletion mutant showed slightly better growth in diurnal light conditions). Synechococcus and 
mutants were also analyzed under suboptimal diurnal conditions and same light irradiation as 
seen in Figure 2.1b. Diurnal cycles greatly impaired all strains’ growth, while Synechococcus 
2973 still demonstrated slightly faster growth than Synechococcus 7942. Based on cell growth 
and biomass composition analysis, under continuous light conditions, Synechococcus 2973 
assimilated ~12.2 mmol-C/gDCW/h in the PBR but only ~6.7 mmol-C/gDCW/h under the 
shaking flask (SF) conditions; while Synechococcus 7942 assimilated ~5.1 mmol-C/gDCW/h in 
the PBR. The estimated values of carbon fixation were further confirmed by the measured net 
CO2 uptake rate using gas chromatography methods (Figure S1) (Mueller et al., 2017). 
The composition of Synechococcus 2973 biomass was measured in both continuous light 
PBR and SF conditions (Supplementing File:Appendix 1). The total protein (~50%) and amino 
acid levels did not vary significantly between PBR and SF conditions; however protein from the 
PBR had more glutamate/glutamine than that from the SF (p-value 0.054 using two-tailed equal 
variance Student’s t-Test). Synechococcus 2973 contained 9 ± 1 % lipids and 1.5 ± 0.5 % 
glycogen in the PBR and 13 ± 2 % lipid and 6.0 ± 1.0 % glycogen in SF conditions. For 
comparison, Synechococcus 7942 biomass composition was quantified under optimal PBR 
conditions and comprised 11 ± 1 % lipids, 13 ± 4 % glycogen, and 41 ± 0.4 % protein. Optimal 
PBR conditions were determined by Yu et al., 2015. Proteinogenic glutamate/glutamine content 
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in Synechococcus 7942 was significantly lower (p-value <0.05) than that in Synechococcus 2973 
biomass regardless of conditions. Fatty acid compositions of lipids in both strains were 
predominantly C16:1 and C16:0 fatty acids (85%), followed by C18:1 and C18:0. Relevant to 
photosynthetic light-harvesting, less chlorophyll a was produced in PBR conditions (4.4 ± 0.5 
µg/mL/OD730 for 2973; 5.2 ± 0.6 µg/mL/OD730 for 7942) compared to SF (7.4 ± 0.3 
µg/mL/OD730 for 2973, p-value <0.01). Increased chlorophyll levels in SF cells could 
compensate for insufficient light conditions.  
 
Figure 2.1 Growth performances of cyanobacterial species. (A) Growth rate of 
Synechococcus 2973, Synechococcus 7942 and the Syn. 2973 Δzwf mutant in PBR and SF 
conditions under continuous light. Doubling times in hours is reported below for each strain. 
†Synechococcus 7942 was grown at 300 μmol photons•m-2•s-1. Standard deviations are a result 
of 3-5 biological replicates. *p-value <0.02 between Syn. 2973 and 7942 PBR conditions using 
two-tailed equal variance Student’s t-Test. (B) Diurnal growth curve and rates of Synechococcus 
strains under SF conditions. 12-hour diurnal growth curve of Synechococcus 2973 WT, 
Synechococcus 7942 WT, Synechococcus 2973 ∆zwf and Synechococcus 2973 ∆pgl. Standard 
deviations are based on three biological replicates.  
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2.2.2 INST-MFA of photoautotrophic metabolism.  INST-MFA relies on measurement of 
transient labeling data of central metabolites. To quench time-course metabolism after 13C-pulse, 
we used ice-cold media and liquid N2 bath to quickly freeze time-course samples (Fu et al., 
2015). The approach avoided traditional cold methanol quenching strategy that causes significant 
metabolite leakage for gram-negative bacteria (i.e., cyanobacteria) (Bolten et al., 2007) and 
resulted in improved LC-MS peak quality (Figure S2) (Millard et al., 2014). The INCA software 
package (isotopomer network compartmental analysis) was used to calculate flux values based 
on labeling data (Young, 2014) (Figure 2.2 and Figures S3 & S4). The fitted model for the 
Synechococcus 2973 in the PBR was statistically acceptable (Sum of square residuals SSR=713, 
with an accepted range of [597 740]). The fitted model for SF had a worse fit (SSR=981, with an 
accepted range of [382 471]). The fitted model for Synechococcus 7942 in the PBR was 
statistically acceptable (SSR=616, range of [543 679]). SSRs were improved if biomass 
composition information and CO2 uptake rate were used to constrain the fluxes. Flux-partitioning 
across conditions and strains was compared through relative flux values that were normalized to 
CO2 uptake rate and are plotted in Figure 2.2 (Confidence intervals and dilution factors are 
described in Tables S3-S5; Figure S3 & S4 show isotopomer fitting quality for individual 
metabolites). Additionally, labeling dynamics for citrate and malate are compared between 
Synechococcus 2973 and 7942 in Figure 2.5. 13C-enrichment for key metabolites is also 
presented in Figure 2.5; Figures S5 & S6. The unusual labeling pattern of certain metabolites 
may be indicative of substrate channeling (or the presence of metabolic inactive pools in bulk 
cytoplasm). While transient isotopic labeling experiments are not direct evidence for substrate 
channeling, it is one explanation for the observation of non-sequential labeling and genome-to-
phenome differences.  
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Figure 2.2 Synechococcus 2973 flux map determined in PBRs and SF and Synechococcus 
7942 from the PBR. Syn. 2973 PBR values are listed first, followed by SF in italicized values 
and the third values are Syn. 7942 PBR. Net fluxes are normalized to net uptake of 100 mol CO2. 
Mean flux values and 95% confidence intervals are given in Table S3, S4, and S5. Estimated net 
CO2 uptake rates (mmol/gDCW/h) were 12.2 (PBR), 6.7 (SF), and 5.1 (PBR- 7942). Green 
represents the pentose phosphate pathways and Calvin cycle, orange arrows represent 
photorespiration pathways, purple arrows represent glycolytic pathways, blue represents the 
TCA cycle, red arrows represent anaplerotic pathways and black arrows represent biomass 
synthesis. Dotted lines represented pathways with enzymes that are not annotated for 
Synechococcus elongatus on the KEGG Genome database.  
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2.2.3 Synechococcus flux maps in PBR and SF cultures. Figure 2.2 provides a comparison of 
the flux distributions between Synechococcus 2973 PBR and SF cultures and Synechococcus 
7942 PBR cultures. Although the cells have significantly different CO2 fixation rates and 
biosynthetic fluxes (i.e., Synechococcus 2973 PBR cultures contained more proteins in biomass, 
while Synechococcus 2973 SF and Synechococcus 7942 PBR cultures had higher carbon 
allocation to glycogen), the carbon partitioning through fluxes in central intermediates was 
similar after normalization to CO2 uptake rate. Synechococcus did not exhibit flux through OPPP 
regardless of the culturing platform or strain. Approximately 12~13% of the fixed carbon was 
directed to the TCA cycle. Synechococcus had no flux from aKG to FUM, resulting in a linear 
TCA pathway that is consistent with those in leaves or other photosynthetic tissues (Young et al., 
2011; Xiong et al., 2015; Ma et al., 2014). The flux distribution explained the absence of a 
number of key genes in Synechococcus 2973 genome, including succinate-CoA ligase, malate 
dehydrogenase, α-ketoglutarate dehydrogenase, and GABA shunt genes. Although cyanobacteria 
are thought to employ a cyclic TCA cycle via GABA shunt for respiratory energy production 
(Xiong et al., 2014), a complete TCA cycle seems non-essential for the Synechococcus elongatus 
strains possibly due to evolutionary non-necessity or energy molecule balance (Rubin et al., 
2015). Based on genome annotation, Synechococcus elongatus synthesizes fumarate from 
aspartate via purine metabolism, which can then be converted into malate and succinate 
(dynamic labeling data shown in Figure S5) providing a possible source of several organic acids 
and bypassing. On the other hand, Synechococcus 2973 had highly active anaplerotic fluxes 
through PEP carboxylase for the synthesis of TCA cycle intermediates, but its malic enzyme 
fluxes were minimal (less than ~1 % of total fixed CO2 in both the PBR and SF conditions). 
Apart from respiratory fluxes, photorespiration was highly elevated in the PBR relative to SF and 
32 
 
Synechococcus 7942 PBR conditions, demonstrating its role in balancing carbon and energy 
fluxes under a particular oxidative state when surplus light is available. Additionally, 
Synechococcus 7942 PBR demonstrated increased fluxes through transaldolase reactions and 
SBPase. 
2.2.4 Isotopic metabolite profiling for relative pool size estimation. We analyzed the change 
of metabolite concentrations in different cyanobacterial cultures (Bennett et al., 2009). Because 
of metabolite leakage for gram negative cyanobacterial cells, the precise determination of 
cyanobacterial pool sizes is difficult. Therefore, we used isotopic ratio method to benchmark the 
change of cyanobacterial metabolite pools against intracellular metabolites from an E.coli culture 
(as standards).  Figure 2.3 shows the relative ratio of metabolite pool sizes normalized by the 
amount of biomass. Comparing to E. coli, cyanobacterial R5P/Ru5P and other sugar phosphates 
were abundant, whereas the pool sizes of TCA metabolites were significantly low (Figure 2.3c). 
Synechococcus 2973 had generally smaller metabolite pools than Synechocystis 6803 (with the 
exception of R5P/Ru5P) and similar metabolite pools compared to Synechococcus 7942 (Figure 
2.3c) with the exception of UDP-glucose (i.e., Synechococcus 7942 contained more UDP-
glucose for glycogen synthesis) (Figure 2.3b). Notably, Synechococcus 2973 had the highest 
NADPH concentration among the three cyanobacterial species (Figure 2.3a). In addition, 
Synechococcus 2973 PBR cultivations decreased central metabolite concentrations (mainly sugar 
phosphates) relative to SF cultures (Figure 2.3d). Lastly, comparing two growth conditions of 
Synechococcus 2973 (Figure 2.3d), the SF cells contained more ADP and AMP than PBR cells, 
suggesting decreased energy charges (relative ATP concentration to overall adenosine phosphate 
concentrations) under suboptimal SF condition.  
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Figure 2.3 Relative pool sizes of Synechococcus 2973, Synechococcus 7942, and 
Synechocystis 6803 to E. coli K-12. A ratio of 1 indicates the same metabolite concentrations 
(normalized to gram biomass) between cyanobacteria and Escherichia coli. A ratio greater than 1 
indicates a larger pool size in cyanobacteria strain than Escherichia coli. Standard deviations are 
based on three cyanobacteria biological replicates. (A). Average relative pool size of energy 
molecules compared to E. coli in PBR conditions.  (B). Average relative pool size of UDP 
glucose to E. coli in PBR conditions. ADP glucose ratio is relative to Synechococcus 6803 
(normalized to 10) due to the lack of ADP glucose in the E. coli control. (C). Relative metabolite 
pool size of Synechococcus 2973, Synechococcus 7942 and Synechocystis 6803 in PBR 
conditions to E. coli K-12. (D). Relative metabolite pool size normalized to free glutamate 
between the shaking flask and PBR conditions for Synechococcus 2973.  
 
2.2.5 Effect of exogenous organic acids on Synechococcus 2973’s growth. Synechococcus 
2973 shows strong sugar phosphate pathways, but its TCA cycle is incomplete with limited flux 
and low metabolite pools. We hypothesized that the addition of exogenous organic substrates 
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may alleviate such biosynthesis bottlenecks. However, cell growth was not enhanced after 
supplying OAA, malate, αKG or organic acids (pyruvate and acetate) in either PBR or SF 
conditions (Figure 2.4a). Nevertheless, cells demonstrated the capability to incorporate 
exogenous nutrients into proteinogenic amino acids (especially for OAA, Figure 2.4b). 
Moreover, unlabeled malate from culture medium could be significantly incorporated into 
aspartate, suggesting an uncharacterized malate dehydrogenase to synthesize oxaloacetate (the 
precursor of aspartate). In summary, Synechococcus 2973 shows poor capability to co-utilize 
organic acids, and its anabolism may limit the conversion of these nutrients into cyanobacteria 
biomass (Yan et al., 2011). 
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Figure 2.4 Biomass growth of Synechococcus 2973 in the presence of carbon sources. (A). 
Growth rate (h-1) of Synechococcus 2973 in two conditions when fed with 4 g/L sodium 
bicarbonate and 6 mM of malate (MAL), acetate (AC), citrate (CIT), OAA, alpha-ketoglutarate 
(aKG), and a mix. Standard deviation is calculated from biological duplicates. There was no 
significant difference between growth rates. (B). Percent 12C-enrichment in amino acids through 
provision of 4 g/L of 13C-bicarbonate and 6 mM of unlabeled organic acids in SF cultures 
(labeling for 48 h) compared against the control of just 4 g/L of 13C-bicarbonate. The amino 
acids were chosen because of their direct relation to key metabolic precursors (AlaPYR, 
Ser3PGA, PhePEP/E4P, GluαKG, AspOAA). [M-57] represents unlabeled amino 
acids. Note: Synechococcus 2973 used unlabeled organic carbon sources to synthesize 
proteinogenic amino acids, the [M-57] % of amino acids increased compared to the control 
sample that was only fed with 13C-bicarbonate. Standard deviations are a result of biological 
duplicates *represents a p-value of <0.02 using two-tailed equal variance Student’s t-Test.  
2.3 Discussion  
2.3.1 Flux comparisons among cyanobacterial species. Synechococcus 2973 and 7942 have a 
number of phenome differences. The CO2 uptake rate in Synechococcus 2973 was more than 
twice the amount of Synechococcus 7942. Synechococcus 2973 showed up to a 3.5-fold greater 
13C-enrichment over Synechococcus 7942 for metabolites such as FBP and S7P (Figure S6) at 40 
seconds, indicating robust Calvin cycle fluxes. From the normalized flux map, there are 
differences in the carbon partitioning as seen in Figure 2.2 and Figure S7. Synechococcus 2973 
flux through fructose-biphosphate aldolase and phosphatase was greater while the flux towards 
glycogen and the malic enzyme were less. Flux from F6P to G6P, which is the key step towards 
OPPP and sugar storage metabolism, was significantly decreased in Synechococcus 2973 under 
both conditions. Malate and citrate were labeled rapidly in Synechococcus 2973 due to the 
enhanced PEPC (phosphoenolpyruvate carboxylase) reaction. Unlike Synechocystis 6803 that 
maintains a functional GABA shunt (Xiong et al., 2014), Synechococcus elongatus apparently 
does not contain the genes to operate a complete TCA cycle (as annotated by the KEGG Genome 
database), but based on labeling data presented here may utilize a linear pathway from OAA to 
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make citrate and subsequently aKG. The GABA shunt contains one decarboxylating reaction and 
the absence of this shunt reduces CO2 loss. Moreover, a succinate dehydrogenase deletion 
mutant was created, and the mutant showed no defected growth under continuous light 
conditions, which confirmed the absence of fluxes from aKG to fumurate. Unlike Synechocystis 
6803, Synechococcus 2973 pyruvate is nearly exclusively made from flux through pyruvate 
kinase, while scarcely using malic enzyme (MAL  PYR + CO2). Pyruvate kinase is a key step 
for producing pyruvate, but its activity in some cyanobacterial species can be inhibited by high 
ATP/ADP ratios during photosynthesis (Bricker et al., 2004). For example, significant amount of 
pyruvate in Synechocystis 6803 was derived from malate degradation (Young et al., 2011), and 
overexpression of pyruvate kinase in cyanobacteria can improve the production of lactate and 
alcohols (Oliver and Atsumi, 2015; Angermayr et al., 2014). However, Synechococcus 2973 has 
naturally evolved to overcome this pyruvate synthesis bottleneck, de-coupling pyruvate kinase 
inhibition from high photosynthesis rates. Furthermore, as shown in Figure 2.2 and genome scale 
modeling (Nogales et al., 2012), strong photorespiration is essential for optimal photosynthesis 
and maximal Synechococcus 2973 growth despite its net carbon loss. Synechococcus 2973 
exhibits twice the O2 evolution rate of Synechococcus 7942 (Mueller et al., 2017). Such high 
oxygen levels power linear electron flow in photosynthesis but can create an overly reduced state 
that must be balanced by photorespiration or cyclic electron flow if the Calvin cycle is operating 
at a high level (Kramer and Evans, 2011). 
 OPPP can generate NADPH and oxidize sugar phosphates as a means to derive more 
reduced compounds. The activation of the OPPP at the same time as the Calvin Cycle generates 
a futile cycle that reduces the efficient use of carbon and energy, which is why in higher plants 
the two are coordinately regulated by multiple mechanisms including redox state and pH 
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(Buchanan, 1980; Werdan et al., 1975). Due to lack of sufficient regulation or Calvin cycle 
bottlenecks, slow growing Synechocystis 6803 demonstrated ~12% CO2 loss through OPPP 
under continuous light (Young et al., 2011), while Synechococcus 2973 does not exhibit 
significant flux through the OPP pathway. To further confirm this point, we constructed 
Synechococcus 2973 zwf and pgl deletion mutants by disrupting the gene encoding G6P 
dehydrogenase and 6-phosphogluconolactonase respectively, so that G6P could not be converted 
to 6PG (Figure S2e & f). The mutants showed similar growth rate to the wild type strain under 
continuous light and diurnal bioreactor conditions (Figure 2.1), indicating the OPPP did not 
provide a benefit to the organism and was futile for photoautotrophic metabolism in 
Synechococcus 2973 (Scanlan et al., 1995). These mutants and metabolic insights from the 
quantification of central carbon fluxes provide new strategies for the redirection of carbon flux 
for the bioengineering of photosynthetic organisms. The observation that Synechococcus 2973 
exhibits a similar growth phenotype to Synechococcus 7942 under diurnal conditions emphasizes 
the necessity for optimal bioreactor conditions.  
2.3.2 The optimal photoautotrophic metabolism (reduced pool sizes, enhanced energy 
levels, and repartitioning of biomass composition). Metabolite concentrations are tied to 
input/output fluxes and can provide insight on biochemical level regulation (Schwender et al., 
2015; Buescher et al., 2015). The lack of correlation between pool sizes and absolute fluxes has 
been shown in literature (Huege et al., 2011; Ma et al., 2014), as well as here between 
Synechococcus 2973, Synechococcus 7942 and Synechocystis 6803. Compared to SF and 
Synechocystis 6803, the concentrations of a number of central metabolites from glycolysis and 
TCA, in particular, in Synechococcus 2973 were reduced in the PBR conditions. Less metabolite 
accumulation in central metabolism under PBR conditions could indicate reduced feedback or 
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higher rates of metabolite turnover. From literature, it is known as cell growth rates and carbon 
influxes increase, the fraction of anabolic enzymes is increased to pull central metabolites 
towards macromolecule synthesis (You et al., 2013). Compared to the heterotroph E.coli, 
cyanobacterial acetyl-CoA/organic acid concentrations were much lower (Figure 2.3c). Such 
observations, together with cultivation experiments using organic acids, indicated that the TCA 
cycle and its associated anabolic pathways in Synechococcus 2973 operate at lower rates than in 
the E.coli chassis, rendering difficulties in producing chemicals from cyanobacterial TCA cycle 
(Xiong et al., 2015). However, in Synechococcus 2973, the photosynthetic capacity generates 
sugar phosphates readily (FBP phosphatase/aldolase, fructose-bisphosphatase, transketolase and 
RuBisCO reactions) and can enhance its growth (Liang and Lindblad, 2016; Uematsu et al., 
2012; Bernstein et al., 2016). Its strength in producing sugar phosphate building blocks can be 
potentially applied for biotechnological productions (Markou and Nerantzis, 2013). 
Additionally, the higher energy charge in the PBR than SF for Synechococcus 2973 may 
benefit anabolic metabolism and cell tolerance to stress conditions (Srivastava et al., 2013). 
Cyanobacterial biosynthesis has been closely tied to photosynthesis and changing bioreactor 
conditions (Carrieri et al., 2015). In SF cultures, there was an increase in lower energy molecules 
(NADP+, ADP, and AMP) inhibiting anabolism, possibly resulting in higher levels of some 
central metabolites. The PBR grown Synechococcus 2973 showed the highest NADPH content 
due to enhanced light-harvesting that can facilitate organic carbon assimilation and biomass 
growth (Zhou et al., 2016; Nogales et al., 2012). Synechococcus 2973 adjusts its PSII/PSI ratio 
throughout growth although it was found to have a slightly lower PSII/PSI ratio than 
Synechococcus 7942 while exhibiting greater O2 evolution (Mueller et al., 2017).  Additionally, 
it may present with the most optimal ATP/NADPH ratio to sustain metabolism while not 
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exceeding ATP demand (Kramer et al., 2011).  This demonstrates its natural advantage in energy 
metabolism regulation and a key to unlocking cyanobacteria growth constraints. While CO2 
fixation rate is the obvious key factor for phenotype divergence, CO2 fixation rate is influenced 
by optimal energy balance, biomass distribution/central carbon fluxes, and compartmentalization 
of photosynthetic reactions.  
 Synechococcus 2973 PBR cells produce little glycogen (~8 times less than 
Synechococcus 7942 PBR cells and 10 times less than the reported value for Synechocystis 6803 
(Iijima et al., 2015)). When less carbon is allocated to make glycogen, more can be partitioned 
toward biomass synthesis, resulting in greater protein levels in Synechococcus 2973 than 7942 
(Stal and Moezelaar, 1997). On the other hand, Synechococcus 2973 produced significantly more 
glycogen under suboptimal SF circumstance, possibly leading to longer cell doubling times.  
2.3.3 Metabolic features of Synechococcus 2973 for bioproduction applications. The 
effective use of microbial chassis relies on the performance of cell central metabolism. 
Understanding and exploring native pathways with high metabolic strengths is a promising 
direction for future microbial cell factories (Nielsen and Keasling, 2016). Our fluxome results 
indicate that Synechococcus 2973 is advantageous for synthesis of targeted products from it 
sugar phosphate pathways under optimal bioreactor conditions. Recently, researchers have 
engineered Synechococcus 2973 to produce ~9 g/L of sucrose under potassium chloride stress 
(Song et al., 2016). This engineered strain also demonstrates excellent potential to produce 
valuable polysaccharide products. On the other hand, it has been observed that while 
cyanobacteria can easily adapt their photosynthetic operations, there is a high number of 
essential metabolic genes involved in photoautotroph growth. This presents additional challenges 
for mutant strain generation or extensive genetic modification (Nielsen and Keasling, 2016). 
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Therefore, Synechococcus 2973 may not be efficiently engineered using numerous heterologous 
enzymes or rewiring fluxes from its weak acetyl-CoA/TCA pathways for broad-scope bio-
productions.   
2.3.4. Subpopulations, metabolic inactive pools, and substrate channeling. Modeling results 
indicated the presence of unlabeled pools that required additional dilution factors for isotopic 
data fitting. For SF cultures, an increase in dilution factors was necessary to improve fitting, still 
resulting in an unaccepted SF fit. The dilution of the metabolite active pool by unlabeled 
metabolites infers phenotypic heterogeneity, i.e., the presence of inactive/non-growth cells or the 
presence of pre-existing sources of carbon that are more slowly turned over after 13C-bicarbonate 
pulses (Mohr et al., 2013). Inactive cells may have biomass degradation and induce reflux of 
unlabeled carbon into the metabolic network (Nargund et al., 2014). Inactive subpopulations or 
the presence of metabolic inactive pools intracellularly can be increased by poor light 
transmittance due to suboptimal culture conditions, cell self-shading and/or insufficient mixing 
conditions (He et al., 2015). This may explain why Synechococcus 2973 does not exhibit 
significant growth advantages in SF conditions.  
 In addition, metabolite channeling can pass metabolite intermediates between enzymes 
without diffusion in the bulk volume of the cell. Channeling can significantly increase pathway 
efficiency (Wheeldon et al., 2016) and in bacteria is often associated with microcompartments 
(i.e., carboxysomes) or organized enzyme metabolons (Conrado et al., 2008; Jandt et al., 2013). 
For fast growing E.coli species, glycolysis channeling (glycolysisosome) has been evident 
(Shearer et al., 2005). Substrate channeling can be inferred from transient labeling experiments 
and isotope dilutions (Wheeldon et al., 2016). When tracing 13C-enrichment from 3PGA to 
downstream metabolites in Synechocystis 6803, it was previously found that certain downstream 
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metabolites could be labeled faster than precursors (e.g., PEP was labeled faster than 3PGA) 
(Young et al., 2011). In this study, we observed 13C-enrichment might not completely follow 
expected precursor-product relationships (Figure S6). Synechococcus 2973 showed rapid 13C-
enrichment to S7P over its precursor FBP/F6P, while Synechococcus 7942 showed an increase in 
enrichment to SBP over FBP/F6P. Because cyanobacteria possess bifunctional FBP/SBPase 
enzymes, the preference for FBP aldolase reactions over trans aldolase reactions may indicate 
channeling systems. The possible channeling routes in the Calvin cycle, especially due to 
microcompartmentation by carboxysomes, may provide advantages for CO2 fixation. Upon 
further analysis, Synechococcus 2973 also shows evidence for channeling of glycolysis 
intermediates towards the TCA pathway with faster citrate M+4 distribution over time that 
exceeds the 13C-enrichment levels of 3PGA (Figure 2.5). These channeling data also suggest a 
heterogenetic distribution of intracellular enzymes and metabolites. It remains unclear whether 
0.2% differences at the genome level or other regulation levels, such as metabolite channeling, 
are responsible for spatial organization of enzymes that confer benefits in growth and 
metabolism in Synechococcus 2973.  
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Figure 2.5 Labeling dynamics for Synechococcus 2973 and 7942 in photobioreactor 
conditions for Citrate, 3PGA, and Malate. (A). The mass isotopomer distribution for citrate 
(M+0) and (M+4) fractions as a function of time. Experimentally measured MIDs are the data 
points, while the line represents the fitted data from INCA. (B). The mass isotopomer 
distribution for malate (M+0) and (M+4) fractions as a function of time. Experimentally 
measured MIDs are the data points, while the line represents the fitted data from INCA. (C). The 
total 13C-enrichment of 3PGA compared to citrate as a function of time from experimentally 
measured MIDs. (D). Substrate channel scheme proposed based on labeling data from 
Synechococcus 2973. Experimentally measured MIDs with error bars represent standard 
deviations from biological duplicates.  
 
2.3.5 Conclusions. Synechococcus 2973 demonstrates efficient carbon fixation and small fluxes 
towards carbon loss and transient storage pathways. Under optimal growth conditions, 
photosynthesis generates abundant NADPH for rapid biomass synthesis. Under suboptimal 
conditions, cell anabolism cannot digest the influx from CO2 fixation, causing an accumulation 
of central carbon metabolites. Synechococcus 2973 demonstrates diverse phenotypes and 
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metabolic regulations based on bioreactor conditions, which can be used for broad 
photosynthetic bioengineering. Moreover, metabolite channeling appears to be involved in 
intracellular movement that can subvert diffusional limitations and improve reaction 
thermodynamics and pathway efficiency (Noor et al., 2014). INST-MFA of cyanobacteria is not 
only important for genome-to-phenome mapping but also crucial for the rational application of 
platform photo-biorefineries. Currently, INST-MFA is still challenging, and flux results may be 
influenced by substrate channeling or subpopulations. Sorting out these factors will require 
advanced labeling experiments (Allen et al., 2012; Mandy et al., 2014) to complement computer 
modeling and labeling experiments. Therefore, mutant creations and biomass composition 
analysis were performed to offer information resources to aid this study.  
2.4 Methods  
2.4.1 Cultivation conditions and transient labeling experiments. Synechococcus 2973 was 
grown in BG-11 medium (pH 8.0-8.5) at 38 ºC with 3% CO2 aeration (2000 mL/min) and 
continuous 500 μmol photons•m-2•s-1 under photobioreactors (Supporting photo 1). 
Synechococcus 2973 was also grown in shaking flasks (atmospheric CO2, 38 ºC and continuous 
and diurnal 100 μmol photons•m-2•s-1 light, 250 rpm). Synechococcus 7942 was grown in 
identical conditions, except in its optimal PBR conditions, where the light condition was 300 
μmol photons•m-2•s-1. Higher light irradiance inhibits Synechococcus 7942 growth. For the 
isotopic pool-size experiment, Synechocystis 6803 was grown in identical photobioreactors at 30 
ºC, 3% CO2 aeration and continuous 300 μmol photons•m-2•s-1 light. For each labeling 
experiment, cultures were diluted to an OD730 0.05 in BG-11 medium without citrate (so citrate 
could not be used a carbon source or affect bulk citrate labeling dynamics) and grown to OD730 
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0.6 (exponential phase) before the experiment was initiated. Prior to the experiment, the 3% CO2 
aeration was replaced with air (0.04% CO2) and a 2 mL aliquot of NaH
13CO3 (>98% purity, 
Sigma Aldrich, St Louis) was injected into each PBR or shaking flask (SF) for a final 
concentration of 4 g/L of NaH13CO3 to saturate the cell with labeled 
13CO2. Each identical 
culture in the PBR and SF was quenched at different time intervals after the 13C-pulse from 20 
seconds to 2 hours. These time-courses samples were analyzed to capture labeling dynamics of 
metabolites. Timed biological duplicates were used to generated standard deviations for 
experimentally measured MID values; however a minimum standard deviation of 3% was used 
in INCA model.     
2.4.2 Metabolite quenching, extraction, and analysis. The "fast-cooling" via cold solvents 
followed by centrifugation is reliable for recovering intracellular labeled metabolites (Fu et al., 
2015). After a 13C-pulse, samples were quenched by mixing with ice-cold minimal medium (<-
5 °C, without a carbon source) in a falcon tube, which was immediately soaked in liquid N2 to 
sustain cold temperature (To avoid ice formation, the culture sample was rapidly swirled for 
several seconds). Then the quenched biomass samples (<0 °C) were harvested via refrigerator 
centrifuge (3 min, 6000 rpm). For LC-MS analysis, the pelleted samples were extracted with a 
chloroform-methanol method (Ma et al., 2014). Ion-pairing LC-MS/MS was performed at the 
Proteomics and Mass Spectrometry Facility, Donald Danforth Plant Science Center, St. Louis. 
The labeling of energy molecules (e.g., NADH and ATP), organic acids and acetyl-CoA were 
quantified using hydrophilic interaction liquid chromatography (HILIC) coupled to electrospray 
time-of-flight MS (Hollinshead et al., 2016) at Joint Bio-Energy Institute, CA.  
2.4.3 Estimation of relative pool sizes of metabolites. Changes of metabolite pool sizes in 
cyanobacteria were analyzed by an MS isotopomer ratio approach (Bennett et al., 2008) (using 
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fully labeled cell extracts as internal standards for semi-quantitative metabolomics (Wu et al., 
2005)). Specifically, E. coli K-12 was cultured with uniformly-labeled 13C-glucose and 13C-
sodium bicarbonate in an M9 minimal media. The estimation of metabolite pool sizes was 
performed by mixing a known amount of labeled E. coli biomass with unlabeled cyanobacteria 
cultures (three biological replicates). Then, the mixtures were quenched by a liquid N2 bath and 
extracted for HILIC-MS analysis (Figure S2c). The isotopic ratio of each metabolite (labeled vs. 
unlabeled) was normalized by the amount of E. coli and cyanobacterial biomass, respectively.   
2.4.4 Biomass composition analysis. The cells were harvested during exponential growth by 
centrifugation, and cell pellets were washed with 0.9% NaCl and ddH2O and then freeze-dried. 
Protein and amino acid compositional analysis was performed by the Molecular Structure 
Facility, University of California (Davis, CA). Carbohydrates, lipids, chlorophyll a, and ash were 
measured by previously reported methods (details in supporting information: Appendix 1).  
2.4.5 GC-MS analysis of proteinogenic amino acids. To confirm the capability of 
Synechococcus 2973 to uptake organic acids, unlabeled seed cultures were inoculated (4% 
inoculation ratio) into the medium with fully labeled NaH13CO3 and unlabeled substrates (6mM) 
including acetate, TCA cycle intermediates (e.g., malate and citrate) and pyruvate in shaking 
flasks or PBRs for cultivation of 48 hours. The labeling in proteinogenic amino acids was then 
analyzed using a TBDMS method (You et al., 2012).  
2.4.6 Isotopically Nonstationary MFA. MFA is estimated based on isotope labeling dynamics 
of the free metabolites. The MFA model included the Calvin cycle, pentose phosphate pathway, 
TCA cycle, the glyoxylate shunt, anaplerotic pathways, and photorespiration pathway. A list of 
reactions in the network model with their atom transitions is provided in Table S1. A lumped 
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biomass equation based on biomass composition analysis and biochemical equations was used to 
fit the model to biomass production (Table S2). The INCA platform (Young, 2014) used a 
custom MATLAB ODE solver to fit over 890, 600, and 800 individual mass fragments for 
Synechococcus 2973 PBR, SF, and Synechococcus 7942 to obtain fluxes in the assumed 
cyanobacterial network, respectively. INCA provided a goodness of fit via a chi-square statistical 
test as well as confidence intervals of all estimated parameters (Model formulation details are 
included in the Supporting Information).  
2.4.7 Construction of the zwf, pgl and the succinate dehydrogenase deletion mutants.  Three 
mutants were built, which served to independently validate the related aspects of metabolism 
described by the modeling process. The ∆zwf mutant was constructed by insertional mutagenesis 
of the first enzyme of the OPPP, glucose-6-phosphate 1 dehydrogenase. The ∆zwf mutant was 
characterized via growth rate (Figure 2.1). The mutant activity was confirmed via IP-LC-MS/MS 
by the absence of the downstream product of its disrupted gene, 6-phosphogluconate (Figure 
S2d,e,f). The ∆pgl and ∆sdh mutant was constructed by a cpf1 based CRISPR system was used 
to delete succinate dehydrogenase from start codon to stop codon from the chromosome. Details 
are provided in the Supporting Information.  
 
 
 
 
47 
 
Chapter 3: Cyanobacteria carboxysome mutant 
reveals the influence of enzyme compartmentalization 
on cellular metabolisms and metabolic network 
rigidity  
 
This chapter has been reproduced from the following manuscript currently undergoing 
preparation:  
 
Abernathy MH, Czajka J, Allen DK, Cameron J, Tang Y. Cyanobacteria carboxysome mutant 
reveals the influence of enzyme compartmentalization on cellular metabolisms and metabolic 
network rigidy. [Currently in preparation] 
Abstract 
Cyanobacterial carboxysomes encapsulate carbonic anhydrase and ribulose-1,5-bisphosphate 
carboxylase/oxygenase and are key organelles that promote CO2 concentration and fixation. 
Genetic deletion of the major structural proteins encoded within the ccm operon in Synechococcus 
sp. PCC 7002 (∆ccmKLMN) disrupts carboxysome formation and significantly affects cell 
physiology. In this study, we employed both metabolite pool size analysis and isotopically 
nonstationary metabolic flux analysis (INST-MFA) to examine metabolic regulation in cells 
lacking carboxysomes. Under high CO2 environments, the ∆ccmKLMN mutant had similar growth 
rates as the control strain and maintained a similar flux distribution through the central metabolism, 
with the exceptions of moderately elevated protein synthesis and photorespiration activity. 
Metabolite analyses indicated that the ∆ccmKLMN strain had larger pool sizes of pyruvate, UDPG, 
and aspartate as well as higher excretions of malate and succinate. Under photomixotrophic 
conditions, both the control strain and the ∆ccmKLMN mutant metabolized acetate and pyruvate. 
Provision of acetate promoted carboxysome mutant growth when light and CO2 were insufficient. 
The results suggest that the ∆ccmKLMN mutant has minimal changes in flux and instead 
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reorganizes its metabolism through significant changes in intracellular metabolite pool 
concentrations. The removal of microcompartments may loosen the flux network regulation and 
allow for redirection of central metabolites to competing pathways (e.g., lactate production). This 
study provides important insights into both metabolic regulation via enzyme compartmentation 
and the compensatory responses in cyanobacterial phototrophic metabolism.    
 
3.1 Introduction 
Cyanobacteria are promising production systems for renewable resource demands because 
they are photosynthetic, genetically tractable, and capable of rapid growth. Photosynthetic 
organisms assimilate carbon using ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO). 
However, in addition to its slow carboxylation kinetics, RuBisCO also oxygenates ribulose-1,5-
bisphosphate (RuBP) producing 2-phosphoglycolate (2PG), a compound that is toxic to cells at 
significant levels (Kern et al., 2011). Cyanobacteria have evolved CO2 concentrating mechanisms 
(CCM) around RuBisCO, encapsulating the enzyme within clathrate structures comprised of 
multiple proteins that form microcompartments referred to as carboxysomes. Carboxysomes result 
from protein-protein interactions between structural proteins and RuBisCO, which allows the 
formation of an icosahedral shell that also encases carbonic anhydrase (CA) (Cameron et al., 
2013). These polyhedral structures concentrate and increase CO2 availability to RuBisCO (Cai et 
al., 2009; Dou et al., 2008), without saturating CA (Mangan and Brenner, 2014). 
Bacteria, as simple systems, are presumed to have little or no spatial subcellular 
organization, and thus the cytosol is generally assumed to be homogenous (Sweetlove and Fernie, 
2018). However, evidence of metabolon and metabolite channeling in bacteria exists (Ishikawa et 
al., 2004; Broddrick et al., 2016; Abernathy et al., 2017a), indicating that enzymes may be more 
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organized than previously suspected. Carboxysome micro-compartmentalization and photosystem 
co-localization on membranes are an obvious exception, and the advanced spatial organization 
confers enhanced growth and productivity. RuBisCo has also been shown to operate apart from 
carboxysomes and organized near the thylakoid membranes along with Calvin cycle enzymes 
(Agarwal et al., 2009; Cameron et al., 2013).  Central intermediates of metabolism are likely passed 
between enzymes without being released into the cytosol (Abernathy et al., 2017b). The 
channeling of metabolites between enzymes could also uniquely contribute to metabolic regulation 
(Sweetlove and Fernie, 2018). In eukaryotes, channeling is often associated with cellular 
organelles and membrane compartments, such as the mitochondria or peroxisomes (Graham et al., 
2007). While less thoroughly studied, the formation of metabolons and enzyme proximity 
channeling may also widely present in bacterial pathways (Abernathy et al., 2017b).  
Cyanobacterial carboxysomes effectively organize RuBisCO for CO2 fixation and are the 
starting point of carbon metabolism in cyanobacteria. By removal of cyanobacterial carboxysomes, 
this study investigates how the redistribution of enzymes in space or disruption of metabolons can 
affect cellular metabolism and the metabolic flux network. Isotopic experiments are regularly used 
to estimate metabolic fluxes and pathway channeling (Shearer et al., 2005; Williams et al., 2011; 
Zhang et al., 2017). In cyanobacteria, isotopically nonstationary metabolic flux analysis (INST-
MFA) uses time-dependent mass isotopomer distributions (MID) of free metabolites to estimate 
fluxes through central metabolism (Young et al., 2011; Abernathy et al., 2017a; Hendry et al., 
2017; Xiong et al., 2015a). The time-dependent labeling experiments can also identify 
heterogeneous intracellular environments (i.e. metabolically inactive pools) (Abernathy et al., 
2017b). In this study, ∆ccmKLMN in conjecture with 13C-MFA offers an effective approach to 
understand Synechococcus 7002 metabolism in the absence of an innate microcompartment that 
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might offer the anchoring point for cascade enzymes (Abernathy et al., 2018). Specifically, 
∆ccmKLMN mutant was grown under 1% v/v CO2 environments (hereby referred to as high CO2 
conditions), and its phenotype was measured for flux reorganization, metabolite concentrations, 
biomass composition, labeling dynamics of cascade metabolites, and photosynthetic capabilities. 
The results provide insight into cyanobacterial metabolism and overlooked metabolons for flux 
regulations. 
3.2 Results  
3.2.1 Growth comparison between the control strain and ∆ccmKLMN mutantThe 
Synechococcus PCC 7002 control strain and the ∆ccmKLMN mutant were grown at high CO2 (1% 
v/v) and continuous light (125 µmol photons m-2•s-1), which provided enough biomass for analyses 
while still maintaining phenotypic growth differences (Figure 3.1). The growth rates in the 
exponential phase were 0.11 ± 0.005 h-1 and 0.085 ± 0.005 h-1 at 1% CO2 and 125 µmol photons 
m-2•s-1 for control and ∆ccmKLMN mutant respectively. In the CO2 high concentration, the 
addition of NaHCO3 did not significantly promote mutant growths. Under low CO2 conditions 
(0.2% v/v CO2), inclusion of 50 mM NaHCO3 raised culture pH to ~9 and significantly reduced 
growth rate for the control strain. When the CO2 concentration was below 0.25%, the ∆ccmKLMN 
mutant was unable to grow, and the presence of 50 mM NaHCO3 led to significant cell death (i.e., 
the drop of OD600 during incubation as seen in Figure 3.1). Under photomixotrophic conditions, 
the control strain did not utilize glycerol to promote cell growth. The mutant showed slight growth 
with glycerol under low CO2 circumstances (0.2% v/v CO2). These observations revealed the 
deleterious impact on biomass productions if the cyanobacterial ability to concentrate CO2 in 
microcompartments is removed.  
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Figure 3.1 Growth as a function of CO2 and light for the control and ∆ccmKLMN strains. 
Low CO2, low light conditions are 0.2% CO2 and 25 µmol m
-2•s-1. High CO2, high light 
conditions are 1% CO2 and 125 µmol m
-2•s-1. Glycerol at a concentration of 0.2% (w/w) and 
sodium bicarbonate (NaHCO3) at a concentration of 50 mM were added to cultures to investigate 
photo-mixotrophic growth rates. 
 
3.2.2 Biomass composition analysis. The biomass compositions (Figure 3.2) were 
measured to reveal the differences in carbon partitioning between the control strain and the 
∆ccmKLMN mutant. The fatty acid profile was compositionally similar between the two strains, 
with the exception of statistically significant (p-value <0.05) increases of 18:2 cis-9,12 and 18:1 
cis-11 fatty acids and a decrease  of 18:1 cis-9 fatty acid in the ∆ccmKLMN mutant. Protein-based 
amino acid profiles were also similar with a except for slightly more leucine and lysine and slightly 
less serine and threonine in the mutant. The biomass of the ∆ccmKLMN strain exhibited a higher 
protein fraction, 51.2 ± 1.7 wt% protein of dry cell weight (DCW), compared to the control strain 
(43.7 ± 0.4%). The total glycogen/carbohydrate and lipid content were comparable with the 
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∆ccmKLMN mutant comprised of 10.4 ± 3.1 wt% carbohydrate and 7.3 ± 3.0 wt% lipids relative 
to the control strain that produced 12.3 ± 3.4 wt% carbohydrate and 6.8 ± 4.9 wt% lipids.  
 
Figure 3.2 Biomass compositional analysis of Synechococcus PCC 7002 control and 
∆ccmKLMN mutant. A.) Fatty acid profile found in each strain as a percent of total dry cell 
weight. B.) Amino acid profile found in each strain as mole percent. C.) Macromolecule biomass 
composition as a percentage of dry cell weight. *indicates a significant difference between PCC 
7002 control and ∆ccmKLMN (p-value < 0.05). Both control and mutant strains were cultivated 
in high CO2, high light conditions (1% v/v CO2 and 125 µmol photons m
-2•s-1). 
 
3.2.3 INST-MFA reveals flux topology in ∆ccmKLMN mutants revealed by INCA. 
Using the biomass constraints as a sink reaction in the metabolic model, isotopically nonstationary 
metabolic flux analysis was performed with the control and ∆ccmKLMN mutant strains under high 
CO2 and high light conditions. Figure 3.3 is scaled with net fluxes normalized to a net CO2 uptake 
of 100 using a network derived from annotated genes found in the KEGG database. The flux 
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through the Calvin cycle was large, about 7 moles of carbon per 100 moles assimilated are lost 
through decarboxylation reactions, and about 11% of the carbon flux is directed to the TCA cycle. 
The INST-MFA model produced statistically acceptable sum-of-squared-residual fits of 549 and 
502 with 95% confidence ranges of [425, 550] and [429, 552], respectively for the carboxysome 
mutant and control strain.    
Based on the INST-MFA analysis, the flux through some central metabolic pathways 
(including the glycolysis, the TCA and the Calvin cycle pathways) were statistically 
indistinguishable between the ∆ccmKLMN strain and the mutant (despite the differences in outflow 
fluxes towards synthesis of biomass and extracellular metabolites). This result indicated that the 
mutant metabolism was able to conserve flux topology after removal of its innate carbon 
concentration mechanism under high light and high CO2 conditions. 
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Figure 3.3 Synechococcus PCC 7002 control and ∆ccmKLMN flux maps as determined by 
INCA (Young, 2014) under high CO2, high light conditions. Net fluxes are normalized to a 
CO2 uptake of 100 mmol of CO2 and reported as mmol/gDCW/h. PCC 7002 ∆ccmKLMN flux 
values are reported in blue, and PCC 7002 control flux values in red. Percentages of total 13C 
enrichment at steady state of some metabolites are represented by bar graphs. 13C enrichment 
was calculated at isotopic steady state using the formula 
1
𝑁
∑ 𝑀𝑖 ∗ 𝑖
𝑁
𝑖=1 . Standard deviations are 
based off biological replicates (n=2). 
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Metabolic regulations for photorespiration. Photorespiration occurs when RuBisCO 
oxygenates RuBP producing 2PG and 3-phosphoglycerate (3PGA). 2PG is metabolized to 
glyoxylate and is then either decarboxylated to formate or processed by conversion to glycine, 
serine, hydroxypyruvate, and finally glycerate, which re-enters the Calvin cycle as 3PGA. The 
KEGG genome annotation of the photorespiratory pathway in PCC 7002 is not complete, thus, the 
extent to which additional pathways are utilized remain unclear. In the cyanobacterial control 
strain, photorespiration is minimized because of the carboxysome and efficient CO2 concentrating 
mechanism, where a measureable net flux of 6.5 moles of 2PG were estimated to be produced per 
100 C-moles of biomass under high light/high CO2 condition. Best estimates of photorespiratory 
flux for the mutant indicated a net flux of 7.6 moles of 2PG per 100 C-moles of biomass. This 
increase in photorespiration is consistent with elevated amounts of free RuBisCO, increased CO2 
compensation points (Marcus et al., 1992), and decreased fluorescence measurements (FV/FM) 
values under high CO2 conditions (Figure 3.4).  The FV/FM ratio measures the normalized quantum 
efficiency of photosystem II (PSII); here, the variable fluorescence (FV) was slightly increased in 
the control strain compared to the ∆ccmKLMN mutant while the maximum fluorescence (FM) 
remained similar, resulting in 1.15-fold higher FV/FM and thus higher photosynthetic efficiency of 
PSII. The ∆ccmKLMN mutant was also found to have a lower net O2 evolution (O2 generation 
through photosynthetic water splitting and O2 uptake through aerobic respiration and 
photorespiration) than the control strain (397 ± 68 µmol O2/mg chl a/hr vs 496 ± 74 µmol O2/mg 
chl a/hr). Under dark conditions, respiratory O2 uptake was found to be slightly higher in the 
∆ccmKLMN mutant and represented a larger percentage of net O2 evolution. In cyanobacteria, 
aerobic respiration during continuous light conditions is limited due to a small TCA cycle flux and 
sufficient energy generation from photosynthesis. Therefore, the majority of respiratory O2 uptake 
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is assumed to be photorespiration and in this case, accounted for about 30 ± 7% of O2 evolution in 
the ∆ccmKLMN strain and 20 ± 3% in the control strain. The Mehler reactions may also account 
for some O2 uptake dependent upon on several factors including carbon content and light 
(Allahverdiyeva et al., 2011). Furthermore, in the carboxysome mutant, glycerate, a downstream 
photorespiration intermediate, was found to have a larger metabolite pool and to be labeled 
quicker, indicating higher flux to glycerate; however this was not the case for 2PG, which was 
found to be labeled faster but also had a smaller metabolite pool (Figure 3.5).Carbon fixation is 
closely tied to PSII activity as acts as a sink for reducing equivalents, but photorespiration mayact 
as a substitute allowing for sustained electron flow. Thus, our results support the hypothesis that 
photorespiration may play a critical role in maintaining photosynthetic efficiency during cell 
stresses.  
 
Figure 3.4 Photosynthetic capacity of PSII (FV/FM) and O2 evolution of Synechococcus PCC 
7002 control and ∆ccmKLMN. Technical (n=2) and biological replicates (n=3) were used for 
standard deviations. *p<0.001.  Percentages represent the respiratory O2 uptake (as measured in 
the dark) as a fraction of the total net O2 evolution. F0 is the minimum fluorescence, FM is the 
maximum fluorescence, and FV is the variable fluorescence. 
 
3.2.4 Change in pool sizes in response to carboxysome knockout. This study further 
investigated ∆ccmKLMN compensatory responses at metabolite levels (Heise et al., 2015). Pool 
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sizes were measured qualitatively using fully 13C labeled E. coli cell extracts as an internal standard 
(Figure 3.5a). The ∆ccmKLMN mutant was found to dramatically increase its intracellular pyruvate 
concentrations (by 18 folds compared to the control), suggesting a severe flux congestion at 
pyruvate node. Moreover, the mutant had significantly higher levels of intracellular UDPG, 
aspartate, and glycerate and less ADPG.  UDPG labeled rapidly in the ∆ccmKLMN mutant (Fig. 
S2), which may be important for sucrose synthesis. Sucrose is often excreted by Synechococcus 
when stressed and may reflect the loss of a carbon concentrating mechanism causing a metabolic 
shift from the competing glycogen pathway (Qiao et al., 2018). The metabolite pool size of RuBP 
was significantly decreased and the levels of 2PG and 3PGA were slightly decreased compared to 
the control. There was also an observed pool size increase and increased 13C-enrichment (Fig. S2) 
in the free amino acid aspartate, which quickly exchanges with OAA, the product of PEP. 
However, the flux through PEP was not elevated in comparison to the control strain as previously 
suggested (Hackenberg et al., 2012). Finally, secreted metabolites were also analyzed in the 
supernatant. The ∆ccmKLMN mutant was found to excrete organic acids including succinate and 
malate (Fig. 3.5b).  Enzymic-based spectroscopic assay (R-BioPharm, Darmstadt) determined that 
the ∆ccmKLMN mutant produced extracellular succinate (2.8 ± 0.3 mg/L) (Table S1). The excreted 
organic acids may have a minor impact on the carboxysome deficient mutant flux estimates.     
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Figure 3.5 Comparison of metabolite pool size between Synechococcus PCC 7002 control and 
∆ccmKLMN. A.) Relative pool size comparisons between the two strains. A y-axis of 1 represents 
equal metabolite concentrations while a y-axis > 1 indicates the factor of pool size in ∆ccmKLMN 
greater than PCC 7002 ctrl.  The relative pool size was normalized using a 13C-labeled internal 
standard and cell density. B.) Secretion of succinate and malate as measured in the supernatant as 
a function of peak intensity, counts per second (cps) and normalized to a 13C labeled internal 
standard.  
 
3.3 Discussion 
3.3.1 Compensatory response in cyanobacteria conserves flux networks. Carboxysomes are 
key microcompartments in cyanobacteria for carbon concentration and assimilation. The loss of 
carboxysomes significantly impairs cell growth under atmospheric and low CO2 conditions. Under 
high concentration CO2 (1% v/v), however, the ∆ccmKLMN mutant maintains flux ratios similar 
to the control strain despite large transcriptional changes seen in carboxysome mutants under high 
CO2 conditions (Hackenberg et al., 2012). At a metabolite level, significant changes in steady-
state metabolite pool sizes, metabolic fluxes, and biomass composition were noted when 
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comparing the control to the ∆ccmKLMN strain. Macromolecule partitioning in cyanobacteria was 
changed with the ∆ccmKLMN mutant containing a higher relative protein content. A slight 
decrease in carbohydrate content of the ∆ccmKLMN strain may represent a shift in carbon 
allocation during disruption of the CCM. The loss of the CCM changes the carbon supply and 
energy-balance, leading to secretion of succinate and malate and an accumulation of intracellular 
metabolites such as UDPG, aspartate, glycerate, and pyruvate. The CCM is closely tied to 
allosteric metabolites (Burnap RL et al., 2015), and a loss of carboxysomes may cue metabolite 
shifts towards free amino acids (i.e. aspartate) and related carbon skeletons (i.e. pyruvate). This 
causes changes in reaction thermodynamics due to metabolic imbalances. The control strain was 
also found to have a slightly higher [ATP]/[NADPH] than the carboxysome-free mutant (Fig. S3) 
and higher photosynthetic capability of PSII (Fig. 3.4). The higher metabolite pool of NADPH in 
the ∆ccmKLMN mutant indicates saturated electron acceptors, which lowers net O2 evolution 
(Wang et al., 2016). Photorespiration was found to be slightly elevated in the ∆ccmKLMN mutant 
as expected (Fig. 3.3 and Fig. 3.4), which would require more ATP and could result in lower 
[ATP]/[NADPH].  While transcriptional and translational control must play an important 
regulatory and adaptive role, it has been proposed that many aspects of metabolic regulation in 
cyanobacteria can exhibit control at the level of individual metabolite concentrations and energetic 
source-sink balances (Cano et al., 2018). Thus, despite changes in the spatial organization, 
complex compensatory responses eventually lead to a highly conserved flux network.  
3.3.2 Differences in the assumed metabolic network of PCC 7002 compared to other 
cyanobacterial species. PCC 7002 had subtle differences in the metabolic network of the model 
cyanobacterium Synechocystis 6803 (Young et al., 2011). In the TCA cycle, PCC 7002 lacks 
fumarate hydratase which interconverts malate and fumarate such that fumarate is solely 
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generated from purine metabolism (Figure 3.3). PCC 7002 also lacks the GABA (γ-aminobutyric 
acid) shunt and produces succinate through the intermediate succinic semialdehyde (Zhang et al., 
2016). Additionally, PCC 7002 genome annotation lacks phosphoketolase, phosphate 
acetyltransferase, and acetate kinase. Thus PCC 7002 cannot generate acetyl-coA directly from 
the pentose phosphate pathway. In contrast, Synechocystis 6803 has an active phosphoketolase 
shunt that splits xylulose-5-phosphate (Xu5P) to acetyl phosphate and glyceraldehyde-3-
phosphate (G3P); acetyl phosphate can then be converted into acetyl-CoA or acetate. 
Synechocystis 6803 may utilize this shunt to enhance acetyl-coA synthesis and increase the ratio 
of phosphoglycerate kinase/phosphoglycerate mutase, an important branch node for 
photosynthetic organisms (Knoop et al., 2013; Xiong et al, 2015b; Chwa et al., 2016). 
3.3.3 Using carboxysome-deficient mutants to redirect carbon fluxes to important 
precursor metabolites. Cyanobacterial flux can be redirected if central carbon sinks or 
competing pathways are altered (Xiong et al., 2015a). Blocking the synthesis of glycogen, which 
can accumulate up to 30% of a cyanobacteria’s dry cell weight (Ungerer et al., 2018), is 
considered a key metabolic strategy for redirecting carbon fluxes. However, knocking out the 
production of glycogen does not typically increase product titers due to significantly decreased 
growth rates (Li et al., 2014). In other studies, knocking out glycogen synthesis resulted in about 
6% more carbon being directed to the TCA and 30% more flux being directed to UDP-glucose 
(Hendley et al., 2017). Here, without blocking competing pathways, the ∆ccmKLMN mutant was 
able to increase UDPG pool sizes (by two folds) as well as UDPG synthesis rates (Fig. 3.5 and 
Fig. S3). The sugar unit is the precursor for sucrose or other valuable polysaccharides like 
heparosan (Sarnaik et al., 2019).  Interestingly, the ∆ccmKLMN mutant under high CO2 and 
normal nitrogen conditions has significantly elevate intracellular pyruvate and excretes organic 
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acids through overflow metabolism. Under N-deprivation, knocking out glycogen synthesis 
elevates pyruvate and other organic acid excretion but causes significantly inhibits growth, 
making it a poor metabolic engineering strategy (Benson et al., 2016; Jackson et al., 2015). In the 
∆ccmKLMN mutant, pyruvate accumulation was high despite unchanged central flux network 
around pyruvate (Figure 3.3 and 3.5). This pyruvate accumulation could be from the malate 
shunt (and thus the aspartate storage pool) or pyruvate kinase and may represent a different 
strategy to alter fluxes for biotechnological applications. For example, the ∆ccmKLMN mutant 
had a 24% increase in lactate productivity (uM lactate/h) and a 125% increase in lactate titer 
(mM lactate) compared to a engineered cyanobacteria lactate producing strain (Clark et al., 
2018). 
 3.3.4 Impact of carboxysome mutation on photomixotrophic metabolism. To probe 
photomixotrophic growth in the WT and carboxysome mutant, labeled glycerol, acetate, and 
pyruvate was used for isotopic experiments (Fig. 3.6). Both strains incorporated acetate and 
resulted in labeled Leu (derived from acetyl-CoA) and Glu (derived from ketoglutarate), which 
indicates that organic carbons can be mainly incorporated to the right branch of the TCA cycle. 
The  incorporation of the 13C-carbon acetate labeling into leucine but not isoleucine indicates PCC 
7002 uses a threonine dependent pathway rather than the citramalate pathway for isoleucine 
synthesis (Wu et al., 2010). Under the high light/CO2 condition, a mixotrophic environment had 
minimal impact on ∆ccmKLMN mutant growth. Under low CO2 conditions, acetate 
supplementation rescued growth of the ∆ccmKLMN mutant and resulted in the incorporation of 
acetate carbon into biomass (revealed by isotopic labeling of amino acids) (Figure 3.6a & b). In 
addition, the ∆ccmKLMN mutant also incorporated glycerol into biomass under low CO2 
conditions. This is consistent with previous literature indicating that glycerol aids in PCC 7002 
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growth at atmospheric conditions (0.04% v/v CO2) by increasing reducing equivalents (NADPH) 
in the cell (Ludwig and Bryant, 2012). Neither strain utilized significant amounts of labeled 
glycerol under high CO2 conditions when with sufficient light sources indicating that the 
assimilation of CO2 was the major source of carbon for metabolism. Finally, pyruvate can be co-
utilized by both strains for synthesis of some amino acids (such as leucine, isoleucine and 
glutamate). However, pyruvate inhibits ∆ccmKLMN mutant growth under low light and low CO2 
conditions. In summary, tests of photomixotrophic conditions suggest that loss of carboxysomes 
has a higher impact on cyanobacterial photomixotrophic metabolism under suboptimal growth 
conditions.  
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Figure 3.6. Steady-state proteinogenic amino acid labeling from labeled glycerol, acetate 
and pyruvate to monitor photomixotrophic growth of PCC 7002 control and ∆ccmKLMN. 
GC-MS data for proteinogenic amino acids under photomixotrophic conditions with 25 mM 
labeled carbon. Standard deviations are estimated based on two biological replicates (n=2). 
Percent 13C increase is graphed. Labeling of amino acids (A) and growth rate change (B) from 
mixotrophic cultures under low light/CO2. Labeling of amino acids (C) and growth rate change 
(D) from mixotrophic cultures under high light/CO2. Growth rate (ΔOD600/day) change (B & D) 
is normalized to the photoautotrophic growth rate of PCC 7002 control. 
 
3.3.5 Insights into channeling-based flux regulation. Presence of metabolon or metabolite 
channeling may cause a heterogeneous mixture of intracellular metabolites. In INST-MFA, 
dilution parameters are typically introduced to aid in model fitting due to observations that 
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metabolites never reach 100% isotopic enrichment (Antoniewicz et al., 2007; Boyle et al., 2017). 
These fitted dilution or G parameters for multiple metabolites represent unlabeled biomass reflux 
or heterogeneous metabolite pools that arise from enzyme localization and/or metabolite 
channeling. Removal of carboxysomes resulted in higher steady state 13C enrichment in sugar 
phosphate metabolites (S7P, 3PGA, RuBP; Figure 3.3) and thus lower inactive pool percentages 
(Tables S1 and S2). This may indicate more homogeneous metabolite pools and the breakage of 
metabolite channels present in the cyanobacteria. Recent literature has focused on metabolite 
channeling as a way for cells to regulate fluxes and cell homeostasis either with dynamic sequential 
protein-protein interactions or enzyme clusters (Zhang et al., 2017; Sweetlove et., 2018; Abernathy 
et al., 2017). Protein-protein interactions and localization of enzymes is a form of control for cells 
(Stipanuk et al., 2018). Calvin cycle enzymes may channel intermediates through enzyme co-
localization, as evidenced through ultra-centrifugation and immunoelectron microscopy studies 
(Agarwal et al., 2009). Genetic removal of carboxysomes could disrupt native metabolite channels 
and cause a more homogeneous environment as observed from higher degree of 13C enrichment 
and higher metabolically active pools in sugar phosphate metabolites. In contrast, the ∆ccmKLMN 
mutant had lower 13C-enrichment for malate and citrate. The INCA based modeling suggests that 
flux results are sensitive to not only pathway topology and reversibility, but also isotopic dilutions 
due to heterogeneous intracellular mixture of metabolites. Carboxysome-free mutants may serve 
as a method of containment for the genetically engineered microbial cell factories (Clark et al., 
2018) and as a method for loosening metabolic rigidity, allowing for flux redirection towards 
pyruvate, TCA intermediates and UDPG; Thus, increasing the mutant’s ability to be engineered 
for biomanufacturing or mixotrophic growth. Deciphering these innate channels and associated 
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flux regulations can improve both metabolic modeling and metabolic engineering effectiveness 
(Abernathy et al., 2017b). 
3.3.6 Conclusions. Carboxysome removal in PCC 7002 alters the spatial organization of CO2 
assimilation. Enzyme organization and protein-protein interactions affect flux networks but the 
quantitative details remain poorly understood. This study offers new insights into metabolic 
rigidity and flexibility complex/multiple-level metabolic controllers. Regulation at transcriptional 
and translational levels (e.g., fine-tuning ribosome production) (Li et al., 2018) as well as 
channeling serve to minimize cellular impact and reorganization under genetic or environmental 
perturbations (He et al., 2017). Future studies are needed to elucidate the rules dictating the 
formation of metabolons a or metabolite channeling in central pathways, and as such will enable 
bio-designers to add an extra level of metabolic control to current methods that rely mostly on 
gene copy number, transcriptional and translational regulations. 
 
3.4 Materials and Methods  
3.4.1 Strains and Cultivation Conditions. Both Synechococcus PCC 7002 control strain and the 
Synechococcus PCC 7002 ∆ccmKLMN mutant were cultured and maintained in A+ medium 
without citrate (18 g/L NaCl, 0.6 g/L KCl, 1 g/L NaNO3, 5 g/L MgSO4•7H2O, 0.05 g/L KH2PO4, 
0.37 g/L CaCl2, 0.03 Na2EDTA•2H2O, 1 g/L Tris HCl, 0.555 mM H3BO3, 2.3 μM ZnCl2, 0.21 μM 
MoO3, 3 μM NH4Fe(SO4)2•12 H2O, 22 μM MnCl2, 0.012 μM CuSO4, 0.05 CoCl2, 0.0004 g/L 
vitamin B12) with appropriate antibiotics (100 μg/mL kanamycin or 25 ug/mL gentamicin 
respectively) (Stevens et al., 1973). Concentrated glycerol and sodium bicarbonate stocks were 
filtered and added to denoted cultures at a final concentration of 0.2% w/w and 50 mM, 
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respectively. The same temperature (37 °C), shaking speed (200 rpm) and culture volumes (20 mL 
of medium in 125 mL shake flasks) were used in all experiments. Cultivations occurred at either 
0.2% v/v CO2 with continuous 25 μmol of photons m-2•s-1 or 1% v/v CO2 with 125 μmol of photons 
m-2•s-1. Optical density was measured at 730 nm (OD730). The Synechococcus PCC 7002 mutants 
were generated previously (Gordan et al., 2016) and obtained from the Pfleger group (University 
of Wisconsin-Madison). Briefly, the control strain was generated by inserting RbcL-GFP in the 
SYNPCC7002_A2842 neutral site along with a gentamicin resistance cassette. The Synechococcus 
PCC 7002 ccmKLMN mutant was generated by replacing ccmKLMN with a kanamycin resistance 
cassette along with RbcL-GFP (Gordan et al., 2016). The GFP in control and ccmKLMN mutant 
were used for the observation and confirmation of carboxysomes inside of cells. 
3.4.2 INST-MFA and 13C Labeling experiments. INST-MFA was conducted at 1% v/v CO2 with 
125 μmol of photons m-2•s-1. For each experiment, cultures were inoculated from a seed culture to 
an OD730 0.05 in A+ medium and grown to exponential phase. Prior to the labeling experiment, a 
2 mL aliquot of saturated NaH13CO3 (> 98% purity, Sigma Aldrich, St Louis) was injected into 
the medium for a final concentration of 4 g/L of NaH13CO3. Following the 
13C-pulse, the cultures 
were quenched at different time intervals (30, 60,120, 180, 300, 150, 600, 900, 3600 s) with ice 
cold medium and liquid nitrogen bath (Abernathy et al., 2017). The time-courses samples were 
centrifuged for 5 minutes (8000 x g, ~0 oC).  Biomass pellets were then frozen at -80 °C until 
metabolite extraction and analysis. Timed biological duplicates were used to generate standard 
deviations for experimentally measured MID values. Relative metabolite pool sizes were analyzed 
by an MS isotopomer ratio approach using fully labeled cell extracts as internal standards, 
specifically, fully labeled E. coli K-12 (cultured with uniformly labeled 13C glucose and 13C 
sodium bicarbonate). The estimation of metabolite pool sizes was performed by mixing a known 
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amount of 13C labeled E. coli biomass with unlabeled cyanobacteria (three biological replicates). 
Then, the mixtures were extracted for LC-MS analysis. The isotopic ratio of each metabolite 
(labeled vs. unlabeled) was normalized by the amount of E. coli and cyanobacterial biomass, 
respectively (Abernathy et al., 2017). 
3.4.3 Metabolite Extraction and analysis. The pelleted samples were extracted with a 
chloroform–methanol method (Ma et al., 2014). Supernatant aliquots were taken for analysis by 
lyophilizing 5 mL of medium. All samples were resuspended in 1 mL of ddH2O for LC-MS/MS. 
Ion-pairing LC–MS/MS was performed at the Proteomics and Mass Spectrometry Facility, 
Donald Danforth Plant Science Center, St. Louis. Succinic acid was quantified using an UV-
method enzyme kit from R-Biopharm (cat No. 10176281035; Darmstadt, Germany) with A+ 
medium as controls. 
3.4.4 Isotopically Nonstationary 13C-MFA. A metabolic network was constructed with carbon 
atom transitions and included the Calvin cycle, pentose phosphate pathway, TCA cycle, 
anaplerotic pathways, and a grouped photorespiration pathway (Table S1). A lumped biomass 
equation based on biomass composition analysis and biochemical equations was used to fit the 
model to biomass production. The INCA platform used a custom MATLAB ODE solver to fit 
the experimentally determined free metabolite labeling data for Synechococcus PCC 7002 
control and the ∆ccmKLMN mutant (Young 2014). INCA provided a goodness of fit via a Chi 
square statistical test as well as confidence intervals of all estimated parameters. Dilution 
parameters from INCA model were further studied to account for labeling dilutions due to 
metabolically inactive pools (Young et al., 2011).   
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3.4.5 Biomass composition analysis. The cells were harvested during exponential growth by 
centrifugation, washed with 0.9% NaCl and ddH2O and then freeze-dried. Protein and amino 
acid compositional analysis was performed by the Molecular Structure Facility, University of 
California (Davis, CA). Total carbohydrate and lipid amounts were measured by previously 
reported methods (Abernathy et al., 2017). Fatty acid relative profile analysis was performed by 
MicrobialID. The biomass measurements were used to generate a biomass described using 
equations described elsewhere (Abernathy et al., 2017). Chlorophyll, pigments, RNA, DNA, and 
inorganics were estimated from previously published literature (Hendry et al., 2017). 
3.4.6 GC–MS analysis of proteinogenic amino acids. To assess the capability of 
Synechococcus 7002 to uptake glycerol, acetate, or pyruvate, unlabeled seed cultures were grown 
at 1% CO2 until exponential phase and used to inoculate A+ medium at 5% v/v containing either 
25 mM of labeled glycerol-2-13C, labeled acetate-13C2, or labeled pyruvate-3-
13C. The cultures 
were transferred to either 1% CO2 or 0.2% CO2 and, after 3 doubling times, the labeling in 
proteinogenic amino acids was analyzed using a TBDMS method (You et al., 2013). 
3.4.7 Measuring photosynthetic parameters and oxygen evolution. Cells were harvested during 
log growth and adjusted based on cell numbers. The fluorescence parameters (FV/FM) of PSII were 
measured using a fluorescence fluorometer, FL-200 (Photon Systems Instruments, Brno, Czech 
Republic). Cells were dark adapted for 90 seconds before F0 and FM were measured using red LED 
measuring light. Using a custom-built Clark-type electrode, light induced oxygen evolution was 
measured for 2 minutes at 37 °C following the addition of 10 mM NaHCO3 as described by a 
previous protocol (Ungerer et al., 2018). For respiratory oxygen uptake, oxygen consumption was 
measured for 2 minutes under dark conditions.  Chlorophyll a content was measured by removing 
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one milliliter of culture, extracting with methanol, and measuring the resulting absorbance at 665 
and 652 nm as determined by a previous method (Porra et al., 1989).  
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Chapter 4: Metabolic engineering of cyanobacteria for 
photoautotrophic production of heparosan, a 
pharmaceutical precursor of heparin  
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Sarnaik A*, Abernathy MH*, Han X, Ouyang, Xia K, Chen Y, Cress B, Zhang F, Lali A, 
Pandit R, Linhardt RJ, Tang Y, Koffas MAG. Metabolic engineering of cyanobacteria for 
photoautotrophic production of heparosan, a pharmaceutical precursor of heparin. Algal 
Research. 2019;37:57-63.  
*Contributed equally as co-authors; I aided in strain engineering, performed data analysis, 
performed lab-scale cyanobacteria cultivations, and drafted the manuscript. 
Abstract 
Heparosan is an unsulfated polysaccharide potentially important for its wide range of cosmetic 
and pharmaceutical applications, particularly as the precursor for the extensively used 
anticoagulant, heparin. Generally sourced from animals, commercially available heparin may 
encounter various immunological and contamination risks. Thus, safe and sustainable microbial 
platforms could serve as an alternative heparin source. Synechococcus, due to their fast 
photoautotrophic growth, strong sugar phosphate metabolisms and generally regarded as safe 
(GRAS) nature, may serve as photo-biorefineries for manufacturing heparosan. In this study, we 
have synthesized an integrative plasmid pUPm48 for cloning galU and PmHS2 genes in 
Synechococcus elongatus PCC 7942. The engineered recombinants (pgp7942) exhibited 
significant production of heparosan under different culture conditions, where the products were 
present in both supernatant and cell biomass. The maximum yield of 0.7 ± 0.2 μg/g-DCW (dry 
cell weight) and a titer of 2.8 ± 0.3 µg/L was achieved by pgp7942 under shake flask and 
continuous light conditions. The analysis also found PCC 7942 encodes a promiscuous 
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uridyltransferase for UDP-glucose synthesis and naturally produces multiple 
glycosaminoglycans including chondroitin sulfate (CS). This study demonstrates for the first-
time cyanobacteria as a promising photoautotrophic refinery for producing a high-value 
polysaccharide commonly from animals.  
 
4.1 Introduction 
Glycosaminoglycans (GAGs) are a class of saccharides consisting of repeating units of 
amino sugars and uronic acids and have increasingly enticed research and commercial interests 
due to their wide range of physiological functions (Chavaroche et al., 2013; Peterson et al., 2008; 
Cress et al., 2014; Badri et al., 2017). These GAGs, heparan sulfate, chondroitin sulfate, and 
hylauronic acid (Figure 4.1), are naturally produced across a range of organisms and play key 
roles in moisture retention, cell adhesion and proliferation. Currently GAGs are mainly extracted 
from food animal tissues (approximately 100 mg per kg of tissue) (Vaidyanathan et al., 2017) 
and are widely used in pharmaceutical and cosmetic applications. However, immunological 
reactions and interspecies disease transfers are a major problem, and a contaminated global 
supply of heparin (an important anticoagulant) in 2007-8 resulted in 100 deaths (Chavarache et 
al., 2013). De novo chemical synthesis of heparin has been attempted and one ultra-low 
molecular weight heparin (<1.5 kDa, fondaparinux) has been commercially successful, but yields 
are low and biological activity is challenging to replicate as a result of polymerization and 
complex sulfation (Liu and Linhardt, 2014).  
The precursor of heparin and heparan sulfates (HS) (Wang et al., 2011; Suflita et al., 
2015) is heparosan (HS-0S), an unsulfated polysaccharide consisting of a linear copolymer of 
repeating units α-1,4 linked D-glucosamine (GlcNAc) and β-1,4-D-glucuronic acid (GlcUA) (Jin 
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et al., 2016). Heparosan has also been used to enhance the efficacy of protein-based therapeutics 
by forming drug conjugates and could serve as a replacement for polyethylene glycol coatings 
for drug delivery applications (Lane et al., 2017). In recent years, the biosynthesis of GAGs from 
microbial production platforms has emerged as an alternative to extraction from animal sources 
(He W. et al., 2015; Englaender et al., 2017). In vitro chemoenzymatic synthesis from in vivo 
synthesized heparosan could serve as an effective alternative to animal derived heparin (Wang et 
al., 2011; Wang et al., 2013a; Wu et al., 2015). As a result, efficient heparosan synthesis 
becomes the primary step towards heparin production (Wang et al., 2011). Heparosan is naturally 
produced by pathogenic bacteria, such as E. coli K5, Pasteurella multocida, Avibacterium 
paragallinarum as a part of polysaccharide capsules, which impart virulence to these organisms 
(Wang et al., 2011; Jin et al., 2016). Heparosan synthesis by genetically modified non-
pathogenic Bacillus subtilis and E. coli BL21 has been successfully achieved by cloning kfiC and 
kfiA genes from E. coli K5, yet molecular weight and homogeneity were difficult to control (Jin 
et al., 2016, Zhang et al., 2012). Nevertheless, Pasteurella multocida possesses a PmHS2 gene 
that encodes for a dual functional heparosan synthase that replaces the two genes, kfiC and kfiA, 
(Chavaroche et al., 2012) and results in smaller-molecular-weight polysaccharide chains 
(DeAngelis and White, 2004).   
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Figure 4.1. Schematic featuring the biosynthetic production pathway of 
glycosaminoglycans in Synechococcus PCC 7942, specifically the expression of heparosan 
and its downstream applications. Genes in red indicate genes that are not annotated in KEGG 
database. Genes in blue are naturally present in Synechococcus 7942. Genes in yellow boxes 
were heterologously expressed in recombinant Synechococcus 7942 for the production of 
heparosan. 6PG, 6-phosphogluconic acid; AcCoA, acetyl CoA; ADP, adenosine diphosphate; 
F6P, fructose-6-phosphate; G1P, glucose-1-phosphate; G6P, glucose-6-phosphate; GalNAc, N-
acetylgalactosamine, GlcN-1P, glucosamine-1-phosphate; GlcN-6P, glucosamine-6-phosphate; 
Gln, glutamine; Glu; Glutamic acid; PPi; pyrophosphate, PYR, pyruvate; TCA, tricarboxylic 
acid; UDP, uridine diphosphate; UTP, uridine triphosphate;  
 
This study aimed at engineering cyanobacteria using PmHS2 from P. multocida (Figure 
4.2a). Being GRAS (generally recognized as safe), cyanobacteria can serve as photosynthetic 
platform for production of valuable chemicals (Yu et al., 2013; Varman et al., 2013). Compared 
to eukaryotic photoautotrophs, cyanobacterial hosts have established genomic data, molecular 
manipulation tools, low cost of culture mediums, and generally faster growth (Lu, 2010). 
Moreover, cyanobacteria possess strong metabolic fluxes through its sugar phosphate pathways 
and high nucleotide sugar pool sizes (Abernathy et al., 2017a). They naturally synthesize 
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complex polysaccharides like glycans for colonization, symbiosis, protection, and food 
reservation (Singh et al., 2005; Kehr and Dittmann, 2015; Philippis et al., 1998). However, to the 
best of the authors’ knowledge, the production of GAGs with specific disaccharide repeating 
units has not been previously reported in cyanobacteria. Here, we selected a model 
cyanobacterum Synechococcus elongatus PCC 7942 (PCC 7942) for the photosynthetic synthesis 
of heparosan to demonstrate their potential as a new chassis for the synthesis of value-added 
carbohydrates and high-value pharmaceuticals (Figure 4.1).  
 
4.2 Materials and Methods 
4.2.1 Chemicals and reagents. T4 DNA ligase, restriction enzymes, and shrimp alkaline 
phosphatase were purchased from New England Biolabs. PrimeSTAR Max DNA polymerase 
(2X) high fidelity PCR master-mix was purchased from Clontech (DSS TaKaRa Bio India Pvt 
Ltd.). NucleoSpin® Gel and PCR Clean-up kit was purchased from Macherey-Nagel (MN, India). 
Plasmid extraction Miniprep kit was purchased from GeneAll (AllianzBio, Mumbai, India). 
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Figure 4.2. Diagrams of recombinant Synechococcus PCC 7942 (pgp7942) grown in various 
conditions for the production of heparosan. (A) Representation of the synthetic operon 
construct, pUPm48, for homologous recombination into NSI of chromosome. (B)   PCC 7942 
transformants, pgp7942, obtained after complete segregation of the cloned gene were analysed 
through colony PCR and agarose gel electrophoresis. galU amplicon in lane 1, PmHS2 amplicon 
in lane 2, entire operon (galU+PmHS2) has been amplified using NSI specific primers in lane 3; 
followed by >1kb DNA ladder in lane 4. Primers used are listed in Table 4.1.  (C) Variable 
growth conditions to grow pgp7942 and wild-type (WT) PCC 7942. The strains were grown 
under two distinct shake flask conditions; 250 photons µmol/m2/s (HL) and 0.2% (v/v) CO2 (HC) 
(condition 1), 100 photons µmol/m2/s (LL) and 0.04% (v/v) atmospheric CO2 (LC) with 
variations in media composition (condition 2). Pgp7942 cells were scaled up under natural 
diurnal light conditions with irradiance of maximum 1200 ± 200 µmol/m2/s and temperature 33 ± 
10 °C with atmospheric CO2 (0.04%) (condition 3).  
 
4.2.2 Microorganisms and culture conditions. Construction and amplification of recombinant 
plasmids were performed in E. coli Top10F (ThermoFisher Scientific) cells. Cells were grown at 
37 °C in Luria Bertani (LB) broth supplemented with 100 µg/mL spectinomycin (HiMedia) 
(Sarnaik et al., 2017). For PCC 7942 cultivation, the seed cultures were grown with continuous 
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illumination of 55 ± 2 µmol/m2/s and 28 ± 0.5 °C temperature. BG-11 medium (supplemented 
with 30 µg/ml of spectinomycin in case of transformants) was used. Experiments were 
performed under several laboratory conditions in shake flasks (50 mL culture volumes) at a 
speed of 250 rpm at atmospheric (0.04% (v/v)) (LC) and 0.2% (v/v) CO2 (HC) at 37 °C and 
continuous light environments (100 photons µmol/m2/s (LL) and 250 photons µmol/m2/s (HL). 
Low nitrogen cultures were prepared with BG-11 medium with 1/5 NaNO3 (0.15 g/L) to promote 
carbohydrate accumulation, while 30 mM of glycerol was added to cultures for 
photomixotrophic growth (Figure 4.2c).  Both cell pellet and supernatant samples were analyzed 
for heparosan. All experiments were performed in duplicates. Cultures were induced with 1 mM 
of isopropyl β- D-1-thiogalactopyranoside (IPTG) at early exponential growth. Culture growth 
was monitored by recording optical densities of the cultures at 730 nm using a UV-Vis 
spectrophotometer and measuring the dry cell weight (DCW) of the lyophilized cell pellets.  
4.2.3 Cyanobacterial plasmid construction and transformation. The plasmid, pUPm48, was 
constructed using the pAM2991 vector for transformation of PCC 7942. Initially, the plasmid 
pU48 was constructed by cloning the galU gene amplified from E. coli MG1655 (UTP-glucose-
1-phosphate uridyltransferase, NC_000913.3) genomic DNA between restriction sites, EcoRI 
and BamHI of the pAM2991 vector (Primers; UE_F and UAB_R) (Table 4.1). The restriction 
AflII site was introduced in the construct using the galU gene reverse primer (UAB_R) for the 
introduction of another gene into pU48. The plasmid pUPm48 was constructed by cloning the 
PmHS2 gene (Heparosan synthase B, AY292200.1) amplified from Pasteurella multocida 
genomic DNA between the restriction sites AflII and BamHI sites of the pR48 vector (Primers; 
PA_F and PB_R) (Table 4.1) (Figure 4.2a). PCC 7942 transformants (pgp7942) were developed 
based on homologous recombination strategy using pUPm48 through natural transformation. The 
77 
 
transformation protocol was followed as demonstrated by Clerico et al. Colonies obtained on 
plates were passaged at least four times to get stable transformants (Sarnaik et al., 2017). Gene 
integration in cyanobacterial genome was confirmed by colony PCR using neutral site primers 
SP48_F and SP48_R (Table 4.1) (Figure 4.2b). Agarose gel electrophoresis of the colony PCR 
samples show bands corresponding to 1 kbps (lane 1, galU gene), 2.2 kbps (lane 2, PmHS2 gene) 
and 3.5 kbps (lane 3, neutral site primers).  
 
Table 4.1. List of primers and sequences used. The underlined sequences are the restriction 
sites for cloning the genes. 
 
Primer 
names 
Sequences 
UE_F 5’-GACTGAATTCATGGCTGCCATTAATACGAA-3’ 
UAB_R 5’-ACTTGGATCCCTTAAGTTACTTCTTAATGCCCATCTC-3’ 
PA_F 5’-AAGTCTTAAGATGAAGAGAAAAAAAGAGATG-3’ 
PB_R 5’-AATCGGATCCTCACAAAAAATAAAAAGGTAAACAG-3’ 
SP48_F 5’- GTCTTTCGACTGAGCCTTTCG - 3’ 
SP48_4 5’ - CAGGCAGCCATCGGAAGC - 3' 
 
 
4.2.4 Analysis of heparosan production using LC-MS 
Materials for digestion of samples and LC-MS analysis. Unsaturated disaccharide standards 
of CS (∆UA-GalNAc; ∆UA-GalNAc4S; ∆UA-GalNAc6S; ∆UA2S-GalNAc; ∆UA2S-Gal-
NAc4S; ∆UA2S-GalNAc6S; ∆UA-GalNAc4S6S; ∆UA2S-GalNAc4S6S), unsaturated 
disaccharide standards of HS (∆UA-GlcNAc; ∆UA-GlcNS; ∆UA-GlcNAc6S; ∆UA2S-GlcNAc; 
∆UA2S-GlcNS; ∆UA-GlcNS6S; ∆UA2S-GlcNAc6S; ∆UA2S-GlcNS6S), and unsaturated 
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disaccharide standard of HA (∆UA-GlcNAc), where ∆UA is 4-deoxy-α-L-threo-hex-4-
enopyranosyluronic acid, were purchased from Iduron (UK). Actinase E was obtained from 
Kaken Biochemicals (Japan). Various polysaccharide lyases were obtained for digestions. 
Chondroitin lyase ABC from Proteus vulgaris was cloned and expressed in E. coli and purified 
in the Linhardt lab. Recombinant Flavobacterial heparin lyases I, II, and III were also expressed 
and purified by the Linhardt lab using E. coli strains provided by Jian Liu (College of Pharmacy, 
University of North Carolina). 2-Aminoacridone (AMAC) and sodium cyanoborohydride were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). All other chemicals were of HPLC grade. 
Vivapure Q Mini H strong anion exchange spin columns were from Sartoriou Stedim Biotech 
(Bohemia, NY, USA). 
GAG extraction, sample desalination and digestion. Lyophilized pellets were re-suspended 
with 15 mL of ddH2O, then sonicated for 10 min in an ice bath using a Misonix Sonicator 3000 
(frequency 20 kHz) with microtip at 40% magnitude, followed by centrifugation at 3220 relative 
centrifugal force (RCF) for 10 min. The supernatant was then collected and freeze-dried. Dried 
supernatant and extracted pelleted samples were re-dissolved in 400 μL ddH2O and desalted by 
passing through a 3 kDa molecule weight cut-off spin column. The casing tubes were replaced 
before 200 μL of digestion buffer (50 mM ammonium acetate containing 2 mM calcium chloride 
adjusted to pH 7.0) was added to the filter unit. Recombinant heparin lyase I, II, III (pH optima 
7.0−7.5) and recombinant chondroitin lyase ABC (10 mU each, pH optimum 7.4) were added to 
each sample and mixed well. The samples were all placed at 37 °C for 12 h, after which 
enzymatic digestion was terminated by removing the enzymes by centrifugation. The filter unit 
was washed twice with 300 μL distilled water and the filtrates containing the disaccharide 
products were dried via vacuum centrifuge. 
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2-Aminoacridone (AMAC) labelling and LC-MS analysis. The dried samples were AMAC-
labelled by adding 10 μL of 0.1 M AMAC in DMSO/acetic acid (17:3 (v/v)) incubating at room 
temperature for 10 min, followed by adding 10 μL of 1 M aqueous sodium cyanoborohydride 
and incubating for 1 h at 45 °C.  A mixture containing all 17-disaccharide standards prepared at 
0.5 ng/μL was similarly AMAC-labeled and used for each run as an external standard. After the 
AMAC-labeling reaction, the samples were centrifuged and each supernatant was recovered for 
LC-MS analysis. LC was performed on an Agilent 1200 LC system at 45 °C using an Agilent 
Poroshell 120 ECC18 (2.7 μm, 3.0 × 50 mm) column. Mobile phase A was 50 mM ammonium 
acetate aqueous solution, and the mobile phase B was 100% methanol. The mobile phase passed 
through the column at a flow rate of 300 μL/min. The gradient was 0-10 min, 5-45% B; 10-10.2 
min, 45-100% B; 10.2-14 min, 100% B; 14-22 min, 100-5% B. A triple quadrupole mass 
spectrometry system equipped with an ESI source (Thermo Fisher Scientific, San Jose, CA) was 
used a detector in multiple reaction monitoring (MRM) mode. The MS parameters were set at 
negative ionization mode with a spray voltage of 3000 V, a vaporizer temperature of 300 °C, and 
a capillary temperature of 270 °C. 
 
4.3 Results and Discussion 
Controlled polymerization of heparosan is an important prerequisite to obtain 
functionally active molecule. Among various natural producers of heparosan, mammals use an 
active hetero-complex of glycosyltransferases EXT1 and EXT2 yielding a polymer of on average 
170 kDa, whereas E. coli K5 synthesizes a polymer of 10-20 kDa using synchronous activity of 
two enzymes KfiA (glucosaminyl transferase) and KfiC (glucuronyl transferase). On the contrary, 
Pasteurella expresses a dual functional glycosyltransferase PmHS1 and its cryptic homolog 
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PmHS2. Functionally, PmHS1 has higher affinity towards short oligosaccharides while PmHS2 
exhibits more affinity towards UDP-sugars which are limiting precursor molecules (Chavaroche 
et al., 2013). The gene, PmHS2, is a glycosyltransferase responsible for the step-wise addition of 
UDP-glucuronic acid (UDP-GlcUA) and UDP-N acetyl glucosamine (UDP-GlcNAc) for 
heparosan polymerization (Chavaroche et al., 2012). Based on these reports, the heparosan 
synthase, PmHS2 was selected for expression of HS-0S in cyanobacteria. (Figure 4.1). 
Being GRAS organisms, cyanobacteria are known to be efficient producers of complex 
polysaccharides that can be extended to pharmaceuticals (Abed et al., 2009). However, natural 
production of heparosan or specific GAGs for biotechnology applications has not yet reported in 
cyanobacteria (Philippis et al., 1998; Kehr and Dittmann, 2015). Therefore, cyanobacterium PCC 
7942 was explored as the host for production of heparosan. Successful functionality of the 
PmHS2 gene product in cyanobacteria requires a large UDP-glucuronic acid pool (Figure 4.1), 
mitigated by expression of galU (UDP-glucose pyrophosphorylase). Thus, for HS-0S production 
in cyanobacteria, the vector construct, pUPm48, with the genes galU and PmHS2 under the Ptrc 
promoter (Figure 4.2a) was able to be successfully integrated into the PCC 7942 genome to 
create the transformants, pgp7942 (Figure 4.2b).  
UDP-glucuronic acid is one of the essential monomeric precursors and is typically 
synthesized from UDP-glucose. While many cyanobacteria do not have an annotated UDP-
glucose pyrophosphorylase that catalyzes the conversion of glucose-1-phosphate to UDP-
glucose, some cyanobacteria encode other enzymes relevant to UDP-glucose production and 
consumption. For example, Synechocystis sp. PCC 6803 (PCC 6803) possesses a gene CugP 
(Uniprot ID CUGP_SYNY3) that encodes for UTP-glucose-1-phosphate uridyltransferase, 
which synthesizes UDP-glucose, same as galU (Maeda et al., 2014). Protein BLAST (BLASTp) 
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of this non-galU type uridyltransferase exhibited 99% sequence similarity with mannose-1-
phosphate guanyltransferase (BAM54903.1) from PCC 6803 (Figure S1). Its NTP_transferase 
functional domain belonging to Glyco_tranf_GTA_type superfamily was verified from 
Conserved Domain database at NCBI (domain architecture ID 11440233). BLASTp of this 
domain displayed 79% sequence homology with mannose-1-phosphate guanyltransferase 
(ABB58003.1, gene: SYNPCC7942_RS10005) from PCC 7942 (Figure S2). We hypothesize 
that the gene RS10005 encodes a promiscuous enzyme that can also synthesize UDP-glucose in 
PCC 7942. This bi-specificity of mannose-1-phosphate guanyltransferase (gene RS10005 from 
PCC 7942) requires further functional annotation. The heterologous gene, galU, assists in UDP-
glucose formation for a sufficient pool of UDP-glucuronic acid for heparosan production than 
native RS10005 alone  
Cyanobacteria tend to synthesize polysaccharides under various physical and chemical 
stress conditions (Philippis et al., 1998). Therefore, to improve heparosan (HS-0S) production 
from pgp7942, cells were grown under different environmental conditions (Figure 4.2c), such as 
high CO2 (HC), photomixotrophic and nitrogen limitations conditions. The strain pgp7942 
produces significantly higher yields of HS-0S under regular nitrate concentrations than the WT 
(Figure 4.3a) with the highest titer 2779 ± 285 ng/L and a productivity of 278 ± 29 ng/L/day 
under HL and HC. Glycerol was added to the medium in LC, LL conditions, but did not result in 
significant improvement of HS-0S production in pgp7942 (Figure 4.3a), with titers of 0.7± 0.2 
μg/L and 0.6± 0.1 μg/L, with and without glycerol respectively under LC, LL conditions. 
Cultures when grown in BG-11 with low nitrate concentration (300 ppm) exhibited the smallest 
HS-0S titer in pgp7942 and significantly impacted HS-0S and GAG titers. This observation 
contrasts to cyanobacterial glycogen or polyhydroxybutyrate (PHB) accumulation under nitrogen 
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starvation as seen in other studies (Monshupanee et al., 2013). The deleterious effect can be 
explained by a depletion of building blocks for product synthesis, such as glutamine, and a 
depletion of light harvesting proteins, such as phycobilisomes, during nitrogen limitation 
(Espinosa et al., 2007).  
LC-MS analysis showed that all PCC 7942 cultures synthesized varying types of GAGs 
and that heparosan, in addition to other GAGs, was also secreted into the supernatant (Figure 
4.3b). Cyanobacteria are known to produce an extracellular matrix (ECM) to serve as protection 
from the outside environment. The ECM is composed of complex heteropolysaccharides 
assembled and exported through multiple pathways and then are attached to the cell surface or 
freed into the surrounding environment as released polysaccharides (Ahmed et al., 2014). 
According to phylogenomic analyses, Synechococcus has been found to possess the least amount 
of proteins serving the ECM due evolutionary loss, which may reduce cross-talk and competition 
for substrates compared to other cyanobacteria species (Pereira et al., 2015). Wild-type 
Synechococcus was found to synthesize chondroitin sulfate (CS) (1.2 ± 0.2 μg/L after 120 h 
under HC, HL conditions) and hyaluronic acid (HA) (0.3 ± 0.1 μg/L after 120 h under HC, HL 
conditions). The transformant, pgp7942, produced similar amounts of HA at 0.4 ± 0.1 μg/L after 
120 h under HC, HL conditions, but less CS at 0.5 ± 0.2 μg/L, indicating possible intermediate 
competition. Higher titers of GAGs and higher supernatant to pellet ratios were obtained in 
pgp7942 cultures grown under continuous 250 µmol/m2/s of light and 0.2% CO2, most likely 
correlated to biomass increase and secretion of product under optimal growth conditions.  
Compared to shake flask cultures of recombinant B. subtilis (Jin et al., 2016), the titer and 
yield reported here is much lower. HS-0S yields on biomass and carbon substrate from pgp7942 
have reached 0.72 ± 0.15 µg/g-DCW (0.83 µg/g-C, using an estimated CO2 uptake of 1 mmol/g-
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DCW/h), while engineered B. subtilis achieved at 90 mg/g-C. This is not surprising since 
heterotrophic bacteria can grow into much higher cell density and use sugar instead of CO2 to 
directly synthesize polysaccharides. 
 
Figure 4.3. Heparosan producing strain, pgp7942, compared to Synechococcus 7942 WT 
under continuous light shake flask conditions. Shaking flask conditions vary in light from 100 
photons µmol/m2/s (LL) to 250 photons µmol/m2/s (HL) and atmospheric CO2 (0.04% (v/v)) 
(LC) to 0.2% (v/v) CO2 (HC), but are held at a temperature of 37 °C, induced with 1 mM of 
IPTG, and have an rpm of 250 for 50 mL culture volumes. Low N indicates BG-11 was used 
with 1/5 of the standard amount of nitrogen typically used. Standard deviations are based off n = 
2. (A) Titer of heparosan (HS-0S) in both cell pellet and extracellular media. ¥ Conditions where 
the supernatant was not analysed but estimated: pgp7942 LC/LL + 30 mM glycerol; pgp7942 
LC/LL + low N; WT HC/HL (B) Titer of total glycosaminoglycans (GAGs) in both cell pellet 
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and extracellular media. (C) Break down of GAG titer in the cell pellet only as heparin sulfate 
(HS), chondroitin sulfate (CS) and hyaluronic acid (HA).  
 
Moreover, WT and pgp7942 cultures were analysed over time for 10 days under HL and 
HC conditions. Productivity (Table 4.2) and titer in pgp7942 increased with dry cell weight, and 
following IPTG induction, HS yield was improved over CS and HA in pgp7942. HS-0S yield 
was highest during early exponential growth and levelled off after 72 h of growth at 0.72 ± 0.15 
µg/g-DCW (Figure 4.4). These time series cultures displayed significant improvement in HS-0S 
titer over WT (> 30 ng/L). Genetic modification nor heparosan accumulation negatively affected 
the growth of the HS-0S producing strain.  
 
 
Figure 4.4. Heparosan producing strain, pgp7942, under continuous 250 photons µmol/m2/s 
(HL) and 0.2% (v/v) CO2 (HC) shake flask conditions. Red arrow indicates time of induction 
with 1 mM IPTG. (A) Titer of heparosan (HS-0S) as measured in the lyophilized cell pellet. (B) 
Yield of glycosaminoglycans, heparan sulfate (HS), chondroitin sulfate (CS), and hyaluronic 
acid (HA), produced in the pellet of strain, pgp7942. (C) Growth curve for the heparosan 
producing strain, pgp7942, and the wild type (WT).  
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Table 4.2. Summary of heparosan production in PCC 7942, WT and engineered 7942 
(pgp7942). Highest heparosan and biomass productivity in the cell pellet are reported for each 
condition. Standard deviation is based off duplicates. All experiments conducted at 33 °C or 37 
°C. *Experiment carried out under natural diurnal conditions in environmental laboratory.  
 
Strain Condition 
description 
Carbon 
source 
Light Heparosan 
Productivity 
(µg/L/day) (n=2) 
Biomass 
productivity 
(at mid-log phase)  
(g/L/day) 
pgp7942 Shaking flask, 
HC/HL 
0.2% CO2 250 
µmol/m2/s 
(continuous) 
0.21 ± 0.03 0.59 ± 0.01 
WT Shaking flask, 
HC/HL 
0.2% CO2 250 
µmol/m2/s 
(continuous) 
0.01 ± 0.01 0.57 ± 0.02 
pgp7942 Shaking flask, 
LC/LL 
0.04% CO2 
(atmospheric) 
+ 30 mM 
glycerol 
100 
µmol/m2/s 
(continuous) 
0.07 ± 0.03 0.35 ± 0.11 
pgp7942 Shaking flask, 
LC/LL 
0.04% CO2 
(atmospheric) 
100 
µmol/m2/s 
(continuous) 
0.06 ± 0.00 0.44 ± 0.01 
 
 
This study observed that PCC 7942 can synthesize multiple GAGs (Figure 4.3b) with WT 
naturally producing chondroitin sulfate (CS). Following induction of the genes galU and PmHS2, 
pgp7942 produced more HS-0S than CS (Figure 4.4b), indicating competition between 
polysaccharide synthesis pathways (Figure 4.3c). Interestingly, PCC 7942 does not have an 
annotated gene for the conversion of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine, 
one of the essential precursors for CS (Figure 4.1), nor have an annotated gene for CS synthase. 
Since cyanobacteria are able to produce a wide range of GAG-like compounds, such as 
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extracellular polymeric substances (EPS) and lipopolysaccharides (LPS), it is likely that there are 
unannotated genes and promiscuous enzymes responsible for complex carbohydrates. For 
example, E. coli K4 possess a CS synthase (WP_000025667) (Ninomiya et al., 2002) and 
BLASTp showed 27% homology to PCC 7942’s cellulase synthase. Further gene function studies 
are required to identify a CS pathway in PCC 7942. 
 
4.4 Conclusions 
PCC 7942 recombinants, pgp7942, were successfully developed for the photoautotrophic 
production of heparosan through homologous recombination of the genes galU and PmHS2. 
pgp7942 cells were cultivated under different environmental conditions yielding maximum 
heparosan production (2.8 µg/L) with high light and high CO2, which was 10
3 folds higher than 
that in wild type strain. PCC 7942 release as well as store GAGs and hence, could serve as 
efficient biosynthetic platforms for continuous production of glycans like heparosan at a 
commercial scale. Further research efforts are needed for polymer characterization and 
regulation; however this study presents proof-in-concept for cyanobacteria as a platform for 
complex carbohydrate synthesis.  
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Chapter 5: Channeling in native microbial pathways: 
Implications and challenges for metabolic engineering   
 
This chapter has been reproduced from the following publication:  
Abernathy MH, He L, Tang YK. Channeling in native microbial pathways: Implication and 
challenges for metabolic engineering. Biotechnology Advances. 2017;6(35)805-814.  
 
Abstract 
Intracellular enzymes can be organized into a variety of assemblies, shuttling intermediates from 
one active site to the next. Eukaryotic reaction compartmentalization within mitochondrion and 
peroxisomes and substrate tunneling within multi-enzyme complexes have been well recognized. 
Intriguingly, the central pathways in prokaryotes may also form extensive channels, including 
the heavily branched glycolysis pathway. In vivo channeling through cascade enzymes is 
difficult to directly measure, but can be inferred from in vitro analysis, reaction thermodynamics, 
transport/reaction modeling, analysis of molecular diffusion and protein interactions, or steady 
state/dynamic isotopic labeling. Channeling presents challenges but also opportunities for 
metabolic engineering applications. It rigidifies fluxes in native pathways by trapping or 
excluding metabolites for bioconversions, causing substrate catabolite repressions or inferior 
efficiency in engineered pathways. Channeling is an overlooked regulatory mechanism used to 
control flux responses under environmental/genetic perturbations. The heterogeneous 
distribution of intracellular enzymes also confounds kinetic modeling and multiple-omics 
analyses. Understanding the scope and mechanisms of channeling in central pathways may 
improve our interpretation of the robust fluxomic topology throughout the metabolic network 
and lead to better design and engineering of heterologous pathways. 
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5.1 Introduction 
 Metabolic flux is controlled by both enzyme kinetics and substrate diffusions. Under in 
vitro enzyme biochemistry, purified enzymes are often dissociated, and metabolites are well-
mixed; so enzymatic reactions have no spatial effect, and the homogenous system can be 
described by Michaelis–Menten models. However, macromolecular crowding in cells has been 
shown to promote enzyme associations and structural organization within the cytoplasm 
(Mourão et al., 2014; Spitzer, 2011). Meanwhile, fluidity in the cytoplasm has been found to be 
closely related to metabolic activity (Parry et al., 2014). Since in vivo environments may 
significantly impede enzyme kinetics (Minton, 2001), enzyme may organize to pass the product 
of one reaction site to an adjacent site without releasing into the bulk phase. Such mechanisms 
not only improve substrate diffusion and reaction-equilibrium, but also benefit other cellular 
functions, including protection of unstable intermediates, forestallment of substrate competition 
or inhibition among different pathways, and maintenance of a stable enzymatic 
microenvironment (Zhang, 2011).  
 Several mechanisms of multi-enzyme channeling for catalyzing cascade reactions have 
been recognized (Wheeldon et al., 2016). Intramolecular tunnels, as evidenced in tryptophan 
synthase, connect two active sites (Miles, 2001). Activated chemical swing arms can pass 
intermediates between active sites as seen in fatty acid synthases and pyruvate dehydrogenase 
complexes. Moreover, electrostatic guidance uses complementary charges between protein 
residues spanning two active sites to direct intermediates as confirmed in malate dehydrogenase 
and citrate synthase (Wu and Minteer, 2015). Additionally, eukaryotes can compartmentalize 
enzymes in cellular organelles—i.e., the TCA cycle is carried out in the mitochondrion. On the 
other hand, evidence has shown that cascade enzymes in central and secondary pathways in 
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prokaryotes, as well as eukaryotes, are also organized extensively (Table 5.1). For example, 
glycolytic enzymes may form glycolysisosomes, which suggests intracellular enzymes are not 
randomly distributed in the cytosol. This hypothesis is not yet generally accepted because central 
metabolism enzymes often have high copy numbers and, metabolite diffusion is believed to be 
sufficiently fast (Wheeldon et al., 2016). This chapter reviews evidences and scopes of natural 
channels in the microbial metabolism as well as methods to measure metabolite channeling 
through cascade enzymes. We further discuss how channeling influences metabolic flux 
regulations in heavily branched central pathways. The validation and understanding of natural 
metabolite channeling through cascade enzymes will offer new guidelines for genome-to-
phenome mapping, metabolic modeling, and bio-systems engineering.  
 
Table 5.1. Evidences of enzyme tunneling or channeling  
Enzyme 
reactions 
Detection method System 
employed 
Species Studied Citation 
Polyfunctional 
enzymes forming 
molecular tunnels 
Kinetic studies, enzyme cross linking, 
LC-MS/MS, SDS-PAGE, and X-ray 
structural analysis 
in vitro Purified enzyme (Huang et 
al., 2001; 
Miles, 2001;  
Dunn, 2012) 
OPPP (oxidative 
pentose phosphate 
pathway) 
Isotopic dilution of 14C-labeled OPPP 
intermediates by unlabeled 
intermediates 
in vitro Purified yeast 
enzymes, yeast 
extract, pea and 
soybean nodule 
extracts 
(Debnam et 
al., 1997) 
Glycolysis to 
lactate 
Isotopic dilution with 13C labeled 
substrates and steady-state MFA 
in vivo Human Cell line 
AGE1.HN 
(Niklas et 
al., 2011) 
TCA cycle Isotopic dilution using [4-
13C]glutamate and [2-13C]acetate and 
observing labeled carbon orientation 
using 
13
C NMR 
in vivo Saccharomyces 
cerevisiae 
(Sumegi et 
al., 1990) 
Calvin cycle Isotopic dilution using 13CO2 and 
INST-MFA 
in vivo Synechocystis sp. 
PCC 6803 
(Young et 
al., 2011) 
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EMPP Isotopic dilution with challenging 
substrates 
in vivo Escherichia coli (Shearer et 
al., 2005) 
TCA cycle 
(from malate to 
citrate) 
LC-MS/MS and SDS-PAGE; Site-
directed mutagenesis; kinetic 
modeling 
in vivo, in 
vitro, and in 
silico 
Recombinant 
enzymes from E. 
coli or 
Saccharomyces 
cerevisiae 
(Bulutoglu 
et al., 2016; 
Vélot and 
Srere, 2000) 
TCA cycle 
(fumarate to citrate; 
malate to citrate) 
isotopic dilution, NMR (
13
C and 1H) 
and steady-state MFA 
In vivo Arabidopsis 
thaliana 
(Williams et 
al., 2011) 
TCA cycle (from 
ketoglutarate to 
succinate/fumarate 
isotopic labeling with 13C glutamate or 
13C acetate; 13C NMR analysis 
In vivo Saccharomyces 
cerevisiae 
(Sumegi et 
al., 1993) 
3PGA to PEP Isotopic dilution using 13CO2 and 
INST-MFA 
in vivo Synechocystis sp. 
PCC 6803 
(Huege et 
al., 2011) 
PEP to PYR to 
lactate 
Isotopic dilution with [U-13C]glucose 
and INST-MFA 
in vivo Chinese Hamster 
Ovary-K1 cell line 
(Nicolae et 
al., 2014) 
Glycolysis Proteomic analysis of mitochondrial 
fractions and 13C-glucose studies 
in vitro Arabidopsis 
thaliana 
(Giegé et al., 
2003) 
PCB-degradation 
pathway 
Kinetic studies compared between 
channeled complex and individual 
complexes 
in vitro Burkholderia 
xenovorans 
(Baker et al., 
2009) 
CoA channeling 
through fatty acid 
synthase 
Substrate pool size quantification and 
comparative enzyme kinetics 
in vitro Purified 
chloroplasts from 
spinach and pea 
shoots 
(Roughan, 
1997) 
Fatty acid β-
oxidation cycle 
Protein crystallization, X-ray 
diffraction, and homology modelling 
in vitro Escherichia coli (Ishikawa et 
al., 2004) 
Polyketide pathway Kinetic analysis of modular enzymes in vitro Saccharopolyspora 
erythraea 
(Wu et al., 
2001) 
Electron transport 
chain complexes I, 
III and IV 
Enzyme activities in the presence of 
specific electron donors and inhibitors 
along for genetically modified 
supercomplexes 
in vivo Mitochondria from 
mouse fibroblasts 
(Lapuente-
Brun et al., 
2013) 
Photosynthesis  
(light-harvesting 
complexes) 
Spectroscopic analyses of isolated 
protein complexes and genetically 
modified complexes 
in vitro Chlamydomonas 
reinhardtii 
(Iwai et al., 
2010) 
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5.2. Kinetic, thermodynamic and biochemistry evidences on channeling 
5.2.1 Kinetic and thermodynamic implications. A cell’s cytoplasm is very crowded with 
macromolecules constituting up to 40% of the matrix volume, which significantly increases 
viscosity and diffusional heterogeneity (Zhang, 2011). Consequently, the formation of enzyme 
associations for metabolite channeling has been hypothesized to overcome many barriers in 
metabolic pathways (Atkinson, 1977). First, low water concentration strongly inhibits a 
reaction’s equilibrium and rate. If insufficient free water exists in the cell to support optimum 
metabolic reaction rates (Hall and Minton, 2003), cells may link enzymes to channel metabolites 
directly through the pathway. Secondly, concentrations of key intracellular metabolites are often 
smaller than the Michaelis constant values of the catalyzing enzymes (Fendt et al., 2010), and 
these metabolite nodes may limit pathway fluxes (Bennett et al., 2009). Channeling improves 
enzyme conversion of low-concentration substrates while not inhibiting reaction rates. Lastly, 
many pathways have thermodynamic bottlenecks. For example, the oxidation of malate to 
oxaloacetate in the TCA cycle has a large positive ∆G°, but the reaction becomes 
thermodynamically favorable if malateoxaloacetatecitrate can be treated as one step (Noor 
et al., 2014). Therefore, channeling is an important mechanism to overcome kinetic and 
thermodynamic obstacles in central metabolism. 
5.2.2 Compartmentalization and tunneling. Compartmentalization of multiple enzymes and 
substrate tunneling within a multi-functional protein complex are well-studied. Cellular 
compartmentalization is a common characteristic of eukaryotes. Their organelles encapsulate 
enzymes or DNA by membranes. Compartments of enzyme complexes can be mitochondrion, 
peroxisomes, chloroplasts, the endoplasmic reticulum, and the Golgi apparatus, which has been 
extensively explored (Huttanus and Feng, 2017). Moreover, polyfunctional enzyme subunits may 
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contain elegant tunnels for intermediate conversions. X-ray 3-D structural analyses provide 
physical evidence of direct enzymatic conversion among active sites without diffusion. 
Tryptophan synthase was studied by the X-ray structural analyses, which revealed the three-
dimensional arrangement of the enzyme subunits to facilitate intramolecular tunneling of the 
intermediate indole (Huang et al., 2001). Transient-state kinetic approaches confirmed direct 
formation of L-tryptophan from indole 3-glycerol phosphate without releasing indole into the 
bulk phase. Similarly, tRNA-dependent amidotransferase, 4-hydroxy-2-ketovalerate 
aldolase/acylating, acetaldehyde dehydrogenase, cytidine triphosphate synthetase, pyruvate 
dehydrogenase, carbamoyl phosphate synthetase, glutamine phosphoribosylpyrophosphate 
amidotransferase, and asparagine synthetase contain multiple active sites (Huang et al., 2001; 
Weeks et al., 2006). These active sites are spatially close (ranging from ~25 Å to ~100 Å in 
length), which diminishes transit time and protects reactive intermediates from contacting with 
the external medium. Tunneling can also sequester reactive intermediates from hostile external 
environments. For example, acetyl-CoA synthase/carbon monoxide dehydrogenase from 
Moorella thermoacetica forms a molecular tunnel with a hydrophobic cavity of 138 Å, which 
controls the Wood-Ljungdahl pathway and reduces CO toxicity (Weeks et al., 2006).  In addition 
to tunneling, other mechanisms may facilitate substrate transport between enzyme reaction sites. 
For instance, multiple subunits within fatty acid synthase shuttle intermediates for growing fatty 
acid chains to various catalytic sites via protein-protein interactions (Mashek et al., 2007). 
Similarly, pyruvate dehydrogenase complexes employ chemical swing arms to pass 
intermediates between dehydrogenase and acetyltransferase to transform pyruvate into acetyl-
CoA (Perham, 2002).  
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5.2.3 In vitro experiments on channeling of cascade enzymes. In vitro analyses of enzyme 
complexes and interactions have been performed by cross-linking/LC-MS, transient 
measurement of reaction rates, isotope labeling, kinetic modeling, SDS-PAGE, and detection of 
cascade resistance to a competing side reaction or a reaction inhibitor (Wheeldon et al., 2016). 
Recently, recombinant citrate synthase (CS), mitochondrial-malate dehydrogenase (mMDH), and 
aconitase were found to adopt a metabolon structure (Bulutoglu et al., 2016). Site-directed 
mutagenesis of conserved arginine residues located in the positively charged electrostatic 
channel connecting mMDH and CS active sites led to impaired bioconversion of malate. This 
explicates why high TCA cycle fluxes can operate in a viscous mitochondrial matrix. 
Additionally, a three-enzyme system (malate hydrogenase, citrate synthase, and lactate 
dehydrogenase) was used to mimic the in vivo TCA pathway malateoxaloacetatecitrate and 
found enzyme co-immobilization increased citrate production rates compared to the soluble 
system (Srere et al., 1973). Some purified enzymes can naturally aggregate to form stable 
channels under in vitro conditions (even in the presence of salt and detergent stresses). For 
example, the Kohl group studied tissue extracts and purified enzymes from the pentose 
phosphate pathway (PPP) (from yeast and plant cells), which channeled [1-14C] glucose into 
14CO2 without influence by the addition of unlabeled intermediates, such as glucose 6-phosphate 
(G6P), 6-phosphogluconolactone, or 6-phosphogluconate (Debnam et al., 1997). They also found 
a lesser degree of channeling of G6P than 6-P-gluconate. This may reflect the fact that G6P has 
more than one metabolic fate (sharing between PPP and glycolysis).  
5.3 In vivo channeling studies 
5.3.1 Approaches to reveal in vivo pathway channeling. Intracellular enzymes along central 
pathways, like the Embden-Meyerhof-Parnas pathway (EMPP), may co-localize to form 
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channels (Table 5.1), such as glycolysisosomes (Shearer et al., 2005). This opinion is still highly 
controversial because it is difficult to investigate enzyme interactions intracellularly. For in vivo 
studies, three common approaches are used. First, genetic engineering can be used to enhance 
channeled pathways or disrupt enzyme interactions (Figure 5.1c.). For example, to investigate 
channeling of TCA cycle enzymes in mitochondria, citrate synthase and malate dehydrogenase 
in Saccharomyces cerevisiae were mutated (Vélot and Srere, 2000). The mutation in citrate 
synthase did not change its kinetic efficiency but caused deficiency in the TCA cycle. Such an 
inhibitory phenotype could be overcome by malate dehydrogenase overexpression. This study 
inferred that enzyme interactions are essential for the TCA cycle functioning. Secondly, 
channeling can be characterized by measurement of molecule movement through channels or 
identify co-localization of enzymes. In vivo diffusivities of small solutes and macromolecules 
can be observed through photo bleaching of fluorescently labeled macromolecules, microscopy 
and time-resolved anisotropy (Mika et al., 2010; Verkman, 2002). The observation of metabolite 
turnover without aqueous-diffusive barriers in crowded cellular environments infers metabolite 
channeling from one enzyme to an adjacent enzyme. Third, 13C or 14C experiments are used to 
detect elusive channeling phenomena because channeling occurrence may create a redistribution 
of C labeling (Niklas et al., 2011). In the TCA cycle of S. cerevisiae, the 13C fractions of the 
second and third carbon in oxaloacetate from [4-13C]α-ketoglutarate were not randomized, which 
reveals possible channeling of succinate (a symmetric metabolite) in the enzyme reactions of α-
ketoglutaratesuccinatefumarate (Sumegi et al., 1993). In another example, when 1st position 
labeled glucose is used as a substrate, the channeled EMPP could bypass unlabeled triose 
phosphate input from the PPP and the Entner–Doudoroff pathway (EDP), altering the isotopomer 
composition of pyruvate and alanine (Tang et al., 2012). Therefore, 13C-metabolite flux analysis 
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(MFA) can offer a noninvasive strategy for the detection of metabolite channeling. Based on the 
network structure and labeling strategies, 13C-MFA models may include the cytosolic pathway 
bypasses or subcellular compartmentations to characterize channeled flux (Williams et al., 2011). 
On the other hand, 13C-MFA often relies on the labeling of amino acids. Without extensive 
isotopomer information of pathway intermediates, 13C-MFA cannot provide conclusive evidence 
of channeling in central pathways.  
 
Figure 5.1. Mechanisms for detecting substrate channeling. (A) By using challenging 
substrates, the Kohl group estimated the extent of EMPP channeling (Shearer et al., 2005). (B) 
To investigate a pathway with a high degree of channeling, first, a reaction step can be weaken in 
the channel (i.e., knockdown an enzyme in the pathway) to squeeze metabolites out of the 
channeling. Following, a 13C-pulse can detect labeling dynamics (Hollinshead et al., 2016). (C) 
By mutating an assembly peptide of an enzyme, individual enzyme activity will not be affected, 
yet the pathway flux may be impaired (Vélot and Srere, 2000). 
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 5.3.2 Detection of leaky channels via dynamic labeling of intermediates. Intracellular 
pathways may form imperfect channels to release metabolites that connect to other pathways 
(Figure 5.2). In pathways with leaky channels, intermediates appear in two separate 
compartments: a channeled pool (with high metabolite turnover rates) and a cytosol pool (with 
much lower metabolite turnover rates). Under this assumption, dynamic labeling using 13C (or 
14C) can identify these leaky nodes. For example, 13C analyses of photoautotrophic metabolism 
in Synechocystis 6803 found channeling of sugar phosphate pathways due to faster labeling in 
downstream products (PEP: phosphoenolpyruvic acid) than its upstream metabolite (3PG: 3-P-
glycerate) right after the cells were fed with 13CO2 (Huege et al., 2011). Another study saw 
metabolite channeling in Calvin cycle intermediates with fructose-6-P, ribose-5-P, and 
glyceraldehyde-3-P being less labeled than downstream intermediates, sedoheptulose-7-P, 
ribulose-5-P and ribulose-1,5-P (Young et al., 2011). In other words, isotopically nonstationary 
experiments may reveal leaky metabolite nodes in a channel because its metabolically inactive 
cytosol pool dilutes the bulk metabolite labeling rate. Although the observation of non-sequential 
labeling of cascade metabolites after the 13C-substrate pulse can be used as a “channeling 
signature”, such method has limitations. First, turnover rates of central metabolites are so rapid 
that labeling among cascade metabolites reaches steady state instantaneously after 13C-pulse 
(Link et al., 2013). Secondly, if the pathway intermediates are perfectly channeled without a 
metabolically inactive pool, channeling signatures will not be observed. 
 Kohl et al. proposed an alternative approach based on the redistribution of isotopes in the 
presence of challenging metabolites (Shearer et al., 2005). In his study of EMPP enzyme 
channeling, E. coli was engineered so that the mutants could uptake both 14C-glucose and 
unlabeled sugar phosphate intermediates (called challenging substrates). Based on different 14C 
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enrichment rates of downstream metabolites with or without the presence of a challenging 
substrates, they built a two-compartment model (channel pool vs. cytosol pool) to quantify the 
fraction of the total flux through the channel as seen in Figure 5.1a. The authors found that the 
addition of unlabeled sugar phosphates in the labeled culture medium have different degrees of 
dilutions on the end-product 14CO2. They found that the glycolysis intermediate fructose-
bisphosphate (FBP) was perfectly channeled so the addition of unlabeled FBP did not affect 
14CO2 evolution from 
14C-glucose. The challenging substrate G6P, on the other hand, diluted the 
14CO2 labeling by ~30%, while unlabeled fructose-6-P (F6P) diluted the 
14CO2 labeling by 
>60%. Thus, G6P and F6P were both channeled to a lesser degree than FBP. This observation is 
consistent with the factors that G6P and F6P are shared metabolites between the EMPP and PPP. 
Such leakage is essential for metabolic network connections. Moreover, fructose-bisphosphate 
aldolase (FBA) is a thermodynamic bottleneck in the EMPP (Flamholz et al., 2013), and the high 
degree of FBP channeling is essential to overcome this barrier. 
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Figure 5.2. Types of substrate channels. (A) Example of a perfect channel. Reactions are said 
to be perfectly channeled if their transient time, τ, which is the time it takes for a reaction to 
reach steady-state flux, approaches zero (B) Example of a leaky channel where intermediates are 
also exchanged with the bulk phase. In this case, its transient time, τ, is an indicative of the 
extent of channeling and is between zero and free diffusion. Leaky channels are necessary for 
connecting different metabolic pathways that share intermediates. 
 
5.3.3 "Squeeze and Pulse" to investigate pathways of high degree of channeling. The use of 
challenging substrates by Kohl group have two potential drawbacks. First, the cell cannot 
naturally uptake challenging substrates without engineering transporters and secondly, the 
mutant may have catabolite repressions. As such, Hollinshead et al. (2016) designed a two-step 
approach to examine channeling without the use of challenging substrates. In the first step, 
genetic tools are used to down-regulate a reaction step, creating a bottleneck in the pathway as 
seen in Figure 5.1b. Such genetic modification aims to squeeze metabolites into cytosol at the 
targeted node. This may decrease the pathway flux, making the measurements of metabolite 
turnover easier. The second step is to pulse 13C-substrate into cell culture, then time-course 
samples are collected to capture the labeling dynamics of the cascade metabolites. If a pathway is 
channeled, the labeling of the precursor metabolites will be slower than their product metabolites 
because a fraction of the precursor metabolites are squeezed outside of the channel to become 
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less reactive. For example, a pfk E. coli mutant was created to decrease the degree of channeling 
in the EMPP. Then 13C-pulse experiments found G6P/F6P had slower labeling rates than their 
product PEP (Hollinshead et al., 2016), supporting the hypothesis of channeling in the EMPP 
(i.e., glycolysisosomes) by Kohl group.  
 
5.4. Modeling/ theoretical investigation of pathway channeling 
5.4.1 Channeling blocks flux towards thermodynamically favorable pathways. The EMPP is 
important for cell growth, thus many efforts have been proposed to bypass this pathway to 
increase catabolism. Figure 5.3 indicates multiple thermodynamic bottlenecks in cascade 
enzymes (highlighted in Figure 5.3a). Alternatively, the EDP requires less enzymatic proteins, 
and its cumulative ΔG° is more favorable than the EMPP (Flamholz et al., 2013). However, E. 
coli prefers to use the EMPP rather than its native EDP, even when the EDP is highly 
overexpressed (Hollinshead et al., 2016).  This dilemma can be explained by the possible change 
of intrinsic Gibbs free energy by EMPP channeling. In a channeled pathway, the local 
concentrations of a reactant and a product can be altered, leading to a more negative ΔG which 
can drive a reaction forward. As illustrated by Figure 5.3b, we present the ΔG of the pathway 
from glyceraldehyde-3-P to 3PG (enzymes gapdh and pgk) as a function of concentrations of 
reactants and products. The ΔG of these two reactions in E. coli is close to zero (Park et al., 
2016), represented as red circles in Figure 5.3b. However, the value can be decreased 
exponentially with a higher concentration of reactant and a lower concentration of product. In 
addition, the ΔG of a reaction can be determined by forward and backward fluxes (Flamholz et 
al., 2012; Park et al., 2016). It is safe to assume that the forward flux is much higher than the 
backward flux in a channeled pathway, rendering ΔG a very negative number. Taken together, it 
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is plausible that a channeled pathway is more thermodynamically favorable than a non-channeled 
pathway, altering pathway preference.  
 
Figure 5.3. Gibbs free energy of reactions in glycolysis. (A) Cumulative Gibbs free energy (ΔG) 
in EMPP and EDP. The highlighted regions indicate the thermodynamic bottlenecks. The error 
bars are the 95% confidence interval of estimated ΔG. (B) Contour plots of ΔG as a function of 
metabolite concentrations in gapdh and pgk reactions (13PG: glycerate 1,3-bisphosphate; GAP: 
glyceraldehyde 3-phosphate; 3PG: 3-P-glycerate). The x and y axes are the concentrations of 
metabolites in log scale, and isolines marked ΔG values. The red circles are the estimated ΔG in 
E. coli cells. ΔG is calculated by eQuilibrator (Flamholz et al., 2012)  (assuming a pH of 7.2 and 
an ionic strength of 0.25 M) and metabolite concentrations are based on a previous report (Bennett 
et al., 2009). In ΔG equation above, J+ and J- represent forward and backward fluxes. 
 
5.4.2. Channeling facilitates transport of metabolites between enzymes. Diffusion is assumed 
to be fast enough for reaction rates in small bacterial cells without the need for metabolite 
channeling (Wheeldon et al., 2016). But others have found that enzymes’ active site orientation, 
size, distance (Bauler et al., 2010), and electrostatic interactions (Eun et al., 2014) influence fast 
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metabolite conversions   In this current study, a diffusion model examined the concentration 
gradient of a metabolite (c) between two cascade enzymes (A, B) with a distance R (Figure 5.4). 
If the enzymes are close to each other (within 20 nm), diffusion was fast enough to diminish 
concentration differences between A and B, regardless of D and k. As distance between enzyme 
A and B increases, the metabolite concentration at the location of enzyme B becomes more 
heavily influenced by the diffusion coefficient. Based on biochemistry experiments, most 
enzymes catalyze their reactions to a rate (average kcat/KM ~10
5 M-1s-1) that is 1,000~10,000 
times slower than the diffusion-rate for collisions of proteins and metabolites (108 M-1s-1) (Bar-
Even et al., 2011). However, such in vitro-measured kinetic parameters may not correlate with in 
vivo enzyme activity. For example, in vitro reconstruction of the EMPP in a cell-free system 
observes protein aggregations and significant loss of kinetic activities at enzyme concentrations 
of a few micro-moles (Liu et al., 2017). In contrast, the bacterial cytoplasm is highly crowded 
with non-uniform macromolecules and “bound” water. At this high volume fraction, intracellular 
suspensions exhibit properties that are characteristic of glass-forming liquids and provide a 
glassy dynamic to the cytoplasm (Parry et al., 2014). Such a high viscosity and tortuosity causes 
transport barriers via the Stokes-Einstein law. If metabolite diffusion coefficients are reasonably 
reduced by 10-fold (Mika et al., 2010) by crowding effects, the metabolite concentration around 
the enzyme B is reduced by ~85%, and thus limit flux towards enzyme B. 
5.4.3 Diffusion and reaction rates along EMPP enzymes. An in silico study was conducted to 
relate enzyme copy number or concentration (enzyme concentration estimated as copy 
number/NA × cell volume (0.7 µM
3)) to diffusion and distance between entities. Relative 
concentration profiles (Figure 5.4b) were determined based on relative time and positioning 
using the equation presented in Figure 5.4a. The variables x, c and t are dimensionless after they 
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are normalized to the distance between A and B (R), the initial concentration of A (C0), and a 
characteristic time R2/D, respectively. The resulting equation is irrelevant to R and D, and here, 
we also assumed that the relative concentration is one at x=0 and zero elsewhere, and the 
concentration gradient is zero at x=R. To achieve 99% of the initial concentration near enzyme 
B, it was found to take roughly two relative time units. Figure 5.4c shows the estimated time for 
one metabolite or protein to travel in a specific distance. A previous review suggests that 1 nM of 
molecules in cells corresponds to 1 µm average intermolecular distance, and that 100 nM 
corresponds to a distance of 0.25 µm (Grima and Schnell, 2008). For enzymes involved in 
glycolysis, their copy numbers are generally high (between 104 and 105) (Voges et al., 2015), 
which gives a concentration of ~100 nM (between 24 nM and 240 nM) for each individual 
enzyme. Under such circumstances, the average time for a NBD-glucose molecule (fluorescently 
labeled deoxyglucose used to monitor glucose uptake) to travel from one enzyme to another one 
is only 2.5 millisec (Figure 5.4c). As displayed in Figure 5.4d with the dotted-line, 2.5 millisec is 
smaller than reaction turnover time of most enzymes (except tim, pgk, pgm, pgl) in the glycolysis 
pathway (Flamholz et al., 2013), further suggesting diffusion poses few bottlenecks.  However, if 
the distance between two enzymes increases 4-fold to 1 µm, the diffusional time increases to 40 
millisec, leading to increased diffusion barriers in the EMPP (except fba). Further, if a pathway 
contains multiple steps, cumulative distance among all enzymes will be increased. For instance, 
the EMPP contains 9 enzymatic steps from G6P to pyruvate. If the model assumes an average 
distance of 0.25 μm and a diffusion coefficient of 50 µm2s-1, 142 millisec is needed for 
conversion from G6P to pyruvate, and the time for diffusion accounts for 14.2% of the total time 
(the sum of diffusion time plus 1/kcat of EMPP enzymes). However, through channeling 
interactions, if the average distance among enzymes is shortened to 0.1 μm, the time fraction for 
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diffusion drops to 2.6%. This shows even a loose channel can promote fluxes through a long 
pathway.  
 
Figure 5.4. A simple model for molecule diffusion in cells. (A) The governing equation in 
dimensionless form, where D (µm2s-1) is the diffusion coefficient, and C0 (mM) is the initial 
concentration. (B) Concentration profile as a function of relative distance and time. The color 
represents the relative level of concentration and the isolines are numbered with corresponding 
concentrations. The model describes the diffusion of a metabolite or a protein A to another protein 
B, while B is assumed to be motionless. The distance between them is R (µm). (C) A table showing 
how long it may take for free metabolites or proteins to reach 99% of initial concentration at B. 
The diffusion coefficients are from a reference (Mika and Poolman, 2011) (D) Average time of 
two reaction events for enzymes in the glycolysis pathway. The values of kcat are from a reference 
(Flamholz et al., 2013). The dotted line indicates that diffusion in this case is slower than most 
reaction turnover times.  
 
5.4.4 Channeling alters enzyme-metabolite and enzyme-enzyme interactions. Proteins or 
macromolecules can be considered to be motionless when compared to free metabolites. For 
example, it may take 2 min for ribosome-loaded mRNAs to travel 1 µm, which is four orders-of-
magnitude longer than a glucose molecule. This finding is consistent with the phenomenon of 
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macromolecular crowding in cells (Ellis, 2001). If enzyme copy numbers are low, the average 
distance between cascade enzymes may be increased, and metabolite channeling is more likely to 
be beneficial to multiply the chances of enzyme-reactant collisions. Secondary metabolism in 
plants has been shown to form channeled pathways to improve low-concentration intermediates 
(Jandt et al., 2013; Jørgensen et al., 2005; Roze et al., 2011). In addition, metabolite channeling 
could also prevent promiscuous side reactions. Promiscuous enzymes (e.g., hydrolase) are 
widely present in microbes as many cross-reactions are being discovered through gene knock 
outs of critical enzymes (Khersonsky and Tawfik, 2010).  Metabolic channeling can help define 
the products of these promiscuous enzymes (Schwab, 2003). While catalytic promiscuity may 
introduce unwanted side reactions, channeling may effectively repress side reactions by 
concentrating enzymes and their desired substrates within a pathway (Piedrafita et al., 2015). 
Therefore, another benefit for metabolite channeling is to improve pathway specificity. Finally, 
intracellular proteins are constantly being broken down by diverse proteases (Oda, 2012). 
Proteolysis is important for metabolic regulation by deactivating enzymes, transcription factors, 
and receptors. In general, proteolysis can be highly promiscuous. To protect a wide range of 
essential enzymes, channeling may reduce the chance of these enzymes being freely exposed to 
non-specific intracellular proteases so that cell only removes unnecessary or abnormal proteins. 
In eukaryotes, enzymes can protect themselves by concentrating in compartments; in 
prokaryotes,  compartments are limited, consequently localization of enzymes could be a natural 
defense against enzyme proteolysis (Gottesman, 1996; Meyer et al., 2014).  
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5.5 Implications of metabolic channeling 
5.5.1 Challenges facing synthetic biology. In metabolic engineering applications, novel 
pathways with beneficial energy and carbon yields have been proposed to improve bio-
productions. However, heterologous pathways typically have inferior efficiency relative to native 
pathways. Unlike native pathways, the engineered pathways are likely unable to overcome 
intracellular crowding effects, diffusion limitations, promiscuous side reactions or optimal 
regulation control. One of the challenges in metabolic engineering is glucose catabolite 
repression, which blocks E. coli utilization of lignocellulosic sugars. Disruption of the presumed 
glycolysis channel (such as knocking out the phosphotransferase system or a key gene in the 
EMPP) decreases biomass growth but improves cell capability to co-utilize C5 sugars (Gonzalez 
and Antoniewicz, 2017; Hollinshead et al., 2016). This finding strongly implies that metabolite 
channeling may block EMPP enzymes from co-utilizing intermediates produced from other 
pathways (e.g., xylose degradation pathway). Such catabolite repression may be reduced if the 
channeled flux is disrupted, allowing the products of C5 sugars to diffuse from the cytosol into 
the pathway channel for metabolic conversion. 
5.5.2 Applications of synthetic channels to benefit bioproductions. Metabolic engineers have 
attempted to increase the intrinsic inefficiency of metabolic reactions through enzyme 
localization and compartmentalization of metabolic pathways. Compartmentalization of 
pathways has been deployed in eukaryotes by tagging enzymes to specific cellular organelles 
(Avalos et al., 2013; Sheng et al., 2016). This approach offers benefits such as inhibition of 
competing reactions, pathway stabilization, substrate concentration, and reducing the release of 
toxic byproducts (Huttanus and Feng, 2017). It also represents a starting point for innovative 
bacteria engineering tactics such as targeting bacterial microcompartments like carboxysomes or 
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heterologously expressing microcompartments (Chen and Silver, 2012;  Parsons et al., 2010; 
Worsdorfer et al., 2011).  
 Another channeling strategy involves the engineering of protein interaction surfaces or 
direct protein fusion of interacting partners (i.e., protein or DNA/RNA scaffolds). Scaffolds 
reduce diffusion time, mitigate toxic metabolite inhibition and make heterologous enzymes more 
stable (Baek et al., 2013; Moon et al., 2010; Sachdeva et al., 2014; Wang and Yu, 2012). For 
example, co-localization of three mevalonate biosynthetic enzymes via a protein scaffold 
achieved improvement in product titer even with low enzyme expression (Dueber et al., 2009; 
Wang and Yu, 2012). DNA scaffolds have also been developed by orderly locating enzymes on 
genomic or plasmid DNA to increase the proximity of enzymes, which has shown to facilitate 
microbial threonine (Lee et al., 2013) and 1,2-propanediol (Conrado et al., 2012) productions. 
RNA scaffolds with distinct protein-docking sites have been designed to offer precise enzyme 
spatial organization. Thus, in vivo RNA assemblies can be used to engineer biological pathways 
with multidimensional architectures, such as hydrogen production (Delebecque et al., 2011).  
 A particularly interesting area of study that benefits from channeling strategies is 
flavonoid production in engineered microorganisms. It is well established that flavonoid 
production in plants is facilitated by the presence of metabolons (Jørgensen et al., 2005). 
However, flavonoid isolation from naturally-producing plant material is difficult, making 
heterologous flavonoid production in recombinant organisms like E. coli attractive. Nonetheless, 
cofactor and substrate supply tend to be the limiting steps in flavonoid bio-production in E. coli.  
For heterologous flavonoid production in recombinant microorganisms, pathway modulation and 
enzyme co-localization have been proved valid strategies. Catechin flavonoid production in E. 
coli was enhanced using combinatorial protein scaffolds with catechin biosynthesis (Zhao et al., 
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2015). To simulate the multi-enzyme complexes involved in flavonoid production in plants, a 
translational protein fusion between two pathway enzymes was used to increase cyanidin 3-O-
glucoside formation over tandem transcriptional expression of the two enzymes (Yan et al., 
2008).  
Heterologous expression of microcompartments and co-localization of enzymes are still 
difficult to employ widely in the metabolic engineering field. The synthetic channel places 
metabolic burdens on the host and may also affect protein folding. The formation of capsids can 
impair cell growth and productivity. Moreover, microcompartments and metabolons are 
constrained by global cell regulations (Chen and Silver, 2012). Current synthetic channeling 
studies focus mainly on cell productivity without knowledge of the structure, mechanism, or 
kinetics of engineered channels. It is often unclear whether improved cell productivity is from 
concentrated metabolite pools, enzyme protection, or elimination of metabolite inhibition. To 
produce heterologous pathways as efficient as native pathways, we need more efforts to 
understand the delicate mechanisms of natural channels in central pathways.  
5.5.3 The impact of channeling on genome-phenome mapping. There have been many studies 
on the mechanisms regulating metabolic fluxes in microbial systems. Most research focuses on 
transcriptional regulations and DNA-to-protein regulations under diverse conditions. Protein and 
metabolite interactions (allosteric regulation) were also proposed to enable instantaneous 
metabolic response and pathway modulation to maintain metabolic homeostasis (Link et al., 
2013). Computational studies have been carried out to relate fluxes to data from the metabolome 
and proteome (Liebermeister and Klipp, 2006; Noor et al., 2016). Most models assume that 
metabolic fluxes are determined by metabolite concentrations and protein abundance. Intuitively, 
gene/protein expressions and metabolite concentrations should have strong influences over their 
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functional outputs—i.e., fluxes. However, much evidence has shown that neither 
transcription/enzyme levels nor allosteric regulation are sufficient to explain the flux variations 
in response to various growth conditions (Blank et al., 2005; Chubukov et al., 2013; Hackett et 
al., 2016). Even among different heterotrophic microbial species, the substrate catabolic fluxes in 
different bacterial families or their mutants show much smaller variations than their genome or 
transcriptional differences (Tang et al., 2009; Wu et al., 2016). This leaves unresolved the 
question of what are the hidden forces that maintain robustness and stability of flux ratios under 
genetic or environmental perturbations (Fischer and Sauer, 2005; He et al., 2017). Recent E.coli 
studies show surprisingly simple regulatory correlations, where only a few global transcription 
factors (e.g., Crp and Cra) and intracellular metabolites (e.g., cyclic adenosine monophosphate, 
FBP, and fructose-1-P) appear to coordinate microbial central metabolism (Kochanowski et al., 
2017). This leaves a strong hypothesis that native bacterial pathways form well-organized 
channels to direct metabolic fluxes via several key regulation nodes.  A wide distribution of 
pathway channels is beneficial for cell metabolism to minimize enzyme synthesis costs and to 
remember an optimal fluxome to organize nutrient influxes throughout the metabolic network. 
From this point of view, channeling can cause enzyme reaction rates to vary non-linearly with 
enzyme or metabolite concentration (Wortel et al., 2014) and thus mislead multi-omics 
investigations of metabolic regulations (Chubukov et al., 2013).  
5.5.4 The impact of channeling on 13C-MFA. 13C-MFA deciphers cell metabolism via the 
labeling of intermediate metabolites, which relies on the assumptions of homogenous cell 
environments and the absence of diffusion limitations. Additionally, 13C-MFA assumes that 
scrambling reactions’ net and exchange fluxes (such as succinate to fumarate) are symmetric 
(Wiechert et al., 2001).  For a complex pathway, channeling can provide alternative isotopic 
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labeling routes. For example, if [3-13C]propionate is used as a substrate, malate will be 
symmetrically labeled in the absence of metabolic channeling. In reality, malate is 
asymmetrically labeled in Saccharomyces cerevisiae, revealing the features of the channeling in 
TCA cycle enzymes (Sumegi et al., 1990). Therefore, precise 13C-MFA must consider the 
channeling influences on molecule orientation and pathway preferences (e.g., addition of 
alternate flux channels in the MFA model). One 13C-MFA study found that the assumption of 
channeling bypasses improved MFA model fit and provided a more accurate description of the 
metabolic network (Williams et al., 2011). However, the use of 13C-MFA to investigate pathway 
channeling relies on precise measurements of labeling positions of key metabolites using both 
MS and NMR as well as goodness of fit by realistic models. It may fail in highly connected 
networks or autotrophic metabolism if model or measurement resolution is not sufficient. 
On the other hand, isotopically nonstationary flux analysis is a new approach to profile 
fluxes by tracing isotopic dynamics along cascade metabolites. Metabolite labeling patterns can 
be confounded by the presence of metabolically inactive pools outside of pathway channels. To 
account for such phenomena, dilution parameters are used to describe a lack of isotopic 
equilibrium due to the existence of two or more metabolite pools (Antoniewicz et al., 2007). 
Dilution factors improve the goodness of fit, but introduce additional degrees of freedom into 
model. This may increase undetermined parts of the metabolic network (van Winden et al., 
2001). Dilution parameters, as a channeling factor, provide quantifications of concentration 
heterogeneity among intracellular metabolites. 
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5.6 Conclusions 
 Intracellular proteins can be organized in a variety of assemblies and functional modules. 
Channeling through central pathways not only improves flux efficiency and reduces promiscuous 
reactions, but also maintains flux rigidity against genetic modifications and harsh environmental 
conditions (He et al., 2017). Characterization of in vivo channeled pathways still lacks standard 
tools, particularly for longer pathways. To obtain clear evidence of metabolite channeling, 
imaging, LC-MS, genetic engineering, protein structural analysis, and 13C-labeling needs to be 
integrated. The knowledge of channeling represents a new type of constraint to improve 
computational predictions of cell physiologies and metabolic engineering strategies. To date, 
many puzzling issues remain regarding the mechanisms for channeling formation, the impact of 
channeling on kinetic and metabolic modeling, and the evolutional/genetic methods to create 
channels for metabolite conversions. Channeling offers an explanation for why non-model 
species with native pathways are much more robust for industrial bio-production. Understanding 
of channeling may allow for the development of more robust synthetic strains with highly 
effective heterologous pathways. 
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Chapter 6: Comparative studies of glycolytic pathways 
and channeling under in vitro and in vivo modes   
 
This chapter has been reproduced from the following publication:  
Abernathy MH*, Zhang Y*, Hollinshead WD, Wang G, Baidoo EEK, Liu T, Tang YJ. 
Comparative studies of glycolytic pathways and channeling under in vitro and in vivo modes. 
AIChE Journal. 2018; doi:10.1002/aic.16367.  
*Contributed equally as co-authors; I contributed to the metabolic flux analysis, pool size 
analysis, 13C isotopically nonstationary labeling experiments, and drafting of the manuscript.  
Abstract 
This study constructed cell-free glycolytic enzyme systems and compared them to their in vivo 
functions in E. coli. Under in vitro conditions, flux regulation followed enzyme concentrations 
and kinetics. In E. coli, only one of the isozymes of phosphofructokinase (PfkA) and fructose-
bisphosphate aldolase (FbaA) facilitate Embden-Meyerhof-Parnas (EMP) flux, but under in vitro 
assays, these isozymes were interchangeable. Additionally, in vitro introduction of the Entner–
Doudoroff (ED) pathway improved glycolysis rates, while in vivo overexpression of the ED 
pathway could not capture significant flux unless its phosphotransferase system (PTS) was 
knocked out. Lastly, in vivo 13C-experiments revealed that the labeling order of EMP pathway 
intermediates was not strictly cascade, indicating intracellular metabolites were not well mixed.  
These enigmatic observations cannot be fully explained by thermodynamics or substrate level 
regulations. This paper supports the long-time conjecture that EMP enzymes are channeled, and 
the PTS may be an anchor point to initiate enzyme assemblies.  
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6.1 Introduction 
 In light of diverse regulatory and metabolite channeling theories, this study re-examined 
E. coli glycolytic pathways: the Embden-Meyerhof-Parnas (EMP) pathway, the pentose phosphate 
(PP) pathway and the Entner-Doudoroff (ED) pathway. Theoretically, the ED pathway would 
increase glycolytic flux in microbial hosts for desired products (Khodayari and Maranas, 2016; 
Liu et al., 2013); thus mutation efforts are employed to improve both native ED pathway usage 
(Hollinshead et al., 2016) and glucose catabolism in E.coli (Charusanti et al., 2010; Huerta-
Beristain et al., 2017). However, the ED pathway in E.coli is always inferior to the EMP pathway 
despite its favorable thermodynamics, less enzymatic steps, and comparable enzyme activities 
(Flamholz et al., 2013; Peng and Shimizu, 2003). Studies on pathway regulations in bacteria often 
focus on reaction thermodynamics, enzyme kinetics, allosteric inhibitions, or enzyme expressions, 
while protein-protein interactions remain unfamiliar. To investigate flux controls among 
competing pathways for glucose catabolism, this study has designed both in vitro and in vivo 
systems in conjunction with reported channeling theories (Huege et al., 2011; Young et al., 2011). 
Via cross-talk and comparisons among enzyme expressions and turnover of cascade metabolites 
under in vivo vs. well-mixed in vitro conditions, we aim to obtain new insights into glycolytic 
regulations. Moreover, the phosphotransferase system (PTS) is the main glucose transporter in E. 
coli (Gosset, 2005) and plays a key role in phosphorylating glucose to glucose-6-phosphate (G6P), 
which is the branching point for the three glycolytic pathways (Flores et al., 2002) (Figure 6.1). 
According to chemotactic assembly theory, the PTS would be a starting point of EMP channeling 
(Zhao et al., 2018). Thus, by using PTS mutants, isotopic labeling and cell free systems, this study 
revisits the flux re-distributions at a major flux control point in E. coli mutants. The outcomes 
support recent views about in vivo flux regulations via channeling (Sweetlove and Fernie, 2018).  
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Figure 6.1. Glycolytic pathway map in E. coli. Both upper EMP and ED enzymes are 
represented. The enzymes in red represent the enzymes that were also present in the cell-free 
system. The ED pathway enzymes are underlined. The boxes represent metabolic pathways 
branching off glycolysis at the G6P node.  
 
6.2 Materials and Methods 
6.2.1 Strain Construction. Wild type (WT) E.coli (K-12 BW25113) and its mutant strains are 
listed in Table S1. The plasmid pED was derived from plasmid pBbE5c-YFP (50-70 copies per 
cell) with the YFP gene replaced with E. coli edd and eda genes, as reported in our previous paper 
(Hollinshead et al., 2016). Briefly, the strain (∆ptsG + ED) was constructed as follows: competent 
cells were made from the ∆ptsG mutant using chilled transformation and storage solution. Heat 
shock transformation was used to transform the ∆ptsG strain with the purified plasmid pED. The 
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resulting strain was plated on kanamycin (20 µg/mL) and chloramphenicol (30 µg/mL) Luria-
Bertani (LB) plates to isolate the transformed cells.  
6.2.2 Media composition and growth experiments. All experiments were started with LB seed 
cultures with appropriate antibiotic. Next minimal M9 medium consisting of 11 g/L of 5x M9 salts 
(Sigma Aldrich, St. Louis, MO), 2 mM MgSO4◦7H2O, 0.1 mM CaCl2◦2H2O, 1 mg/L of thiamine 
hydrochloric acid, 3 mg/L of FeSO4◦7H2O, and trace minerals was inoculated (1% v/v) with 10 
g/L glucose. All cultivations were aerobic 5 mL cultures on a rotary shaker at 250 rpm and 37 °C. 
Mutant cultures were supplied with 20 µg/mL kanamycin and 30 µg/mL chloroamphenicol as 
needed. To induce plasmid genes, 0.05 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was 
added at early exponential phases.  
6.2.3 Steady state labeling experiments and GC-MS analysis. E. coli cultures were inoculated 
in fresh M9 minimal medium (0.5% v/v) and were grown with 10 g/L 1-13C glucose (Sigma 
Aldrich, St. Louis, MO) (n=2) until isotopic steady state. Amino acid extraction and GC-MS 
analysis were performed as described previously during exponential growth phase (You et al., 
2012). The fragments [M-15]+ or [M-57]+ and [M-159]+ or [M-85]+ were used for isotopic tracing. 
Using a previously reported algorithm, the natural isotopic abundance was corrected for the 
derivatized amino acids (Wahl et al., 2004). Based on mass isotopomer distribution (MID) data 
from labeled amino acids, flux ratios among glycolytic pathways (Figure 6.3) were computed using 
software WUFlux (He et al., 2016). Standard deviations were calculated based on the measurement 
errors of MID data.  
6.2.4 Isotopically nonstationary labeling experiments and pool size analysis. E. coli WT and 
mutant cultures were inoculated from overnight M9 cultures in fresh M9 minimal medium with 2 
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g/L glucose and allowed to grow for approximately 4 hours. Cultures in exponential growth phase 
were pulsed with 13C6-glucose for a final concentration of 4 g/L. To measure the 
13C-incorporation 
into metabolites over time, cultures were quenched at different time points (from 5 s to 30 s) using 
ice-cold media and a liquid nitrogen bath. All time points were completed in duplicates. Then 
biomass was harvested through centrifugation, and the pelleted samples were extracted with a 
chloroform-methanol method before LC-MS analysis (Ma et al., 2014). The labeling of central 
metabolites were quantified at Joint Bio-Energy Institute (Berkeley), using hydrophilic interaction 
liquid chromatography (HILIC) coupled to electrospray time-of-flight MS, as described in our 
recent paper (Hollinshead et al., 2016). For metabolite pool-size analysis, WT E. coli was grown 
with 13C6 glucose and served as the internal standards. Mutant strains were grown with M9 minimal 
medium with 2 g/L unlabeled glucose and harvested at exponential phase. Fully labeled WT 
cultures and unlabeled culture were mixed and metabolites were extracted for LC-MS analysis. 
The relative pool sizes between WT and mutant strains were calculated based on isotopomer 
enrichment ratios. 
6.2.5 Protein purification. Enzymes (Table S2) were individually overexpressed and purified 
from recombinant E. coli strains as described in our recent paper (Liu et al., 2017). Freshly purified 
protein was concentrated using Amicon Ultra-15 centrifugal filter devices (Millipore, Darmstadt, 
Germany). Concentrated protein was applied to a PD-10 column (GE Healthcare) equilibrated with 
storage buffer (100 mM phosphate buffer, 10% glycerol, pH 7.6) for buffer exchange. Protein 
concentrations were measured with a Pierce BCA protein assay kit (Thermo Fisher Scientific, 
MA). Proteins were stored at -80 oC after flash freezing in liquid nitrogen.  
6.2.6 In vitro assays of EMPP and EDP enzymes. In all in vitro assays, 0.1 to 1.0 μM of each 
protein component, 0.5 mM ATP, 2 mM ADP, 2.5 mM NAD+ were added to a reaction buffer 
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containing 50 mM sodium phosphate buffer (pH 7.6), 1 mM potassium chloride, 1 mM Tris (2-
carboxyethyl) phosphine (TCEP), 2 mM magnesium chloride, 0.2 mM 2,3-bisphosphoglyceric 
acid (2,3-BPG). For EDP related assays, 2.5 mM NADP+ and 0.2 mM FeSO4 were added as well.  
Reactions were initiated by adding 5 mM glucose and incubated at 37 oC. Upon adding glucose to 
initiate the reactions, all contents were quickly mixed, and the increase in absorbance at 340 nm 
due to NAD(P)H formation was measured in a microplate reader (as a convenient way for tracking 
glycolytic activity). In brief, for individual enzyme activity, reactions were measured 
spectrophotometrically and the unit (U) or amount of purified protein that converted one μmol of 
substrate into product per minute was determined. 
6.3 Results and Discussion  
6.3.1 Comparative studies on isozymes’ functions under in vitro and in vivo conditions. E. coli 
phosphofructokinase, Pfk, has two isozymes that convert F6P to FBP. Under in vivo conditions, 
PfkA has higher copy numbers than PfkB (Table 6.1), and knocking out pfkA significantly impairs 
E. coli glucose metabolism (Table 6.2). In contrast, knocking out the isoenzyme gene pfkB has a 
negligible effect on E. coli growth (Robinson and Franenkel, 1978; Long et al., 2016). Under in 
vitro conditions here, purified PfkB exhibits twice the enzyme activity (U/mg) as PfkA and 
removal of PfkA has minimal impact on the in vitro glycolysis reaction rates (Table 6.2). 
Following Pfk, the isozymes, fructose-bisphosphate aldolase-A and B (FbaA and FbaB) reversibly 
cleave FBP (Figure 6.1). Under in vivo conditions, fbaA knockouts are lethal to E. coli, while 
ΔfbaB does not affect cell growth (Table 6.2). Under in vitro conditions, FbaA has a higher activity 
than FbaB and the removal of FbaA slowed down but did not stop the glycolytic reaction. As 
expected, all tested isozymes in Table 6.2 were interchangeable under in vitro conditions. For 
example, in the absence of PfkB or FbaA, in vitro EMP flux could be recovered if excessive PfkA 
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or FbaB were added. We also tested the double deletion of Pfk or Fba and different crowding 
effects under in vitro conditions (Table 6.2). Removal of both PfkA and FbaA isozymes caused 
the highest reduction of the EMP flux, while removal of PfkA and FbaB showed minimal impact. 
In summary, in vitro systems represent homogenous environments, and multiple systems level 
interactions are lost (Graham et al., 2007). Therefore, pathway function correlates well with 
activities and concentrations of individual enzymes. On the other hand, intracellular systems may 
not be ‘well mixed’ and enzyme-enzyme interactions or enzyme clustering may play a key role in 
directing EMP fluxes (Sweetlove and Fernie, 2018; Shearer et al., 2005). For example, it has been 
reported that Pfk and Fba enzymes form channels via electrostatic forces to confer catalytic 
advantages with minimal enzyme usage (Matic et al., 2001), and metabolic flux can be highly 
nonlinear to enzyme expression levels (Siddiquee et al., 2004). 
Table 6.1. Glycolysis genes and reported enzyme kinetics.  Gene location in E. coli 
(taxid:679895) was determined through NCBI nucleotide blast. The standard condition for ∆G: 
pH = 7.2, ionic strength = 0.25 M, metabolite concentrations = 1 M. a:(Taniguchi et al., 2010), 
b:The actual ΔG was calculated by eQuilibrator (Flamholz et al., 2012) using reported metabolite 
concentrations (Bennett et al., 2009)., c:(Flamholz et al., 2013). 
Pathway Reaction Gene Gene 
location  
In vivo 
conc. 
(nM)a 
ΔG 
(standard 
condition) 
(kJ/mol) 
ΔG 
(actual, 
kJ/mol)b 
 
kcat 
(1/s)c 
 
KM 
(mM)c 
 
Measure
d enzyme 
activity 
(U/mg) 
Upper 
glycolysis 
Glc->G6P glk 2501940-
2502905 
   410 0.08 2.12 
G6P-> F6P pgi 4223686-
4225335 
169 2.5 -0.3 120 0.28 NM 
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F6P-> FBP pfkA 4097480-
4098442 
126 -17.2 -19.8 167 0.16 0.71 
pfkB 1800627-
1801556 
37 1.86 
FBP-> 
GAP + 
DHAP 
fbaA 3063524-
3064603 
676 21.5 -2.8 10.5 0.17 1.97 
fbaB 2170991-
2172043 
ND 0.66 
DHAP-> 
GAP 
tpiA 4100668-
4101435 
768 5.5 -0.5 9000 1 NM 
PPP G6P-> 
6PGL 
zwf 1929096-
1930571 
113 -5 0.0 174 0.174 7.11 
6PGL-> 
6PG 
pgl 794042-
795037 
ND -23.2 -31.2 1900* 0.02* NM 
ED only 6PG-> 
KDPG 
edd 1927050-
1928861 
17 -43.1 -46.4 257* 0.04* NM 
KDPG-> 
GAP+PYR 
eda 1926372-
1927013 
ND 16.3 -0.8 83 0.1 0.07 
Lower 
glycolysis 
GAP-> 
BPG 
gapA 1857028-
1858023 
2380 3.9 -1.9 268 0.89 4.71 
BPG-> 
3PGA 
pgk 3064818-
3065981 
564 -18.6 -0.4 654* 0.0018* NM 
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3PGA-> 
2PGA 
gpmA 782299-
783051 
760 4.2 -2.8 530* 0.65* NM 
gpmM 3778620-
3780164 
ND 
2PGA-> 
PEP 
eno 2900002-
2901300 
567 -4.1 -2.4 78* 0.3* NM 
PEP-> 
PYR 
pykA 1931906-
1933348 
119 -26.3 -11.8 232* 0.31* 0.17 
pykF 1749955-
1751367 
0.2 0.21 
ND: no data available. NM: not measured.  
Source organism is E. coli unless noted by * 
Table 6.2. In vitro test of EMP isoenzymes via a factorial experiment. In vitro rate changes (%) 
based on the control condition after the removal or addition of Pfk and Fba isoenzymes. The 
control condition is all EMP enzymes at a concentration of 100 nM. In vivo rate changes were 
based on a recent report (Long et al., 2016).  Confidence intervals (95% CI) were determined 
through reiterations of curve fitting calculations resulting in corresponding lower and upper 
bounds (LB, UB). 
PfkA 
(nM) 
PfkB 
(nM) 
FbaA 
(nM) 
FbaB 
(nM) 
In vitro rate change (95% CI: LB, UB) In vivo rate 
change  
0  100  100  100  0% (-2%, +103%)  - 75% 
100  0  100  100  -42% (-34%, -51%) -8% 
100  100 0  100   -71% (-61%, -83%) -100% (lethal) 
100  100  100  0  -5% (-2%, -9%) ~0% 
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0  100  0  100  -71% (-55%, -73%) No Data 
100  0  100  0  -37% (-34%, -40%) 
0  100 100  0  -13% (-2%, -26%) 
100  0  0  100  -42% (-37%, -49%) 
500  0  100 100  -26% (-21%, -35%) 
1000 0 100 100 +144% (+131%, +165%) 
100 100 0 500 +113% (+103%, +122%) 
100 100 0 1000 +161% (+157%, +163%) 
Control plus 225g/L polyethylene 
glycol 3550 
+103% (-19%, +110%) 
 
6.3.2 The effect of ED pathway overexpression on in vitro and in vivo glycolytic rates. To 
explore the flux control of glycolytic pathways, the competing native ED pathway was 
overexpressed (ED pathway enzymes underlined; Figure 6.1). Reaction thermodynamics and 
kinetics of the ED reactions have advantages over the EMP pathway, and the ED pathway requires 
fewer reaction steps and much lower protein synthesis costs (Flamholz et al., 2013). In a cell-free 
system, we tested glycolytic enzymes with concentrations ranging from 100 to 1000 nM (enzymes 
included in in vitro reactions are listed in Table S2) (Liu et al., 2017). Although the ED pathway 
demonstrated catabolic rates lower than the EMP pathway at the same enzyme concentrations 
(Figure 6.2a, Table 6.1), in vitro overexpression of ED enzymes could significantly increase 
glucose conversions (Figure 6.2b). As expected, in vitro introduction of the ED enzymes could 
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also recover glucose catabolic rates in the absence of PfkA or FbaA, two key enzymes for in vivo 
EMP pathway control.  
 
Figure 6.2. In vitro reaction rates of the EMPP and EDP. (A). Reaction rates with protein 
concentrations at 1000 nM. Reactions were assumed to be first-order processes and the rate 
constants, k (1/hr), were calculated based on absorbance curves and minimizing the sum of squared 
residuals. (B). Reaction rates with varied enzyme concentrations.     
 
 E. coli metabolism is highly regulated, namely through transcriptional and allosteric 
regulation, which is closely tied to catabolite repressor/activator proteins and carbon substrates. 
Despite bypassing transcriptional regulation via plasmid engineering, overexpressing the native 
ED pathway does not increase flux through the ED pathway, and the engineered strain still prefers 
to utilize its EMP pathway rather than its ED pathway (Figure 6.3). One possible explanation is 
that EMP channels protect their intermediates from competing reactions such as the ED pathway. 
To test this hypothesis, presumed channels must be disrupted while still maintaining enzyme 
functions. In E. coli, the PTS uses PEP to phosphorylate glucose into G6P and is thought to be the 
first step of EMP channeling (Zhao et al., 2018; Flores et al., 2002). By knocking out the PTS, the 
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presumed channel could be disrupted, facilitating flux redistributions from the EMP towards the 
competing ED pathway. Thereby, we constructed PTS-knock-out mutants to examine their in vivo 
flux redistributions via metabolic flux analysis (Figure 6.3). The ΔptsG mutant showed less flux 
through the EMP pathway, while its PP pathway flux was significantly elevated. After 
overexpression of native edd and eda in the ΔptsG mutant, the ED pathway effectively hijacked 
PP pathway fluxes from the 6PG node and became a dominating glycolysis route. Intracellular 
metabolite analyses further confirmed the flux redistributions (Figure 6.4). The ΔptsG mutant had 
much smaller pool sizes in upper EMP pathway metabolites (FBP, GAP/DHAP and PGA) but 
larger PEP concentrations than WT strain. Furthermore, overexpression of the ED pathway drained 
the G6P and F6P pools, and the ΔptsG or ED pathway overexpression had slight impact on the 
concentrations of TCA cycle metabolites.   
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Figure 6.3. Metabolic flux analysis (determined by WUFlux) in different E. coli strains (A). 
WT (B). WT with an overexpressed ED pathway (ED) (C). a PTS mutant (ΔptsG) and (D). a PTS 
mutant with an overexpressed ED pathway (ΔptsG + ED). Maximal growth rates (GR) are given 
as hr-1 based on biological triplicates, presented at the top right of every flux map. Flux map arrows 
represent the flux distribution throughout the central pathways. The table represents the percentage 
of G6P flux being directed along the EMP, PP or ED pathways. Experimental flux ratios were 
determined by 13C-MFA. Standard deviations were calculated based on the measurement errors of 
MID data.  
 
6.3.3 Transient labeling of E. coli EMP intermediates. To explore heterogeneous metabolite 
pools in the EMP pathway, we used isotopically nonstationary 13C-labeling, which can probe the 
bulk pool’s labeling dynamics and be used to investigate substrate channeling (Sweetlove and 
Fernie, 2018). In our transient study, we observed faster FBP, DHAP, and 3PGA labeling (bulk 
M+6 MID and M+6 counts) than their upstream precursors G6P and F6P (Figure 6.5a). This 
reversal of the labeling order could be explained by the channeling theory: G6P is not uniformly 
mixed in the cytosol, and instead, the portion of G6P outside of the enzyme channel becomes less 
metabolically active, contributing largely to the M+0 pool during dynamic labeling experiments. 
Such dilution of intracellular metabolite labeling has been reported by isotopic nonstationary flux 
analysis of bacterial metabolisms (Huege et al., 2011; Young et al., 2011; van Winden et al., 2001). 
Conversely in the ∆ptsG and ∆ptsG+ED mutant, labeling between G6P, F6P, and FBP was strictly 
sequential (labeling enrichment: G6P>F6P>FBP), along with a decrease in the FBP pool (Figure 
6.4). Moreover, ∆ptsG and ∆ptsG+ED mutants had much slower labeling in FBP than other 
cascade metabolites, PGA and DHAP, forming a "V" shape in Fig. 6a. The higher labeling of FBP 
downstream products was consistent with observed elevated bypass fluxes via PP pathway and ED 
pathway in these mutants. During dynamic 13C labeling of ∆ptsG mutants (Figure 6.5b), FBP 
contained much more M+3 isotopomer (3 labeled carbons) than its precursor F6P due to the 
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increase of reversed Fba reactions from C3 sugar phosphates (PGA/DHAPFBP). This result was 
consistent with the report of the gluconeogenesis in PTS mutants (Flores et al., 2005).  
 
Figure 6.4. Metabolite pool size comparison to WT E. coli K-12. Pool size analysis of PTS 
mutant (ΔptsG) and a PTS mutant with an overexpressed ED pathway (ΔptsG + ED) compared to 
the WT. A ratio of 1 means both strains had the same pool size per biomass (n=3). 
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Figure 6.5. Labeling dynamics following 13C6-glucose pulse in different E. coli strains (A). On 
the left axis, the fully labeled or M+6/M+3 mass isotopomer ratio is plotted for WT, ΔptsG, and 
ΔptsG + ED. Mass isotopomer ratios are the relative abundance of mass isotopomers where M+0 
is fully unlabeled, M+3 is three labeled carbons (fully labeled for PGA and PEP) and M+6 is six 
labeled carbons (fully labeled for FBP). Cultures were pulsed with 13C6-glucose for 5 s. The right 
y-axis is the absolute M+6 cps. (n=2) (B). Mass isotopomer distribution of M+3 in F6P and FBP 
(n=2).  
 
6.3.4 Broader perspective on the glycolysisosomes. The common view of cell metabolism and 
metabolic modeling assumes enzymes and metabolites are homogenously distributed throughout 
the cell, but amidst surmounting observations, this assumption fails. In this study, both in vitro and 
in vivo glycolytic systems were compared. We demonstrated knocking out the PTS in E. coli 
loosens the metabolic flux network and changes reaction directions towards competing pathways. 
Although this work did not directly prove that intracellular enzymes self-organize to form subtle 
metabolons36, dynamic labeling experiments provide reasonable in vivo channeling tests for 
systems perturbed at possible channeling flux control nodes (Sweetlove and Fernie, 2018; 
Abernathy et al., 2017b; Shearer et al., 2005). Intuitively, MalateOxaloacetateCitrate in the 
TCA cycle of eukaryote cells have been proved to be highly channeled (Wu and Minteer, 2015; 
Bulutoglu et al., 2016). In this study, labeling rates among PEP, citrate, malate, and succinate in 
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the wild type E.coli were compared in Figure S2. After pulsing cells with 13C6-glucose, PEP 
carboxylase led to amount of 13C3 (M+3) labeled C4 TCA metabolites (e.g., malate and 
oxaloacetate), while pyruvate dehydrogenase produced fully labeled Acetyl units (M+2). We 
expected that citrate synthase would generate 13C5 (M+5) citrate. However, no M+5 citrate could 
be detected (only M+2 or M+3) by LC-MS. Such enigmatic observations were consistent with 
confounding labeling patterns due to metabolite channeling (Abernathy et al., 2017b), and in turn 
could introduce errors into 13C-based flux analysis.   
6.3.5 Conclusions. Proximity channeling through metabolic pathways cannot be measured 
intracellularly via typical tools (such as protein imaging and protein structural analysis) due to 
weak and possibly transient interactions. Therefore, the hypothesis of metabolite channeling 
through the EMP pathway is still controversial (Graham et al., 2007; Shearer et al., 2005). This 
study compared in vitro and in vivo glycolytic activities, which elucidated different performances 
of glycolysis enzymes under two modes and offered explanations of intracellular EMP functions 
using the channeling theory. The observed differences in metabolite isotopic dilutions may be due 
to disruption of metabolite channels and provides a general in vivo approach for probing organisms 
for substrate channeling. However, this study still cannot answer many remaining questions 
regarding the structural formation of glycolysisosomes or potential mechanisms for metabolite 
channeling (Sweetlove and Fernie, 2018; Wheeldon et al., 2016). Novel in vivo tools are needed 
to further understand and validate proximity channeling in native pathways.  
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Chapter 7: Conclusions and future directions   
7.1 Conclusions 
Cyanobacteria hold enormous potential as cost-effective biocatalysts for the direct 
conversion of CO2 to value-added chemicals. However, their scaled industrial use has been 
limited due to bioprocess and economic feasibilites. The bioproduction of small molecules, such 
as biofuels, bioplastics, or some bioactive compounds, requires genetic engineering of 
cyanobacteria, effective redirection of carbon and robust strains for outdoor cultivations. To 
rationally engineer these photosynthetic organisms for efficient bioproduction requires further 
knowledge about photosynthesis and carbon assimilation efficiencies, metabolic regulation, and 
genome to phenome mapping.  
This thesis used isotopically nonstationary metabolic flux analysis, which quantifies 
cellular carbon metabolism, to investigate desired cyanobacterial phenotypes for biotechnology 
applications. In the second Chapter, the fast growing cyanobacteria, Synechococcus UTEX 2973, 
was probed, which revealed ideal carbon partitioning for biomass growth, fast reincorporation of 
carbon, and considerable photorespiration for properly balancing increased photosynthetic rates. 
The fast growth of Synechococcus UTEX 2973 allows cyanobacteria to compete with its 
heterotrophic counterpoints, aiding in productivity rates for scaled processes. Increased carbon 
assimilation in Synechococcus UTEX 2973 did not require substantial central carbon metabolism 
rewiring. The robust central metabolism flux ratios discovered in the differing phenotypes 
prompted us to explore metabolite channeling as a flux regulation mechanism. In eukaroytes, 
channeling is often associated with membranes; thus in Chapter 3, we examined a carboxysome-
deficient mutant with INST-MFA and pool size analysis. We found by knocking out the 
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carboxysome, we could redirect fluxes to important metabolites for many biotechnology 
applications by possibly creating a more homogeneous cytoplasm. The carboxysome-deficient 
mutant was found to accumulated UDP glucose and pyruvate, which can aid biotechnology 
applications as demonstrated in Clark et al., 2018 through lactate production. Additionally, these 
high CO2 requiring phenotypic strains represent a method of containment for genetically 
modified cyanobacteria. Despite the drastically different cyanobacterial phenotypes examined, 
many carbon fluxes were found to be robust, while metabolite pool sizes were found to change 
more drastically, and labeling dynamics revealed possible substrate channels. High flux through 
sugar phosphate pathways and large nucleotide sugar pools in cyanobacteria motivated us to 
demonstrate proof-in-concept photoautotrophic production of a high-value saccharide, 
heparosan, in cyanobacteria. 
 In Chapter 5, metabolite channeling was further explored in silico and reviewed across 
species, demonstrating the prevelance of substrate channeling in nature. Using a model system 
(E. coli) in Chapter 6, this thesis further elucidated channeling in central catabolic pathways to 
try and advance our understanding of this important metabolic controller. It was found the 
phosphotransferase system may anchor glycolytic channels, restricting flux to other catabolic 
pathways, and many enzymes in the glycolytic pathways elucidated different performances under 
in vivo and in vitro modes. While genomic and transcriptomic modifications are typically the 
dominating metabolic engineering strategies, protein-protein interactions (e.g., metabolite 
channeling), enzyme-metabolite interactions and catabolic regulation in cyanobacteria still 
represent a relatively unexplored field.  
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7.2 Future directions 
7.2.1 Future directions for cyanobacteria engineering. This thesis revealed the importance of 
metabolite and channeling regulation, showed further challenges that face photomixotrophic 
growth, and translated our results into engineering strategies for cyanobacteria. While 
cyanobacteria require simple nutrients, grow fast and can be genetically manipulated, their 
complex metabolic regulation and inherent challenge of converting oxidized CO2 to a more 
reduced form may mean these generally regarded as safe orgnaisms (GRAS) are better suited for 
the production of a high-value products rather than commodity chemicals. Learning more about 
how these organisms regulate their metabolism and other cellular processes will help propel 
cyanobacterial biorefineries. Photofermentation is one way to increase cyanobacteria 
productivity and titer using cheap carbon sources, such as glycerol. However under different 
conditions, cyanobacteria strains utilized organic substrates in a variety ways demonstrating the 
need for further investigation in photofermentations and catabolic repression in cyanobacteria. 
Furthermore, while many metabolic engineering strategies redirect carbon fluxes by knocking 
out or down competing pathways, carboxysome-deficient mutants represent another strategy for 
the redirection of fluxes that does not impair growth or require nitrogen deficient conditions to 
produce polysaccarides. Finally, using the fast growing cyanobacteria strain, producitivites can 
be enhanced or engineering strategies can be transferred to other model cyanobacteria strains. 
Concentrated efforts are needed to fully understand roboust platform strains for a rational 
bioproduct in order to facilitate stable scaled bioprocesses.  
 
7.2.2 Future directions for metabolite channeling. Channeling improves bioconversion rates, 
stabilizes low copy number enzymes, and reduces side products from promiscuous enzymes. It 
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has been hypothesized to control fluxes through metabolic pathways and facilitate cascade 
reactions in a crowded environment. Channeling is a natural evolution outcome; yet despite 
experimental evidence, there are many unresolved questions. Superior modeling and 
thermodynamic approaches need to be developed that integrate all the metabolite controllers 
represented in Figure 1.3. Little knowledge exists about how bacteria spatially organize their 
enzymes; however recent research has found that heterologous enzyme expression is influenced 
by its location on the genome, although it is not clear why (Englaender et al., 2017). During 
pathway engineering, overexpression of a gene cluster is in general more efficient than 
expressing multiple enzymes from different sources. Although it is common for a gene cluster to 
translate a biosynthesis pathway, genes of cascade enzymes in central metabolism are often not 
located next to each other but still may form channels. Thus, it is unclear whether gene location 
or other factors (e.g., pH, ion strength, electrostatic interactions, metabolites, or membrances) 
coordinate enzymes. To test this hypothesis, genetic engineering can disrupt the presumed 
channels via plasmid or chromosome relocations. Structure-guided enzyme mutations can be 
performed to weaken enzyme-enzyme interactions without affecting enzyme activity to monitor 
channel effects. Chemical cross-linking combined with mass spectrometry may examine protein 
assemblies and reveal both the structure and the interactions of cascade enzymes (Liu et al., 
2015; Tan et al., 2016).  
 Additionally, genome scale modeling can assess channeling using experimental 13C-MFA 
and transcriptomic data. Predicted intracellular fluxes from genome scale modeling can be used 
as a theoretical baseline for comparing against experimentally determined pathway fluxes via 
13C-MFA to identify pathways that are showing higher flux than expected based upon expression 
activity. This analysis will be useful for considering the coordinated effects of regulatory 
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mechanisms that can lead to the identification of pathways exhibiting channeling. Finally, 
metabolic engineers often build heterologous enzymes or synthetic pathways to redirect 
metabolic fluxes towards the desired products (Bogorad et al., 2013), but natural channeling 
mechanisms may cause design flaws. Increases in enzyme copy numbers do not always aid in the 
expression of a heterologous pathway (Englaender et al., 2017) nor does uptake of a significant 
intermediate aid in heterologous pathway production (He et al., 2017). These observations leave 
additional questions for metabolic engineers in regards to integration of channeling knowledge 
for strain development and computational strain design. 
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9. Appendix 1: Supporting Information for Chapter 2  
 
Deciphering cyanobacterial phenotypes for fast photoautotrophic growth via isotopically 
nonstationary metabolic flux analysis 
 
Biomass composition analysis. Protein and amino acid compositional analysis was performed by 
the Molecular Structure Facility, University of California (Davis, CA) and measured by hydrolysis 
and oxidation with performic acid. For lipid measurement, biomass was mixed with chloroform-
methanol-water (2:1:0.8) and shaken (200rpm) for 3 h. After the complete extraction of lipids from 
the biomass, the resulting chloroform layer was dried to determine the weight of the lipid residue. 
The fatty acid composition was then analyzed via GC-MS after transesterification. Glycogen was 
analyzed colorimetrically at 680nm as a reducing sugar based on a previously published anthrone 
protocol (Seifter et al., 1949). Chlorophyll a was extracted with 100% methanol in the dark for 24 
h. The concentration was determined spectrophotometrically at 665 and 652 nm according to 
previous literature (Porra et al., 1989). Other photosynthetic pigments were not accounted in the 
lumped biomass equation due to minimal biomass contribution (Schledz et al., 2001). Ash weight 
of the biomass samples was calculated from the mass difference after complete combustion. Total 
carbohydrate was measured based on sulfuric acid hydrolysis protocols 
(www.nrel.gov/biomass/analytical_procedures.html), which was performed by Dr. Wei Liao 
group at Michigan State University. Nucleotide contents were estimated based on mass balance 
(Shastri and Morgan, 2005).  
Ion-pairing LC-MS/MS method: For LC-MS analysis, the pelleted samples were extracted with 
a chloroform-methanol method (Ma et al., 2014). The aqueous phase from the extraction was 
transferred into GC vials, lyophilized, and stored at -80 oC. Dried samples were reconstituted in 
water for LC-MS/MS analysis. Ion-pairing LC-MS/MS was performed on a Shimadzu HPLC 
linked to an ion-trap triple quadruple MS/MS system (4000 QTRAP and 6500 QTRAP, AB Sciex 
Instruments) at the Proteomics and Mass Spectrometry Facility, Donald Danforth Plant Science 
Center, St. Louis, MO. The mobile phases utilized for a gradient elution were 10 mM tributylamine 
(Acros, Belgium) and 11 mM acetic acid (A) and methanol (B). A Synergi Hydro-RP column (80 
Å, 150 x 2.00 mm, Phenomenex Inc., CA) was used with the following gradient profile: 0% B (0-
5 min), 0-45% B (5-50 min), 45-90% B (50-52 min), 90% B (52-57 min), 90-0% B (57-59 min), 
0% B (59-64 min).  Negative ionization mode and multiple-reaction monitoring mode were used, 
and all data acquisition and analysis was performed on the Analyst software (AB/MDS Sciex). 
Mutant Construction. For the zwf mutant, a plasmid was designed to target a 1000 bp region 
(extending from nucleotides 41-1041) of the zwf open reading frame for replacement with a 
kanamycin resistance cassette by double homologous recombination. A circular polymerase 
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extension cloning (CPEC) method (Quan and Tian, 2011) was used to generate an upstream (1000 
bp)-kanamycin-downstream (1000 bp) construct in pBR322. Sequencing and restriction digestion 
were used to confirm the resulting plasmid (pSL2480), which was introduced into Synechococcus 
2973 cells by tri-parental conjugation as previously described (Yu et al., 2015). To create the cargo 
strain, the pSL2480 plasmid was first transformed into competent HB101 E. coli cells containing the 
pRL623 helper plasmid.  Overnight cultures (100 µL each) of the cargo strain and the conjugal strain 
(pRL443) were washed with distilled water and mixed with 200 μl of washed Synechococcus 2973 cells.  
Cell mixtures were plated on BG-11 + 5% LB (v/v) agar plates containing 10 µg/ml kanamycin. Plates 
were placed under continuous illumination (~100 μmol photons•m-2•s-1) at 38 °C. Mutant colonies 
appeared within 4-5 days and segregation was confirmed by PCR. 
 A cpf1 based CRISPR system was used to delete 6-phosphogluconolactonase and succinate 
dehydrogenase from start codon to stop codon from the chromosome (Ungerer and Pakrasi, 2016).  
In brief, oligos targeting the gene’s coding region were cloned into the aarI sites on pSL2680 to 
target the nuclease to the chromosomal region containing the gene of interest.  Next a region 2kb 
in length containing 1kb of upstream and downstream sequences were assembled into the resulting 
plasmid using Gibson assembly.  The resulting plasmid was introduced into Synechococcus 2973 
cells by tri-parental conjugation.  After repatchings onto selective media, patches were sequenced 
and a patch that was positive for the deletion was started in BG-11 without antibiotics and grown 
to an OD730 of 1.0.  Serial dilutions were plated to obtain single colonies. Colonies that were cured 
of the editing plasmids were then sequenced to verify the deletion of 6-phosphogluconolactonase 
and succinate dehydrogenase. 
INST-MFA model formulation: The INCA model listed in Supporting Table 1 and its results 
listed in Supporting Table 3, 4 and 5, along with the lumped biomass equation generated from 
Supporting Table 2 are based on the following:  
I. The INCA platform is convenient because it does not need to estimate metabolite pool 
sizes; however, the platform has to solve numerically stiff ODE equations for isotopomer 
changes through very different time scales of metabolite labeling (Nöh et al., 2007). 
Therefore, it is computationally expensive for flux calculations and confidence interval 
estimations. 
II. Metabolite levels and fluxes were assumed to be constant throughout the experiment and 
were not perturbed by the addition of sodium bicarbonate. The effect of isotope 
discrimination was assumed to be negligible.  
III. Succinate and fumarate are symmetrical molecules, and this was accounted for within the 
INCA model.  
IV. It is unknown whether the TCA cycle in Synechococcus is closed by the GABA shunt 
(Xiong et al., 2014) or the oxoglutarate dehydrogenase pathway (Zhang and Bryant, 2011); 
thus the reaction network was modeled as AKG  SUC + CO2, lumping both shunts into 
one closed TCA reaction. The SSR of the model was not changed when this reaction was 
removed, obtaining a p-value of 6.5•10-1 based on the chi-square statistical test with one 
degree of freedom. This indicates that the flux was not significantly different from zero. 
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However, the sequential labeling of free glutamate and succinate suggests a low, yet 
measurable GABA shunt in Synechococcus 2973 (Supporting Figure 4). 
V. Although there is limited to no evidence for a bacterial glyoxylate shunt in Synechococcus, 
we included this pathway in the model to be consistent with the previous work. Addition 
of the glyoxlate shunt only slightly changes model fitting quality, while the resulting flux 
of glyoxylate shunt was still close to zero (p < 0.001, based on chi-square statistical test 
with two DOFs).  
VI. To test the presence of OPPP, we removed these two equations (G6P6PG, 6PGRu5P 
+CO2) from the model. This resulted in reduced set of DOFs. Without the OPPP, the model 
fitting quality was not significantly changed. This indicates very little flux through OPPP 
and was not a consequence of the choice of measurements because oxidation that produces 
CO2 and a pentose phosphate would be unique to the labeling in the Calvin cycle.  This 
was additionally confirmed by OPPP knock out mutant, Δzwf.  
VII. Confidence intervals were evaluated using two different methods due to numerical stiffness 
problems that were encountered. The approaches gave similar results and therefore served 
to confirm each other. Numerical stiffness problems are expected due to label accumulation 
processes occurring over a large range of time scales. To solve the entire non-stationary 
isotopomer reaction network with high numerical precision is much more difficult than 
solving for steady state isotopomer balance equations (Nöh et al., 2007).  Thus, in addition 
to parameter continuation, we used the Monte Carlo method to examine to confidence 
intervals based on potential measurement timing errors (Zhao and Shimizu, 2003). 
Specifically, the sample quenching time points were perturbed by normally distributing 
noise within measurement timing variations (±3 seconds). INCA was then restarted for flux 
calculations. By repeatedly running INCA using perturbed timing of isotopomer data, the 
resulting distribution of flux values allowed for the estimation of flux standard errors when 
measuring the rapid turnover of intracellular metabolites subjected to manual errors as seen 
in Supporting Table 3. Additionally, while INCA-based MFA did not require the pool size 
estimation, if we added estimated pool sizes (MAL, PEP, AcCoA, SUC, CIT) from 
isotopomer ratio analysis (Bennett et al., 2008), the flux results from PBRs had improved 
SSR and facilitated determination of unresolved confidence intervals (Supporting Table 3). 
As expected, net fluxes remained relatively similar to flux results without pool size 
constraints. 
VIII. The uneven distribution of the residuals in the shaking flask model demonstrated that they 
were less consistent and of reduced quality (Supporting Figure 3). Dilution factors (Young 
et al., 2011) were required for several metabolites that were significantly less labeled than 
their downstream products, including: 3PGA, F6P, FBP, and SBP (Figure 5). In INCA 
platform, dilution parameters are often required to describe the lack of equilibrium between 
labeled and unlabeled pools or labeling dilution from unknown resources. The dilution 
factors were more crucial for the shaking flask conditions, which represented a higher 
degree of inactive metabolite pools.  Besides the inactive pools prescribed for the PBR, an 
additional dilution for DHAP, CIT, PEP, and MAL improved the SF-based model fitting. 
Poor quality of SF flux results is not surprising because sub-optimal and light-limiting SF 
conditions causes sub-populations of cyanobacteria with different metabolisms (He et al., 
2015). 
IX. Several assumptions were made when quantifying the biomass components. Glycogen was 
assumed to have a molecular weight of 666.58 g/mol, chlorophyll a was assumed to have 
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a molecular weight of 893.5 g/mol, lipids were assumed to have a molecular weight of 270 
g/mol, DNA was assumed to have a molecular weight of 487 g/mol, and RNA was assumed 
to have a molecular weight of 499.5 g/mol.  
 
Biomass Composition Analyses of Synechococcus 2973 and Synechococcus 7942. Standard 
deviations are reported from biological duplicates to quadruplicates. † or * indicates p-value <0.05 
using two-tailed equal variance Student’s t-Test.  
Biomass components 
(unit: % of gDCW) 
Syn. 2973- 
Photobioreactor 
Syn. 2973- Shaking 
Flask 
Syn. 7942- 
Photobioreactor 
Protein  52.7 ± 2.5  49.4 ± 2.1  40.9 ± 0.4 
Lipid 9.3 ± 0.6 13.2 ± 2.4  10.7 ± 0.6 
Glycogen  1.5 ± 0.5†* 6.0 ± 1.0* 12.6 ± 4.3† 
Other sugars 6.5 ± 0.7 NA NA 
Ash 7 ± 1 NA NA 
Chlorophyll a % 1.2 ± 0.2  1.0 ±  0.3  1.2  ± 0.1  
Chlorophyll a 
(μg/mL/OD
730) 
4.4 ± 0.5* 7.4 ± 0.3* 5.2 ± 0.6 
RNA/DNA 21.8a 16.9a 21.1a 
Amino Acid profiles 
(unit: mmol/gDCW) 
Syn. 2973- 
Photobioreactor 
Syn. 2973- Shaking 
Flask 
Syn. 7942- 
Photobioreactor 
Glycine 0.44 ± 0.02 0.48 ± 0.07 0.34 ± 0.00 
Proline 0.21  ± 0.01 0.24 ± 0.04 0.16 ± 0.00 
Alanine 0.62  ± 0.03 0.67 ± 0.08 0.49 ± 0.01 
Valine 0.31  ± 0.01 0.35 ± 0.06 0.25 ± 0.01 
Leucine 0.46  ±  0.02 0.53 ± 0.08 0.37 ± 0.01 
Isoleucine 0.23  ±  0.01 0.27 ± 0.04 0.19 ± 0.01 
Methionine 0.08  ±  0.00 0.08 ± 0.01 0.06 ± 0.01 
159 
 
Cysteine 0.04  ±  0.00 0.04 ± 0.01 0.03 ± 0.00 
Phenylalanine 0.20  ±  0.01 0.24 ± 0.04 0.15 ± 0.00 
Tyrosine 0.16  ±  0.00 0.18 ± 0.03 0.13 ± 0.00 
Histidine 0.06  ±  0.00 0.08 ± 0.011 0.04 ± 0.00 
Lysine 0.21  ±  0.01 0.22 ± 0.04 0.16 ± 0.00 
Arginine 0.27  ± 0.01 0.28 ± 0.04  0.21 ± 0.00  
Glutamate and 
Glutamine 
0.60 ± 0.05* 0.44 ± 0.05 0.36 ± 0.00*  
Aspartate and 
Asparagine 
0.45  ± 0.02 0.49 ± 0.07 0.41 ± 0.01  
Serine 0.27  ±  0.02 0.30 ± 0.04 0.21 ± 0.00  
Threonine 0.29  ±  0.01 0.32 ± 0.05 0.22 ± 0.00 
Fatty acid profiles 
(wt%) 
Syn. 2973- 
Photobioreactor 
Syn. 2973- Shaking 
Flask 
Syn. 7942- 
Photobioreactor 
C14:1 0.3 ± 0.1 1.1 ± 0.4 2.5 ± 0.1 
C14:0 1.2 ± 0.5 0.7 ± 0.07 2.5 ± 0.3 
C16:1 32.3 ± 0.1 39.9 ± 1.4 35.0 ± 0.1 
C16:0 53.3 ± 1.3 56. 3 ± 0.6 51.4 ± 0.1 
C18:1 9.4 ± 0.1 1.8 ± 0.7 4.8 ± 0.4 
C18:0 2.9 ± 0.9 0.3 ± 0.3 3.1 ± 0.1 
NA: measured values from the biomass analysis service center had high noises.   
aEstimated based on biomass composition and the reference (Shastri and Morgan, 2005). Previous study 
indicates that flux result is not sensitive to the measured nucleotide composition of the cells (Pramanik and 
Keasling, 1997). 
 
Table S1. A complete list of reactions and atom transitions for the Synechococcus elongatus 
UTEX 2973 metabolic network.  
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Glycolysis and the Oxidative Pentose Phosphate pathway 
G6P (abcdef)  F6P(abcdef) 
G6P (abcdef)  6PG (abcdef) 
6PG (abcdef)  Ru5P (bcdef) + CO2 (a) 
F6P (abcdef)  FBP (abcdef) 
FBP (abcdef)  DHAP (cba) + GAP (def) 
DHAP (abc)  GAP (abc) 
GAP (abc)  3PGA (abc) 
3PGA(abc)  2PGA (abc) 
2PGA (abc)  PEP (abc) 
PEP (abc)  PYR (abc) 
 
The Citric Acid Cycle and Amphibolic reactions 
PYR (abc)  AcCoA(bc) + CO2 (a) 
OAA (abcd) + AcCoA (ef)  CIT (dcbfea) 
CIT (abcdef)  ICIT (abcdef) 
ICIT (abcdef)  AKG (abcde) + CO2 (f) 
AKG (abcde)  SUC (bcde) + CO2 (a) 
SUC (abcd)  FUM (abcd) 
FUM (abcd)  MAL (abcd) 
MAL (abcd)  OAA (abcd) 
MAL (abcd)  PYR (abc) + CO2 (d) 
PEP (abc) + CO2 (d)  OAA (abcd) 
ICIT (abcdef)  SUC (dcef) + GLX(ab) 
GLX (ab) + ACA (cd)   MAL (abdc) 
 
Calvin-Benson-Bassham Cycle 
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Ru5P (abcde)  X5P(abcde) 
Ru5P (abcde)  R5P (abcde) 
Ru5P (abcde)  RuBP (abcde) 
RuBP (abcde) + CO2 (f)  3PGA (cde) +3PGA (fba) 
X5P (abcde)  GAP (cde) + EC2 (ab) 
F6P (abcdef)  E4P (cdef) + EC2 (ab) 
S7P (abcdefg)  R5P (cdefg) + EC2(ab) 
F6P (abcdef)  GAP (def) + EC3 (abc) 
S7P (abcdefg)  E4P (defg) +EC3 (abc) 
DHAP (abc) + E4P (defg)  SBP (cbadefg) 
SBP (abcdefg)  S7P (abcdefg) 
 
Photorespiration 
RuBP (abcde)  3PGA(cde) + 2PG (ba) 
2PG (ab)  GLC (ab) 
GLC (ab)  GLX (ab) 
GLX (ab) + GLX (cd)  GA (abd) + CO2 (c) 
GA (abc)  2PGA (abc) 
 
Glycogen Synthesis and breakdown 
G6P (abcdef)  G1P(abcdef)  
G1P (abcdef)  GLYC (abcdef) 
 
 
 
Biosynthesis Syn. 2973-Photobioreactor 
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0.404*R5P + 3.132*AcCoA + 
0.023*G6P + 0.358*E4P + 
0.519*3PGA + 0.715*PEP + 
3.234*PYR + 1.477*OAA + 
0.760*αKG + 0.080*GAP 
 Biomass + 0.522*FUM + 
1.850*CO2  
Biosynthesis Syn. 7942-Photobioreactor 
0.465*R5P + 3.789*AcCoA + 
0.188*G6P + 0.275*E4P + 
0.461*3PGA + 0.550*PEP + 
2.698*PYR + 1.154*OAA + 
0.805*αKG + 0.218*GAP 
 Biomass + 0.528*FUM + 
1.369*CO2  
Biosynthesis Syn. 2973-Shaking Flask  
0.426*R5P + 4.846*AcCoA + 
0.090*G6P + 0.417*E4P + 
0.580*3PGA + 0.834*PEP + 
3.701*PYR + 1.313*OAA + 
0.868*αKG + 0.175*GAP 
 Biomass + 0.536*FUM + 
2.142*CO2  
 
Table S2. Equations used to form the lumped biomass equation. The equations represent the 
formation of amino acids, nucleotides, photosynthetic pigments, and lipids to central metabolites. 
Using measured and literature values for amino acids, carbohydrates, lipids, nucleotides and 
pigments, the stoichiometric molar quantity for central metabolites per 1 kg of DCW was 
determined.  
Amino Acids (Shastri and 
Morgan, 2005) 
Carbohydrates and lipids (Shastri and 
Morgan, 2005) 
Nucleotides (Yang et al., 2000) 
and pigments 
GLU + ATP + 2*NADPH 
=> PRO + NADP+ + ADP 
G6P => Glycogen R5P + 1.2*ASN + 0.25*SER + 2*GLN + 
0.25*GLY + FTHF+ 0.5*CO2 + 2.3*H2O 
+ NADPH + 0.76*NAD+ + 8*ATP => 
DNA + 0.75*FUM + 2*GLU + THF+ 
8*ADP + 0.76*NADH + NADP+ 
PYR + GLU => ALA 
+AKG 
7*AcCoA + 12*NADPH =>C14 
+7*CoA + 12*NADP+ 
R5P + 1.2*ASN + 2.1*GLN + 0.54*GLY 
+ 1.1*FTHF+ 0.54*CO2 + 2.2*H2O + 
0.79*NAD+ + 8.2*ATP => RNA + 
0.75*FUM + 2.1*GLU + 1.1*THF + 
8.2*ADP + 0.79*NADH 
2*PYR + GLU => VAL + 
CO2 + AKG 
7*AcCoA+12*NADPH => C14  + 
7*CoA + 12*NADP+ 
8Glu+4GAP+4PYR=>Chl a 
163 
 
2*PYR + AcCoA + GLU => 
2*CO2 + AKG + LEU + 
CoA 
8*AcCoA+14*NADPH => C16 + 
8*CoA + 14*NADP+ 
 
THR + NH3 + PYR + GLU 
+ 6*NADPH => ILE + 
AKG + CO2 
8*AcCoA + 14*NADPH => C16 + 
8*CoA + 14*NADP+ 
 
ASP + SUCCoA + CYS + 
5*MeTHF + ATP + 
2*NADPH => MET + SUC 
+ CoA + PYR + NH3 + THF 
+ ADP + 2*NADP+ 
8.5*AcCoA + 15*NADPH => C17  
+ 8.5*CoA+ 15*NADP+ 
 
CHM + GLU => PHE + 
AKG + CO2 
8.5*AcCoA + 15*NADPH => C17 
+ 8.5*CoA + 15*NADP+ 
 
CHM + GLU + NAD+ => 
TYR + AKG + CO2 + 
NADH 
9*AcCoA + 16*NADPH => C18 + 
9*CoA + 16*NADP+ 
 
R5P + GLN + 2*ATP + 
2*NAD+ => HIS + GLU + 
2*PP + AICAR + 2*NADH 
+ 2*ADP 
9*AcCoA + 16*NADPH => C18 + 
9*CoA + 16*NADP+ 
 
ASP + SUCCoA + GLU + 
PYR + 2*NADPH + ATP 
=> LYS + AKG + CoA + 
CO2 + SUC 
  
2*GLU + AcCoA + CP + 
ASP + 2*ATP + NADPH => 
ARG + AKG + FUM + Ac + 
CoA + 2*ADP + NADP+ 
  
SER => GLY   
AKG + 2*NH3 + NADPH + 
ATP => GLN + NADP+ + 
ADP 
  
OAA + GLU => ASP+AKG   
NH3 + ASP + ATP => ASN 
+ ADP 
  
SER + FTHF + GLY => 
MeTHFA 
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E4P + 2*PEP + ATP + 
NADPH => CHM + ADP 
  
3PGA + GLU + NAD+ => 
SER + AKG + NADH 
  
SER + AcCoA => Cys + Ac 
+ CoA 
  
ASP + 2*ATP + 2*NADPH 
=> THR 
  
 
Table S3. Net fluxes and dilution parameters determined by 13C INST-MFA for the 
Synechococcus 2973 photobioreactor model. Relative mean values are net fluxes relative to a 
net CO2 uptake rate of 100 (actual uptake rate was estimated as 12.2 mmol/g-DW/h and those 
mean values are reported as well). Mean parameter estimates and 95% confidence bounds using 
INCA’s parameter continuation method are shown below. Dilution parameters represent the 
fraction of active pool in the cell. Although INCA platform does not need pool size measurement, 
including the pool size data can improve the model confidence interval. For example, * indicates 
a net flux where the 95% confidence intervals were not resolved. Constraining several pool size 
measurements with estimated values (MAL, PEP, AcCoA, SUC, CIT) resulted in the best fit model 
and resolved the confidence interval issue and are noted by *. In addition, average flux values and 
their flux ranges were also calculated via Monte Carlo method as stated above (randomly perturbed 
sampling time within measurement errors, n=50). The Monte Carlo based flux estimation gives 
the possible flux ranges due to imprecise timing during sample harvesting processes. In the Figure 
2 of the main text, we reported the flux results without constraining the pool sizes.  
Reaction Relative mean values Confidence 
Intervals 95% 
Monte Carlo 
based flux 
estimation 
Absolute 
mean 
values Pool size  
not  
constrained 
Pool size 
constrained 
 
G6P <-> G1P 0.0 0.0 0.0, 0.0 0.0 ± 0.0 0.0 
G1P <-> GLYC 0.0 0.0 0.0, 0.0 0.0 ± 0.0 0.0 
G6P <-> F6P -0.1 -0.1 -0.9, -0.1 -0.1 ± 0.06 -0.01 
G6P -> 6PG 0.0 0.0 0.0, 0.09 0.0 ± 0.06 0.0 
6PG -> RU5P + CO2 0.0 0.0 0.0, 0.09 0.0 ± 0.06 0.0 
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F6P <-> FBP -39.9 -39.4 -42.6, -34.5 -41.0 ± 0.8 -5.1 
FBP <-> DHAP + GAP -39.9 -39.4 -42.6, -34.5 -41.0 ± 0.8 -5.1 
DHAP <-> GAP -78.6 -77.7 -80.3, -75.3 -79.6 ± 2.9 -10.0 
GAP <-> 3PGA -197.4 -195.2 *-197.3, -188.8 -199.9 ± 7.2 -25.1 
3PGA <-> 2PGA 25.0 25.0 23.7, 26.6 25.0 ± 2.3 3.4 
2PGA <-> PEP 29.3 28.8 28.9, 29.6 29.7 ± 1.3 3.8 
PEP <-> PYR 22.0 19.7 21.0, 22.2 20.9 ± 0.8 2.6 
RU5P <-> X5P -78.5 -77.6 -81.1, -76.4 -79.5 ± 2.9 -10.0 
RU5P <-> R5P -37.5 -37.1 -38.8, -36.5 -37.8 ± 1.6 -4.8 
RU5P -> RUBP 116.0 114.7 112, 119.6 117.3 ± 4.4 14.7 
RUBP + CO2 -> 3PGA 
+ 3PGA 
107.9 107.1 *105.5, 109.2 110.3 ± 2.9 13.9 
X5P <-> GAP + EC2 -78.5 -77.6 -81.1, -76.4 -79.5 ± 2.9 -10.0 
F6P <-> E4P + EC2 39.8 39.4 38.7, 41.1 40.3 ± 1.4 5.1 
S7P <-> R5P + EC2 38.7 38.3 37.7, 40.0 39.2 ± 1.43 4.9 
F6P <-> GAP + EC3 0.0 0.0 0.0, 2.7 0.0 ± 0.8 0.0 
S7P <-> E4P + EC3 0.0 0.0 -2.7, 0.0 0.0 ± 0.8 0.0 
DHAP + E4P -> SBP 38.7 38.3 *35.3, 43.6 39.5 ± 1.2 4.9 
SBP -> S7P 38.7 38.3 *35.3, 43.6 39.5 ± 1.2 4.9 
PYR -> AcCoA + CO2 12.1 11.7 11.7, 12.7 12.2 ± 0.8 1.6 
OAA + AcCoA -> CIT 2.7 2.3 2.3, 3.1 2.6 ± 0.5 0.4 
CIT <-> ICI 2.7 2.3 2.3, 3.1 2.6 ± 0.5 0.4 
ICIT <-> AKG + CO2 2.3 2.3 2.3, 2.8 2.3 ± 0.1 0.3 
AKG -> SUC + CO2 0.0 0.0 0.0, 0.6 0.0 ± 0.0 0.0 
SUC <-> FUM 0.4 0.0 0.0, 0.8 0.3 ± 0.5 0.1 
FUM <-> MAL 2.0 1.6 1.6, 2.3 1.9 ± 0.5 0.3 
MAL <-> OAA 2.0 -0.3 1.3, 2.4 0.5 ± 0.9 0.0 
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MAL -> PYR + CO2 0.0 1.9 *0.0, 5.0 1.4 ± 1.2 0.3 
PEP + CO2 -> OAA 5.1 7.0 *5.1, 9.9 6.7 ± 1.3 1.0 
ICIT -> GLX + SUC 0.4 0.0 0.0, 0.9 0.3 ± 0.5 0.1 
GLX + AcCoA -> 
MAL 
0.0 0.0 *0.0, 0.3 0.0 ± 0.0 0.0 
RUBP -> 3PGA + 2PG 8.1 7.6 6.8, 10.6 9.1 ± 2.6 0.8 
2PG -> GLC 8.1 7.6 6.8, 10.6 9.1 ± 2.6 0.8 
GLC -> GLX 8.1 7.6 6.8, 10.6 9.1 ± 2.6  0.8 
GLX + GLX -> GA + 
CO2 
4.2 3.8 3.1, 5.6 4.7 ± 1.1 0.5 
GA <-> 2PGA 4.2 3.8 3.1, 5.6 4.7 ± 1.1 0.5 
0.404*R5P + 
3.132*AcCoA + 
0.023*G6P + 
0.358*E4P + 
0.519*3PGA + 
0.715*PEP + 
3.234*PYR + 
1.477*OAA + 
0.760*AKG + 
0.144*GAP -> 
Biomass + 0.522*FUM 
+ 1.850*CO2 
3.0 3.0 3.0, 3.0 3.1 ± 0.1 0.4 
Dilution Parameters       
R5P 0.72 0.72 0.68, 0.75 0.78 ± 0.1 0.75 
F6P 0.78 0.78 *0.74, 0.80 0.79 ± 0.1 0.78 
3PGA 0.73 0.73 0.69, 0.76 0.78 ± 0.1 0.79 
2PG 0.55 0.55 0.50, 0.60 0.61 ± 0.2 0.61 
SBP 0.87 0.86 0.81, 0.91 0.87 ± 0.3 0.83 
FBP 0.89 0.88 0.85, 0.94 0.90 ± 0.1 0.87 
 
Table S4. Net fluxes and dilution parameters determined by 13C INST-MFA for the 
Synechococcus 2973 shaking flasks. Values are relative to a net CO2 uptake rate of 100 (actual 
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uptake rate was estimated as 6.7 mmol/g-DW/h). Median parameter estimates and 95% 
confidence bounds using INCA’s parameter continuation method are shown. Due to suboptimal 
cultivation conditions, we did not perform further confidence interval analysis using fixed 
metabolite pool size or Monto Carlo methods. 
Reaction Mean value LB 95% UB 95% 
G6P <-> G1P 0.0 0.00 0.00 
G1P <-> GLYC 0.0 0.00 0.00 
G6P <-> F6P -0.2 -1.25 0.23 
G6P -> 6PG 0.0 0.00 1.13 
6PG -> RU5P + CO2 0.0 0 1.02 
F6P <-> FBP -37.8 NaN -35.65 
FBP <-> DHAP + GAP -37.8 NaN -35.65 
DHAP <-> GAP -74.3 -75.34 -73.57 
GAP <-> 3PGA -186.7 -189.93 -184.76 
3PGA <-> 2PGA 30.1 29.33 NaN 
2PGA <-> PEP 30.1 30.13 NaN 
PEP <-> PYR 23.4 22.20 24.68 
RU5P <-> X5P -74.1 -75.59 -73.34 
RU5P <-> R5P -35.4 -36.19 -35.06 
RU5P -> RUBP 109.5 107.99 11.52 
RUBP + CO2 -> 3PGA + 3PGA 108.7 107.96 NaN 
X5P <-> GAP + EC2 -74.1 -75.59 -73.34 
F6P <-> E4P + EC2 37.6 37.20 38.32 
S7P <-> R5P + EC2 36.7 36.14 37.27 
F6P <-> GAP + EC3 0.0 -1.06 27.62 
S7P <-> E4P + EC3 0.0 -27.62 1.06 
DHAP + E4P <-> SBP 36.5 11.48 37.55 
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SBP -> S7P 36.5 11.48 37.55 
PYR -> AcCoA + CO2 15.3 14.93 NaN 
OAA + AcCoA -> CIT 2.2 2.20 NaN 
CIT <-> ICIT 2.2 2.20 NaN 
ICIT <-> AKG + CO2 2.2 2.20 NaN 
AKG -> SUC + CO2 0.0 0.00 NaN 
SUC <-> FUM 0.0 0.00 NaN 
FUM <-> MAL 1.4 1.37 NaN 
MAL <-> OAA 1.0 -0.23 2.18 
MAL -> PYR + CO2 1.2 0 2.84 
PEP + CO2 -> OAA 4.6 3.40 6.95 
ICI -> GLX + SUC 0.0 0 0.07 
GLX + AcCoA -> MAL 0.8 0 1.36 
RUBP -> 3PGA + 2PG 0.8 NaN 1.43 
2PG -> GLC 0.8 NaN 1.43 
GLC -> GLX 0.8 NaN 1.43 
GLX + GLX -> GA + CO2 0.0 0.00 0.93 
GA <-> 2PGA 0.0 0 0.93 
0.426*R5P + 4.846*AcCoA + 
0.090*G6P + 0.417*E4P + 
0.580*3PGA + 0.834*PEP + 
3.701*PYR + 1.313*OAA + 
0.868*AKG + 0.175*GAP -> 
Biomass + 0.536*FUM + 
2.142*CO2 
2.5 
 
2.53 
 
2.53 
 
Dilution Parameters    
R5P 0.86 0.77 1.00 
F6P 0.55 0.46 0.65 
3PGA 0.63 0.54 NaN 
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DHAP 0.21 0.10 0.31 
SBP 0.46 0.37 0.53 
FBP 0.52 0.42 0.62 
CIT 0.12 0.00 1 
MAL 0.66 0.00 1 
 
Table S5. Net fluxes and dilution parameters determined by 13C INST-MFA for the 
Synechococcus 7942 photobioreactor model. Values are relative to a net CO2 uptake rate of 
100 (actual uptake rate was estimated as 5.1 mmol/g-DW/h and those absolute mean values are 
reported as well). Median parameter estimates and 95% confidence bounds using INCA’s 
parameter continuation method are shown.  
Reaction Relative mean value Confidence 
Intervals 95% 
Absolute mean 
values 
PS not 
constrained 
G6P <-> G1P 0.0 0.0, 0.0 0.0 
G1P <-> GLYC 0.0 0.0, 0.0 0.0 
G6P <-> F6P -0.6 -9.9, -0.62 -0.04 
G6P -> 6PG 0.0 0.0, 9.3 0.005 
6PG -> RU5P + CO2 0.0 0.0, 9.3 0.005 
F6P <-> FBP -16.3 -24.4, -16.2 -2.0 
FBP <-> DHAP + GAP -16.3 -24.4, -16.2 -2.0 
DHAP <-> GAP -77.3 NaN, -77.2 -4.0 
GAP <-> 3PGA -194.2 NaN, -194.1 -10.1 
3PGA <-> 2PGA 30.5 27.8, 32.3 1.6 
2PGA <-> PEP 30.5 30.5, 32.3 1.6 
PEP <-> PYR 22.2 20.4, NaN 1.2 
RU5P <-> X5P -76.7 NaN, -76.7 -4.0 
RU5P <-> R5P -36.4 NaN, -36.4 -1.9 
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RU5P -> RUBP 113.1 113.0, 123.5 5.9 
RUBP + CO2 -> 3PGA 
+ 3PGA 
113.1 113.0, 123.5 5.9 
X5P <-> GAP + EC2 -76.7 NaN, -76.7 -4.0 
F6P <-> E4P + EC2 38.8 38.8, NaN 2.0 
S7P <-> R5P + EC2 37.9 37.9, NaN 2.0 
F6P <-> GAP + EC3 -23.1 -38.9, NaN -0.1 
S7P <-> E4P + EC3 23.1 NaN, 38.9 0.1 
DHAP + E4P -> SBP 61.0 15.5, 76.9 2.0 
SBP -> S7P 61.0 15.5, 76.9 2.0 
PYR -> AcCoA + CO2 15.1 15.1, NaN 0.8 
OAA + AcCoA -> CIT 2.7 2.6, 4.5 0.2 
CIT <-> ICI 2.7 2.6, 4.5 0.2 
ICIT <-> AKG + CO2 2.7 2.6, 4.5 0.2 
AKG -> SUC + CO2 0.0 0.0, 1.9 0.03 
SUC <-> FUM 0.0 0.0, 1.9 0.03 
FUM <-> MAL 1.7 1.7, 3.6 0.1 
MAL <-> OAA 0.0 -1.8, 1.2 0.1 
MAL -> PYR + CO2 1.7 0.0, 3.7 0.02 
PEP + CO2 -> OAA 6.4 5.0, 8.4 0.3 
ICIT -> GLX + SUC 0.0 0.0, 0.002 0.0 
GLX + AcCoA -> MAL 0.0 0.0, 0.04 0.0 
RUBP -> 3PGA + 2PG 0.0 0.0, 0.3 0.002 
2PG -> GLC 0.0 0.0, 0.3 0.002 
GLC -> GLX 0.0 0.0, 0.3 0.002 
GLX + GLX -> GA + 
CO2 
0.0 0.0, 5.0 0.001 
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GA <-> 2PGA 0.0 0.0, 5.0 0.001 
0.465*R5P + 
3.789*AcCoA + 
0.188*G6P + 
0.275*E4P + 
0.461*3PGA + 
0.550*PEP + 
2.698*PYR + 
1.154*OAA + 
0.805*AKG + 
0.218*GAP -> Biomass 
+ 0.528*FUM + 
1.369*CO2 
3.3 3.3, 3.3 0.17 
Dilution Parameters    
PEP 0.77 0.71, 0.82 0.77 
RuBP 0.64 0.57, 0.70 0.49 
3PGA 0.74 0.70, 0.79 0.72 
S7P 0.57 0.51, 0.63 0.47 
SBP 0.54 0.46, 0.58 0.48 
FBP 0.51 0.44, 0.54 0.49 
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Figure S1  Comparison of CO2 uptake rate measured by gas chromatography 
headspace/chlorophyll a content and estimated from the biomass composition. Total CO2 
was calculated from previously described methods as the sum of the dissolved and gaseous CO2 
in a culture (Xiong et al., 2015). Standard error bars were based on measured standard deviations 
from biomass composition of 5 biological replicates; *represents a p-value of <0.02 using two-
tailed equal variance Student’s t-Test.  
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Figure S2. Synechococcus 2973 metabolites analyzed by LC-MS. A) FBP- the sample was 
extracted by methanol quenching method. 1 e4 represents its intensity (cps). B) FBP- the sample 
was extracted by liquid nitrogen quenching. 4.5 e4 represents its intensity (cps). C) PEP- 
metabolite pool size estimation by extracting a mixture of labeled E. coli and non-labeled 
Synechococcus 2973 cultures. (D-F) are chromatograms of 6PG (6PG standard, 6PG from 
Synechococcus 2973, and 6PG from Synechococcus 2973 Δzwf).  
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Figure S3. A. The reported sum of square of residuals (SSR) for isotopomer fitting of 
individual metabolite from INCA modeling simulations (without adding the pool sizes as 
constraints). The PBR had a smaller SSR (713), while the SF model had much higher SSR 
(981).  
 
 
 
 
 
 
 
 
 
 
 
175 
 
Figure S4. Dynamic labeling patterns from INCA for all metabolites measured using IP-LC-
MS/MS or HILIC-MS for Synechococcus 2973 under PBR conditions.  Experimentally 
measured MIDs with error bars representing standard measurement errors from biological 
duplicates. PGA (185), 6PG (275), PEP (167), G6P (259), R5P (229), S7P (289), SBP (269), SUC 
(118), MAL (134), F6P (259), CIT (192), FBP (339), G1P (259), 2PG (155), are all the metabolites 
listed with their nominal masses of M0 mass isotopomer shown in parentheses.  
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Figure S5. The average percent 13C-enrichment of Citrate, Malate, Succinate, and free 
Glutamate in the photobioreactor conditions for Synechococcus 2973 and Synechococcus 
7942 as a function of time. Average 13C-Enrichment is calculated from experimentally measured 
MIDs where N is the number of carbons, Mi is the MID of the ith isotopomer, average 
13C-
Enrichment is 
1
𝑁
∙  ∑ 𝑀𝑖 ∙ 𝑖
𝑁
𝑖=1  , and error bars represent average standard deviations from biological 
duplicates.   
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Figure S6. Average 13C-enrichment of metabolite intermediates in the CBB cycle and PPP, 
in Synechococcus 2973 and Synechococcus 7942. Average 13C-Enrichment is calculated from 
experimentally measured MIDs where N is the number of carbons, Mi is the MID of the ith 
isotopomer, average 13C-Enrichment is 
1
𝑁
∙  ∑ 𝑀𝑖 ∙ 𝑖
𝑁
𝑖=1  , and error bars represent average standard 
deviations from biological duplicates.   
 
Figure S7. Net fluxes fold changes of Synechococcus 2973 over Synechococcus 7942 net 
fluxes. Fold change was calculated as the normalized net flux of 2973 over the normalized net 
flux of 7942 minus 1. Metabolic pathways and enzymes in the dark blue follow the y-axis scale 
on the left, while metabolic pathways and enzymes in light blue follow the y-axis scale on the 
right.  
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Supporting Photo 1. Multi-cultivator system used to cultivate fast growing cyanobacteria, 
Synechococcus 2973. The system is from Photon Systems Instruments (MC 1000) and uses cool 
white LEDs with adjustable irradiance.  
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10. Appendix 2: Deciphering cyanobacterial 
phenotypes for fast photoautotrophic growth via 
isotopically nonstationary metabolic flux analysis  
 
Doi: 10.1186/s13068-017-0958-y  
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11. Appendix 3: Supporting information for Chapter 3  
 
Supporting Information: Carboxysome mutant reveals influence of enzyme 
compartmentalization on cellular metabolisms and metabolic network rigidity 
 
 
Table S1. Measured succinic acid in the supernatant from cultures harvested during later 
exponential growth at 1% CO2, 125 µmol photons m-2•s-1. A UV-method (Absorbance 340 
nm) was used to measure succinate and A+ media served as a control. 
Strain Succinic acid (mg/L) 
Synechococcus PCC 7002 control  1.7 ± 1.0 
Synechococcus PCC 7002 ∆ccmKLMN  2.8 ± 0.3 
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Figure S1. Labeling dynamics of key metabolites. Percentages of total 13C enrichment are 
shown by red line. 13C enrichment was calculated at 15 minutes using the formula 
1
𝑁
∑ 𝑀𝑖 ∗ 𝑖
𝑁
𝑖=1 , 
where Mi is the mass isotopomer distribution (e.g., M+0, M+1). Standard deviations are based 
on biological replicates (n=2).   
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Figure S2. Comparison of energy-molecule pool size between Synechococcus PCC 7002 
control and ∆ccmKLMN strain. Relative pool size comparisons between the two strains. The 
relative pool size is normalized a 13C-labeled internal standard and optical density. A y-axis of 1 
represents equal metabolite concentrations while a y-axis > 1 indicates the factor of pool size in 
∆ccmKLMN greater than PCC 7002 ctrl.   
 
 
 
Table S2. List of metabolic reactions and carbon transitions for the cyanobacterial 
network.  
Glycolysis and OPP 
G6P (abcdef) <-> F6P (abcdef) 
G6P (abcdef) -> RU5P (bcdef) + CO2 (a) 
F6P (abcdef) <-> FBP (abcdef) 
FBP (abcdef) <-> DHAP (cba) + G3P (def) 
DHAP (abc) <-> G3P (abc) 
G3P (abc) <-> 3PGA (abc) 
3PGA (abc) <-> 2PGA (abc) 
2PGA (abc) <-> PEP (abc) 
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PEP (abc) -> PYR (abc) 
 
Calvin cycle 
RU5P (abcde) <-> X5P (abcde) 
RU5P (abcde) <-> R5P (abcde) 
RU5P (abcde) <-> RUBP (abcde) 
RUBP (abcde) + CO2 (f) -> 3PGA (cde) + 3PGA (fba)  
X5P (abcde) <-> G3P (cde) + EC2 (ab) 
F6P (abcdef) <-> E4P (cdef) + EC2 (ab) 
S7P (abcdefg) <-> R5P (cdefg) + EC2 (ab) 
F6P (abcdef) <-> G3P (def) + EC3 (abc) 
S7P (abcdefg) <-> E4P (defg) + EC3 (abc) 
DHAP (abc) + E4P (defg) -> SBP (cbadefg) 
SBP (abcdefg) -> S7P (abcdefg) 
TCA 
PYR (abc)  -> ACA (bc) + CO2 (a) 
OAA (abcd) + ACA (ef) <-> CIT (dcbfea) 
CIT (abcdef) <-> ICI (abcdef) 
ICI (abcdef) <-> AKG (abcde) + CO2 (f) 
SUC (abcd) <-> FUM (abcd) 
MAL (abcd) <-> OAA (abcd) 
AKG (abcde) -> SUC (bcde) + CO2 (a) 
Amphibolic reactions 
MAL (abcd) -> PYR (abc) + CO2 (d) 
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PEP (abc) + CO2 (d) -> OAA (abcd)  
 
Photorespiration 
RUBP (abcde) -> 3PGA (cde) + 2PG (ba) 
2PG (ab) <-> GOX (ab) 
GOX (ab) + GOX (cd) -> GA (abd) + CO2 (c) 
GA (abc) <-> 2PGA (abc) 
Carbohydrate synthesis  
G6P (abcdef)  <-> G1P(abcdef) 
G1P (abcdef) <-> ADPGLU (abcdef) 
G1P (abcdef) <-> UDPGLU (abcdef) 
ADPGLU (abcdef) -> CARB (abcdef) 
UDPGLU (abcdef) -> CARB (abcdef) 
 
Biomass synthesis  
ccmO 
0.304*R5P + 2.87*ACA + 0.35*E4P + 0.874*3PGA + 0.7*PEP + 3.178*PYR + 
1.158*OAA + 0.86*AKG + 0.218*G3P + 1.247*CARB -> Biomass + 0.423*FUM + 
1.851*CO2 
ctrl 
0.294*R5P + 2.32*ACA + 0.290*E4P + 0.724*3PGA + 0.58*PEP + 2.768*PYR + 
1.028*OAA + 0.8*AKG + 0.218*G3P + 1.273*CARB -> Biomass + 0.388*FUM + 
1.536*CO2 
 
Table S3. Reported flux values for carboxysome-deficient mutant normalized to 100 mmol 
CO2 uptake with 95% confidence intervals.  
REACTION FLUX  LB UB 
G1P <-> ADPG 2.9401  0 3.1172 
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G1P <-> UDPG 0.1771  0 3.1172 
ADPG -> CARB 2.9401  0 3.1172 
UDPG -> CARB 0.1771  0 3.1172 
G6P <-> G1P 3.1172  3.1172 3.1172 
G6P <-> F6P -3.1358  -3.8582 -3.1358 
G6P -> 6PG 0.0186  0.0186 0.741 
6PG -> RU5P + CO2 0.0186  0.0186 0.741 
F6P <-> FBP -81.5917  -82.4334 -78.8007 
FBP <-> DHAP + G3P -81.5917  -82.4334 -78.8007 
DHAP <-> G3P -82.5157  -83.6758 -80.1135 
G3P <-> 3PGA -205.704  -208.223 -202.561 
3PGA <-> 2PGA 20.2565  19.9989 21.3306 
2PGA <-> PEP 24.0751  24.0751 24.8792 
PEP <-> PYR 17.2682  12.5943 17.9652 
RU5P <-> X5P -79.3798  -80.2052 -77.009 
RU5P <-> R5P -38.4925  -38.9052 -37.3071 
RU5P -> RUBP 117.891  114.2738 119.1046 
RUBP + CO2 -> 3PGA + 
3PGA  
110.2539  109.6525 112.2565 
X5P <-> G3P + EC2 -79.3798  -80.2052 -77.009 
F6P <-> E4P + EC2 40.1274  38.942 40.54 
S7P <-> R5P + EC2 39.2525  38.0671 39.6651 
F6P <-> G3P + EC3 38.3285  36.8091 38.7149 
S7P <-> E4P + EC3 -38.3285  -38.7149 -36.8091 
DHAP + E4P -> SBP 0.924  0.6991 1.3489 
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SBP -> S7P 0.924  0.6991 1.3489 
PYR -> ACA + CO2 12.454  9.324 12.454 
OAA + ACA -> CIT 2.1498  2.1498 2.9538 
CIT <-> ICI 2.1498  2.1498 2.9538 
ICI <-> AKG + CO2 2.1498  2.1498 2.9538 
AKG -> SUC + CO2 1.00E-07  2.49E-14 0.8041 
SUC <-> FUM -1.0700  -1.0700 -0.2659 
MAL <-> OAA -4.1732  -4.1732 2.78E-05 
OAA <-> FUM 0.0126  -0.7915 0.0126 
MAL -> PYR + CO2 4.1732  2.78E-05 4.1732 
PEP + CO2 -> OAA  5.0571  NaN 9.2303 
RUBP -> 3PGA + 2PG 7.6371  5.456 8.1179 
2PG -> GOX 7.6371  5.456 8.1179 
GOX + GOX + -> GA + 
CO2 
3.8186  2.728 4.059 
GA <-> 2PGA 3.8186  2.728 4.059 
MAL ACTIVE POOL 
% 
55.3376  49.4393 61.2363 
G1P ACTIVE POOL % 96.0571  93.976 99.152 
G3P ACTIVE POOL % 86.0372  83.7826 87.624 
RUBP ACTIVE POOL 
% 
73.3102  23.3224 29.9672 
ADPG ACTIVE POOL 
% 
80.8518  77.3005 84.5299 
2PG ACTIVE POOL % 38.2508  33.3206 42.933 
S7P ACTIVE POOL % 99.4983  98.227 100 
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CIT ACTIVE POOL % 49.8401  45.6888 52.906 
AKG ACTIVE POOL 
% 
37.4669  31.2021 45.7623 
DHAP ACTIVE POOL 
% 
96.8664  96.0636 97.3956 
BIOMASS 2.4997  2.4997 2.4997 
 
Table S4. Reported flux values for the PCC 7002 control strain normalized to 100 mmol 
CO2 uptake with 95% confidence intervals.   
REACTION FLUX  LB UB 
G1P <-> ADPG 3.2956  0 3.2956 
G1P <-> UDPG 0.0102  0 3.2956 
ADPG -> CARB 3.2956  0 3.2956 
UDPG -> CARB 0.0102  0 3.2956 
G6P <-> G1P 3.3058  3.3058 3.3058 
G6P <-> F6P -3.3109  -4.4113 -3.3109 
G6P -> 6PG 0.0051  0.0000 0.8005 
6PG -> RU5P + CO2 0.0051  0.0000 0.8005 
F6P <-> FBP -80.3426  -96.0094 68.2221 
FBP <-> DHAP + G3P -80.3426  -96.0094 68.2221 
DHAP <-> G3P -80.9157  -81.9816 -80.8641 
G3P <-> 3PGA -210.805  -210.8050 -203.8840 
3PGA <-> 2PGA 23.3265  19.8311 24.8898 
2PGA <-> PEP 26.4518  23.0811 26.7398 
PEP <-> PYR 17.1981  5.4974 18.4974 
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RU5P <-> X5P -73.0284  -78.2532 -72.3706 
RU5P <-> R5P -35.3217  -37.9401 -35.3217 
RU5P -> RUBP 119.525  119.5250 119.7250 
RUBP + CO2 -> 3PGA + 
3PGA  
113.0252  113.0252 113.2107 
X5P <-> G3P + EC2 -73.8284  -78.3706 -73.8284 
F6P <-> E4P + EC2 36.9499  36.5379 39.5966 
S7P <-> R5P + EC2 36.0785  36.0785 38.7740 
F6P <-> G3P + EC3 36.9499  33.0022 NaN 
S7P <-> E4P + EC3 -36.9499  NaN 33.0022 
DHAP + E4P -> SBP 3.0763  NaN 6.0763 
SBP -> S7P 3.0763  NaN 6.0763 
PYR -> ACA + CO2 12.396  8.8499 13.9086 
OAA + ACA -> CIT 2.1411  2.0693 2.3279 
CIT <-> ICI 2.1411  2.0693 2.3279 
ICI <-> AKG + CO2 2.1411  2.0693 2.3279 
AKG -> SUC + CO2 1.00E-07  0 0.0587 
SUC <-> FUM -0.6500  -0.6500 -0.5913 
MAL <-> OAA -3.0165  -3.4086           -2.7356 
OAA <-> FUM -0.4506  -0.5093 -0.4506 
MAL -> PYR + CO2 3.0165             -3.4086           -2.7356 
PEP + CO2 -> OAA  6.0891               6.0055 6.1636 
RUBP -> 3PGA + 2PG 6.5123  0 8.1206 
2PG -> GOX 6.5123  0 8.1206 
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GOX + GOX + -> GA + 
CO2 
3.2562  0 4.0603 
GA <-> 2PGA 3.2562  0 4.0603 
MAL ACTIVE POOL 
% 
73.9178  71.9027 74.6608 
G1P ACTIVE POOL % 99.0018  98.9600 100 
G3P ACTIVE POOL % 66.1728  64.9492 68.3012 
RUBP ACTIVE POOL 
% 
89.5316  89.2329 91.0861 
ADPG ACTIVE POOL 
% 
65.2371  63.9442 67.0693 
2PG ACTIVE POOL % 40.6058  37.3491 NaN 
S7P ACTIVE POOL % 97.6785  93.8407 96.558 
CIT ACTIVE POOL % 47.2332  45.6201 48.3448 
AKG ACTIVE POOL 
% 
100.000  86.9059 100 
DHAP ACTIVE POOL 
% 
81.0967  79.8689 83.1862 
BIOMASS 2.8365  2.8365 2.8365 
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12. Appendix 4: Supporting information for Chapter 4  
 
Supporting Information: Metabolic engineering of cyanobacteria 
 For photoautotrophic production of heparosan,  
a pharmaceutical precursor for heparin 
 
 
Figure S1: cugP gene from PCC 6803 synthesizes enzyme UTP-glucose-1-phosphate 
uridyltransferase possessing NTP_transferase domain. It displays 99% sequence similarity with 
mannose-1-phosphate guanyltransferase from the same strain which is principally involved with 
synthesis of GDP-mannose (KEGG REACTION R00885).  
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Figure S2: Pair-wise sequence alignment of mannose-1-phosphate guanyltransferases from PCC 
6803 and PCC 7942 exhibited 79% sequence similarities with e-value of 0.0. 
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13. Appendix 5: Channeling in native microbial 
pathways: Implications and challenges for metabolic 
engineering  
Doi: 10.1016/j.biotechadv.2017.06.004 
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14. Appendix 6: Supporting information for Chapter 6 
 
Supporting Information: Comparative studies of glycolytic pathways and 
channeling under in vitro and in vivo modes 
 
 
 
Figure S1. Total 13C Enrichment (fractional abundance) as a function of time following a 
13C6 glucose pulse in wild-type E. coli K-12 and ∆ptsG and ∆ptsG + ED mutants.  Total 13C 
Enrichment is calculated as 1/N * ∑ Mi*i, where N is the number of carbons in the metabolite 
and Mi is the fractional abundance of the ith isotopomer.  
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Figure S2. Fractional abundance of mass isotopomers M+0 – M+5 for PEP, CIT, aKG, and 
MAL (30 seconds after U-13C glucose pulse in wild-type E. coli K-12 and ∆ptsG and 
∆ptsG+ED mutants). Predicted labeling patterns are predicted where L in AcCoA represents the 
labeled or active pool of AcCoA, U in AcCoA represents the unlabeled or inactive pool of 
AcCoA, and A represents the labeled OAA pool from anapleuortic pathways. Important enzymes 
are listed by gene names in the pathway in purple.   
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Figure S3. NAD(P)H formation as a measure of absorbance340 nm with EMP enzymes (100 
nM) in various crowding agents.  
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Table S1. E. coli strains used in this study. 
Strains Description JBEI ICE code Source 
BW25113 WT Keio collection WT 
(∆lacZ4787::rrnB3 
hsdR514∆araD-
B567∆rhaD-B568 rph-1) 
- (Baba et al., 2006) 
WH03 BW25113 + pED (derived 
from pBbE5c-YFP with 
gene replaced by edd and 
eda) 
JBEI-11465 (Hollinshead et al., 2016) 
∆ptsG Keio collection strain 
JW1087-2 
(∆lacZ4787::rrnB3 
hsdR514∆araD-
B567∆rhaD-B568 rph-
1∆ptsG763::kan) 
- (Baba et al., 2006) 
WH05 BW25113 ∆ptsG + pED - This study  
 
Table S2. Purified proteins used in this study. 
Name Description Source organism Reference 
Glk Glucokinase Escherichia coli BL21 (Liu et al., 2017)  
Pgi Phosphoglucose isomerase Escherichia coli BL21 (Liu et al., 2017)  
PfkA 6-phosphofructokinase I Escherichia coli BL21 (Liu et al., 2017)  
PfkB 6-phosphofructokinase II Escherichia coli BL21 (Liu et al., 2017)  
FbaA Fructose-
bisphosphate aldolase class II 
Escherichia coli BL21 (Liu et al., 2017)  
FbaB Fructose-
bisphosphate aldolase class I 
Escherichia coli BL21 (Liu et al., 2017)  
TpiA Triosephosphate isomerase Escherichia coli BL21 (Liu et al., 2017)  
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GapA NAD+-dependent glyceraldehyde 3-
phosphate dehydrogenase 
Escherichia coli BL21 (Liu et al., 2017)  
Pgk Phosphoglycerate kinase Escherichia coli BL21 (Liu et al., 2017)  
GpmA Phosphoglycerate mutase I Escherichia coli BL21 (Liu et al., 2017)  
GpmM Phosphoglycerate mutase II Escherichia coli BL21 (Liu et al., 2017)  
Eno Enolase Escherichia coli BL21 (Liu et al., 2017)  
PykF pyruvate kinase I Escherichia coli BL21 (Liu et al., 2017)  
PykA pyruvate kinase II Escherichia coli BL21 (Liu et al., 2017)  
Zwf Glucose-6-phosphate-1-
dehydrogenase 
Escherichia coli BL21 (Liu et al., 2017)  
Pgl 6-phosphogluconolactonase Escherichia coli BL21 (Liu et al., 2017)  
Edd 6-phosphogluconate dehydratase Escherichia coli BL21 This study  
Eda 2-keto-3-deoxy-6-phosphogluconate 
(KDPG) aldolase 
Escherichia coli BL21 This study 
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15. Appendix 7: Comparing studies of glycolytic 
pathways and channeling under in vitro and in vivo 
modes 
 
Doi: 10.1002/aic.16367 
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